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SUMMARY
Until two decades ago the fate and function of lymphocytes
were largely unknown. The discovery that these cells
were long-lived, showed unique mobility in migrating from
the blood into the specialized lymphatic tissue of lymph
nodes and spleen and repeatedly returning to the blood,
and were immunologically competent, provided the basic
answers to these questions. However, many aspects of the
mechanisms involved in the initiation and propagation of
immune reactions remained unclear. In particular it was
not known to what extent lymphocytes entered other tissues
and how, if at all, this behaviour was altered in sites of
inflammation. It might be expected that immunologically
active cells would enter non-lymphoid tissues as many
immune reactions are implemented at least in part in these
peripheral sites; also direct examination of afferent
lymph draining non-lymphoid tissue has detected some
lymphocyte traffic. The studies reported here were
designed to provide quantitative estimates of lymphocyte
migration into non-lymphoid tissues under normal and
pathological conditions and attempts were made to define
the kinetics of this flow of cells and to investigate some
aspects of the control mechanisms that may regulate it.
To this end the basic techniques of marking rat thoracic
duct lymphocytes and tracing their distribution in
syngeneic recipients, that allowed Gowans and his
colleagues to establish the concept of the recirculating
/•
pool of small lymphocytes, were used. Critical evaluation
of different labelling methods was essential, as great
sensitivity was required in order to detect accurately the
small concentrations of labelled cells expected in non-
lymphoid tissues.
Radioisotopic labelling of lymphocytes would allow
estimation of their tissue distribution after iv transfer
by assay of total tissue radioactivity provided the label
remained attached to the cells and these cells were extra-
vascular. The contamination duct to intravascular
labelled cells was minimized by perfusing a large volume
of saline through the whole circulatory system before
sampling the tissues. An indirect measure of the extent
of loss of isotope from the injected cells was made by
assaying the activity in many compartments particularly
those free from cells such as plasma, urine and the
perfusion washout fluid. Examination of the latter also
provided information about widespread contamination of
tissues by freely diffusible isotopes and was important in
assessing the usefulness of particular labelling compounds
for the purpose of tracing lymphocytes to areas of low
cell concentration.
A comparison of the distribution of activity after labell¬
ing lymphocytes with many isotopes showed serious limit¬
ations in the use of some 'labels' but suggested that the
results obtained using ^Cr were most likely to provide
realistic estimates of labelled cell content of tissues.
Ranges for lymphocyte cell content and flux (10^ - 10~*
lymphocytes/gm/hr) in non-lymphoid tissues were derived
from kinetic distribution studies using multiple recip¬
ients of the same labelled cell population and examining
groups of recipients at intervals after cell transfer.
The estimates were in the same range as those derived from
data on afferent lymph cellular flow obtained by direct
measurements in other species such as sheep and pigs. The
time taken for labelled cells to traverse non-lymphoid
tissues while not measurable precisely was probably shorter
than that taken to enter and leave either spleen (5-6 hrs)
or lymph nodes (l8 hrs).
Migration of lymphoc
skin was found to be
time remained rapid.
ytes into inflammatory lesions in the
increased and usually the transit
Exposure of lymphocytes to a low
dose of trypsin in vitro drastically reduces their
efficient migration into lymph nodes: it was found that
such treated cells also failed to migrate in increased
numbers into lesions in the skin but entry into normal
tissues was unaffected. It was suggested that in both
lymph nodes and cell-mediated immune lesions the enzyme
treatment in some way interfered with the lymphocyte-
endothelial cell interaction; this implied there was a
change in the inflamed venular endothelium that allowed a
more efficient clearance of lymphocytes from the blood.
It was further suggested that the highly specialized
function of lymph node post-capillary venular endothelium
that is associated with a morphological specialization may
be an adaptation of a temporary functional change that
occurs in venular endothelium in cell-mediated immune
lesions because this latter type of lesion is widespread
even in invertebrate animals but lymph nodes are very
recent developments in phylogenetic terms.
Using the same techniques of following labelled cells
supplemented by autoradiography of recipients' tissues the
migration of thoracic duct lymphocytes to the 'primary'
lymphoid organs was studied. The thymus and bone marrow
are both sites of very active lymphocytopoiesis which is
mainly independent of antigenic stimulation. Both have
been regarded as insignificant compartments of the
recirculating lymphocyte pool. However, the thymus was
found to contain a greater concentration of radioactivity
than all other non-lymphoid tissues except liver and kidney
and contained approximately 0.1% of the total recirculat¬
ing pool at equilibrium. The kinetic distribution curve
was similar to that for lymph nodes suggesting a modal
transit time of at least eighteen hours. Autoradiography
showed that the migrating cells were limited to the thymic
medulla.
The bone marrow was
an injected 'bolus'




were extravascular and later returned to the blood some¬
what more rapidly than the lymphocytes that entered the
spleen. The existence and size of this migration pathway
was confirmed using a functional indicator of lymphocytes
and the capability of the bone marrow to act as a
'secondary' lymphoid organ was examined. It was shown
that this tissue could concentrate particulate antigen
from the blood, and support antigen-induced transformation
and proliferation of lymphocytes and these findings taken
with the high flux of immunocompetent lymphocytes suggested
that this organ could function in the initiation and




Lymphocytes have been defined by several criteria. By
morphology under the light microscope mammalian lympho¬
cytes are mostly round cells of less than eight microns
diameter with a round nucleus and a thin rim of cytoplasm.
Such cells are the main cellular constituent of lymph in
the major lymphatic ducts and are also present in high
concentrations in lymph nodes and the white pulp of the
spleen. The thymus contains large numbers of these cells
which can also be found in discreet aggregations in the
gut-associated lymphoid tissues and similar structures in
other parts of the body such as the nodules found in a
subepithelial position at intervals along the bronchi. The
blood contains significant numbers of lymphocytes as does
the bone marrow. In addition cells with lymphocyte morph¬
ology can be identified in low concentration scattered
through most tissues and more concentrated aggregates
occur in chronic inflammatory lesions such as the
granulomata of tuberculosis.
Since the demonstration that lymphocytes have an immuno¬
logical function and are essential for the development of
specific activity to antigens by either a humoral response
- ie the production of antibody molecules - or a cell
mediated response as in delayed type hypersensitivity or
homograft rejection, much work has been carried out to
determine the precise mechanisms involved in such reactions
This together with studies investigating the origin and
fate of lymphocytes has given rise to some generally
accepted notions about the role of lymphocytes in immune
responses.
This simplified summary of these ideas does not include a
comprehensive review of the evidence that has been produced
for each point.
In the mammal and particularly in rodents in which most of
this work has been done, lymphocytes are produced by
division and maturation of haemopoietic pluripotent stem
cells (Micklem et al 1966). In the embryo this occurs in
the yolk sac blood islands, in the foetus in the liver and
splenic red pulp, and in the adult mainly in the bone
marrow. Such immature lymphocytes comprise at least two
populations, one of which migrates and undergoes further
maturation and division in the thymus to give rise to T
cells (Miller 1966, Wolstenhdme & Porter rev.1966), while
the other undergoes maturation without thymic influence to
B cells. In birds such as the chicken this latter matur¬
ation is under the influence of the Bursa of Fabricius
(Chang et al 1955) , but in rodents mainly occurs in the
liver of the foetus (Owen et al 1974) and in the bone
marrow of adults (Osmond & Nossal 1974 a & b) although
this latter micro-environment is not essential (Kincade et
al 1975, Rozing et al 1976). There are therefore at least
two populations of lymphocytes both of which are believed
to contain cells that have specific receptors for
particular antigens (Hammerling & McDevitt 1976, Makela
1970).
The blood lymphocyte content remains remarkably constant
despite the entry of enough cells into this compartment
both from the major lymphatic ducts and by new cell
production in the primary lymphoid organs - bone marrow
and thymus (Everett et al 1964) to replace the total blood
population several times each day (Mann & Higgins 1950;
rev.Yoffey & Courtice 1956).
This posed the question of the fate of blood lymphocytes.
The use of radioisotopes allowed rigorous proof of the
idea already suggested by circumstantial evidence that many
lymphocytes were long-lived and continuously recirculated
in high numbers between the blood and secondary lymphoid
organs - the lymph nodes and spleen (Gowans 1957 a & b,
1958j 1959; Gowans & Knight 1964; Everett et al 1964) •
It has also been suggested that most if not all long-lived
recirculating lymphocytes have been derived by clonal
expansion of lymphocytes that have reacted specifically
with antigen (Greaves et al rev.l9743 Sprent rev.1977).
'Virgin' B lymphocytes at least, which are competent to
react to antigen, but have not yet done so probably have a
short life span in the absence of such specific interaction
and are thus part of a population that is being replaced
continuously (Strober 1970). The distribution and fate of
such cells is less clear. However the important points
that emerge are that lymphocytes are highly motile cells
that have the ability to bind and react with antigen.
These properties must be correlated with the ability of
the animal to react immunologically to an antigenic
stimulus. Most natural external antigens gain access to
the body across the skin or alimentary or respiratory
epithelium rather than by direct invasion of the blood or
secondary lymphoid organs yet it has been amply proved
that these latter organs are important in the development
of immune responses. The response may result in the
production of effector function that in turn results in
inflammation at the peripheral site of antigen entry.
Although antibody molecules could be distributed from
lymph nodes or spleen to the periphery without movement of
cells the latter is obligatory for the development of cell
mediated immune reactions. The initial sensitization of
the animal to antigen could depend entirely upon movement
of antigen to the secondary lymphoid organs and although
such movement is known to occur it has also been shown that
sensitization of lymphocytes can occur at the periphery
(Macher & Chase 1969, de Sousa & Parrott 1969). In fact
it is likely that this must be so as lymph nodes are phylo-
genetically recent and animals that have no such structures
produce effective immune responses.
8
There is thus strong circumstantial evidence to suggest
that lymphocytes migrate through all tissues in order to
permit senzitization and effector functions. Direct
evidence of such migration has been obtained by draining
the contents of afferent lymphatic vessels in large animals
where such procedures are feasible. In the sheep, for
example, the cell output from such vessels was very much
lower than that of efferent lymphatics (Smith et al 1970a)
confirming the idea that most of the efferent duct cell
content was derived directly from the blood within the
lymph nodes but this large discrepancy in total cell
output figures has tended to de-emphasize the possible
functional importance of the blood - afferent lymphatic -
lymph node migration pathway.
In simplified terms the immune response can be considered
as a reflex arc initiated by an antigenic stimulus applied
at the periphery. There follows a complex interaction
between antigen, both T and B lymphocytes and macrophages
all of which can be mobile. The secondary lymphoid organs
provide the most efficient site for this interaction which
has many similarities to a synaptic junction including
both suppressive influences and a memory factor supplied
by the high volume lymphocyte flux using the direct blood-
. lymph node or spleen pathway of recirculation. The blood
distributes the effector function either as cells or anti¬
body or both to all tissues including the original site of
antigen entry and allows an inflammatory response to
develop which in general is appropriate in time and situation.
The aim of this project was therefore to attempt to quant¬
ify the migratory flux of lymphocytes through non-lymphoid
tissues under both normal and pathological conditions in
order to gain insight into the relative importance of this
migratory route and also to look for factors involved in
the control of inflammatory lesions which involve lymphocytes.
The results to be described also throw some light on the
extent of lymphocyte migration through the primary lymphoid
organs and suggest that these organs, as well as being
sites of antigen-independent lymphopoiesis, also have some
of the functions which have been conceived to be exclusive
to secondary lymphoid organs.
The hypothesis of the recirculating lymphocyte pool arose
from the work on the migration of small lymphocytes mainly
through the lymph nodes (Gowans 1959) and spleen (Ford
1969a). This pool comprises a multicompartmental system
with interchange of lymphocytes between some of the
compartments at varying rates. This type of model can be
studied by standard tracer techniques and the kinetics of
distribution between the compartments can be determined if
marked members of the mobile population are introduced into
one compartment and other compartments are sampled after
various time intervals. Interpretation of this type of
data is valid if the mobile population is homogeneous and
its constituent members act independently.
As far as lymphocytes are concerned this requires some
method of identification of cells introduced into an
animal which must also accept the 'marked cells' as normal.
Available markers for isogeneic or syngeneic lymphocytes
vary in their suitability for different purposes. Chromo¬
some abberations that are not lethal or toxic allow 'normal'
cells or their descendants to be followed for long periods
provided that preparations of dividing cells are available
to allow identification. Functional and antigenic markers
allow the study of sub-populations of cells that may not
be morphologically identifiable. Radioactive isotopes can
allow positive identification of labelled cells in auto¬
radiographic preparations of tissue sections and within
limitations can also allow indirect scoring of cells in
tissues by measurement of total tissue radioactivity.
For this project a compromise between purity of cell type
in the population under study, known physiological migra¬
tory capacity and ease of availability of large numbers of
lymphocytes was achieved by using thoracic duct lympho-
cytes (TDL) obtained from inbred strains of rats. For most
of the work such cells were labelled with various radio¬
active isotopes and introduced into the blood of syngeneic
recipients which were examined after various time intervals
I
CHAPTER TWO
General Materials and Methods
1 Cell suspension media, fluids for injection, etc.
(i) PBS Dulbecco's phosphate buffered saline
(Oxoid, Code BR 14a)
Tablets dissolved in distilled water
and solution autoclaved and then
stored at 4°C.
(ii) DAB Dulbecco1s sterile PBS with added
mineral salts (Ox_oid, Code SR 39a).
Stored at 4°C.
(iii) DAB- l) DAB with added Heparin (Evans Medical
DAB-20) Q . . . i rn W -r • tSpeke, Liverpool, GB) to a final
dilution of 1 or 20 units/ml.
(iv) RPM1- Cell culture medium Rosewell Park
I64O Memorial Institute I64O with added
L Glutamine (Gibco-Biocult, Irvine,
Scotland) stored sterile at 4°C.
(v) FCS Foetal calf serum (Gibco-Biocult,
Irvine, Scotland). Sterile aliquots
of 10ml stored at -20°C. Thawed
before use.
(vi) Ficoll Pharmacia Fine Chemicals, Upsalla,
Sweden. 14% in distilled H^O.
(vii) Hypaque 45% Sodium diatrozoate (Winthrop Labs
Surbiton, GB).
(viii) EDTA Ethylenediaminetetraacetic acid.Eithe
di- or tetra- sodium salts.
(BDH, Poole, GB).
2 Animals
Several strains of closely inbred rats bred and main¬
tained in the departmental colony were used. hybrids
between some of the inbred strains were also used. For
individual experiments animals of similar weight but
either sex were used and cell transfer was between
syngeneic donors and recipients unless otherwise stated.
TABLE 2.1
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AO on PVG/c background congenic strain.
3 Surgical Procedures
(i ) Thoracic Duct Cannulation
The method used was that described by Ford & Hunt
(Handbook of Experimental Immunology 2nd ed.1972,
Ed.Weir), which is Gowans' modification of the
technique originally described by Bollman et. al.
(1948). The plastic cannula (PP50 Portex Ltd)
was preformed by mild heat and filled before
insertion with DAB-20 to help prevent clotting
while lymph flow was being established.
Cannulated rats were maintained in barred restrain¬
ing cages (Bollman 1948). An intravenous infusion
was administered via a plastic cannula and hubless
23g needle inserted into a lateral tail vein and
held in place with adhesive tape which also served
to splint the tail. After an initial dose of 1.0ml
of DAB-20, DAB-1 was infused at 2-3ml/hr via a
roller pump.
Lymph was collected into sterile 100ml glass
conical flasks containing 5ml of DAB-20 as anti¬
coagulant. The flasks were kept on ice and
collections of up to 16 hrs were made before
renewing the flask.
(ii) Cell Injections
All injections were carried out under light ether
anaesthesia. Intravenous (iv) injections of cell
suspensions in PBS, DAB or RPMI-I64O were into a
lateral tail vein via a 23g or 25g needle. Up to
2ml was routinely injected over a few seconds with
no adverse effect on any recipient.
(iii) Whole Body Perfusion
This technique was developed in an attempt to
remove most intravascular cells from the body. It
also yielded important information relating to
the distribution of cell-free radioactivity with
some of the radioisotopes.
The recipient was placed under deep ether anaes¬
thesia and a cardiac blood sample was obtained
(usually 5ml) via a 21g needle introduced through
the diaphragm into the apex of the heart.
Immediately afterwards the rat's neck was dis¬
located and the chest opened so that the sternum
was separated from the ribs on either side,
reflected upon the sternomanubrial joint and
pinned to the cork dissecting board. The thymus
was dissected free of the major vessels in the
mediastinum and a linen suture was passed around
the ascending aorta. A plastic cannula (PP90
Portex Ltd) filled with DAB-20 was then inserted
through the apex of the left ventricle into the
root of the aorta where it was secured by the
ligature. This procedure was carried out as fast
as possible to minimize vascular reactions to the
inevitable anoxia.
A large volume of saline was then introduced into
the arterial circulation after the inferior vena
cava in the thorax and the right and left atria
had been severed to allow escape of the perfusate
into the thoracic cavity. The perfusate fluid
was collected by means of a suction pump. The
perfusion was done by gravity feed or by syringe
and routinely 250ml of DAB-20 and PBS was intro¬
duced over about ten minutes. The effluent
perfusate though frankly bloody to begin with
very rapidly became clear and most perfused
tissues became obviously blanched. Patchy
perfusion was often encountered in the kidneys
especially if any delay was present during the
establishment of perfusion. This was presumed to
be due to vascular spasm.
The lungs were perfused directly via a cannula
introduced through the right ventricle into the
pulmonary artery though this was technically more
difficult than for the aorta. Because it was
almost impossible to suture the cannula in place
without tearing the pulmonary artery, the cannula
was held in place for a short time with forceps
and the perfusion prolonged just enough to effect
maximum blanching of the lungs. There was usually
a small degree of patchy petechial haemorrhage in
these organs.
For tissue fixation after preliminary perfusion
with DAB-20, 1% Gluteraldehyde was introduced into
the arterial circulation resulting in marked
muscle spasm and rapid fixation of most tissues.
Cell Preparation and Counting
Routine counts of thoracic duct cells were made in a
Coulter Electronic Particle Counter with suitable
dilutions of lymph or cell suspensions in Isoton
diluent. The threshold was set to avoid counting the
few contaminating erythrocytes which have significantly
smaller cell volume. For peripheral blood the diluted
suspension was treated with Zaponin and counted in the
Coulter counter or after treatment with acetic acid and
either Leishman or Toluidine Blue stain, counts were
made in Neubauer improved haemocytometer chambers
viewed with transmitted light with x 10 or x 25 object¬
ive lenses.
Viability of lymphocyte suspensions was assessed by
counting the proportion of cells that successfully
excluded 0.2% Trypan Blue at room temperature over a
period of 5 minutes.
5 Dissection
Weighed carcasses were carefully dissected and individ¬
ual organs were separated cleanly from adjacent
structures, removed, weighed and processed. Heparinized
blood samples were divided; 2.0ml were diluted with
8.0ml PBS and layered on 3•0ml of Ficoll (67ml 14%) /
Hypaque (20ml 45%) mixture, centrifuged at 1200g for
30 mins at 15°C and the interface layer collected for
assay of blood leukocytes. A further 2.0ml was centri¬
fuged at 1500g for 10 mins to obtain plasma.
6 Histology
(i) Fixatives
a Cacodylate Buffered Glutaraldehyde 1%
a




30mlBuffer (Sodium cacodylate 42.8g (0.2M)
1 N HC1 6.9ml, distilled water
to 1000ml)
This was used for all perfusion fixation and
also for post-perfusion immersion fixation.
b Neutral Formal Saline was used as an alternative
immersion fixative for non-perfused tissues.
(ii) Processing and Tissue Sectioning
Fixed tissues were processed for paraffin embedding
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and microtomy by standard procedures, and sections
were cut at 5u and either stained with Haema-
toxylin and Eosin or 'dipped' for autoradiography.
Occasional tissues were examined after cutting
sections of tissue, frozen with solid CO2, in a
freezing microtome at -20°C.
7 Radio Assay
(i) Autoradiography
Dewaxed slides or washed smears were dipped in
freshly prepared emulsion warmed to 42°C in the
dark. The^,emulsion was Ilford G5 diluted 2:1
with distilled water with addition of glycerol to
give a final concentration of . The dipped
slides were allowed to dry in air after placing
on draining racks at an angle of about 60°. When
absolutely dry the slides were placed in light-
tight plastic boxes (Clay-Adams Inc) at 4°C to
allow exposure. After exposure for usually 2-6
weeks the emulsion was developed with Kodak D-19
developer for 5-10 minutes at 20°C in total dark¬
ness. After rapid and thorough rinsing the
emulsion was fixed with Kodak 'Metafix' for 10
minutes and then washed again.
Sections were stained through the emulsion with
either Methyl Green and Pyronin or Haematoxylin
and Eosin.
(ii) Assay of ft-radioactivity by Liquid Scintillation
Counting
The method described by Ford & Hunt (Handbook of
Immunology Ch.23, 2nd ed.l973> Ed.D M Weir) was
used with one important modification. The use of
Hydrogen Peroxide (100 vols) to bleach pigment in
the digested samples and therefore reduce colour
quenching was found to cause spurious counts in
O
the low energy range (narrow H window),
particularly when clear fluids were examined.
A series of experiments showed that these arte-
factual counts were due to the presumably
following chemiluminescence of nascent oxygen
from unreacted ^2^2' Several methods of attempt¬
ing to remove excess (incubation at 50°C for
2 hrs, addition of the enzyme catalase, shaking
and prolonging the interval between addition of
and the scintillant mixture) were only
partially successful and the most efficient method
was found to be the addition of 2% normal rat
erythrocytes to the sodium hydroxide used for the
original digestion of all samples except those
already heavily contaminated with blood. This
Cv
allowed maintenance of a standard treatment for
all samples.
Table 2.2 shows data extracted from an experiment
in which samples of non-active and tritium cont¬
aining fluids were treated with digestion, with
and without and compared with the same fluids
counted without any treatment except the addition
of scintillant. The was added 48 hrs before
the scintillant and the vials were then allowed
to stand for 12 hrs before counting. Counts per
minute over 10 mins for each sample were then
measured at 12 hr intervals for 4 days for both
3
Narrow and Broad H channels. The external
standards ratio (ESR) value gives a measure of
the quenching for each sample and as usual this
value falls slightly with time for all samples.
It is clear that the samples with added but
no means of reacting it produce a large excess of
counts and that the major proportion of such
3
counts is in the Narrow H range, whereas true
background counts are distributed with approx-
3 3
imately half in the Narrow H range, and true H
counts with approximately two thirds in this range.
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Counting was done in a Beckman LS 250 dual
channel system with automatic quench correction
and external standard ratio facilities which
allowed simultaneous counting of and where
necessary. Disintegrations/min were calculated
from counts/min with reference to calibration
coefficients and degree of spillover between
channels.
(iii) Assay of V~radioactivity with deep-well ^
scintillation spectrometer
Weighed tissue or fluid samples were assayed
without processing in capped plastic tubes in an
LKB (Wallac) Ultragamma 1250 dual channel ^ ray
spectrometer with a 2 x 2" thallium-activated
sodium iodide crystal. Pulse height analyser
facilities for each channel and automatic
comparison of counts in each channel with refer¬
ence samples allowed discrimination between
isotopes when necessary. Counts/min were not
converted to dpm for Y emitters but were related
to a standard sample for each experiment.
Counts of both ^ and Y activity were accumulated
to give a standard deviation (SD) about the mean
count rate of under 10% and in most cases well
below 1%. Count rates less than 2 SO above mean
background levels were discarded.
CHAPTER THREE
A Comparison of Radioisotopic Cell Markers for
Studying Lymphocyte Migration in vivo
Introduction
General considerations of using tracer methods for invest¬
igating cell migration have been discussed in the General
Introduction. The choice of a marker depends on the
particular purpose for which it is intended. Low energy
^-emitting radionuclides are preferable for high
resolution autoradiography. However, y-emitters have the
advantage of being detectable at greater distances from
their source and therefore they avoid the necessity of
complex digestion and counting procedures.
The ideal label for cell marking is one which is efficient
ly taken up and bound to intracellular constituents with¬
out being toxic or disturbing the normal function of the
cell. It should also be readily detectable and remain
with the cell as long as the latter is alive. Such a com¬
pound does not exist and thus compromises must be made
according to particular circumstances.
For the study of lymphocyte migration, particularly to
non-lymphoid tissues where total tissue radioactivity
should reflect viable cell content - ie the indirect
scoring of cells - the most important feature about a
marker is that any label that is not associated with cells
should not contaminate the tissues. Thus a degree of
elution from the labelled cells could be tolerated if such
free label was rapidly excreted rather than re-utilized.
This type of factor is much less critical in situations
where direct scoring of marked cells is feasible - eg
chromosome or autoradiographic analysis of cells in smears
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where the scoring of cells as labelled depends on a
positive association of cell and marker so that with
radiolabels as long as enough activity remains with the
cell to develop the autoradiographic grain the cell will
be scored and grains not related to cells are ignored.
The type of radioactive compounds available for labelling
lymphocytes fall into three categories:
(i) Physiological metabolic precursor molecules
with one or more atoms of the radioisotopic
form. These are for practical purposes
indistinguishable chemically or biologically
from the non-active molecule and are least
likely to be chemically toxic if used in
physiological concentrations. Examples are
tritiated or carbon labelled amino-acids or
nucleotides.
(ii) Analogues of compounds that would otherwise
be included in Category (i) but containing a
radioactive atom that replaces a non-active
atom of different species which does not
interfere with the metabolism of the compound
but may introduce an extra element of chemical
toxicity - eg Selenium-75 substituted for
i 9 c
sulphur in methionine or JI attached to
deoxyuridine that will compete with thymidine
for incorporation into deoxyribonucleic acid
(DNA).
(iii) Unphysiological radioactive compounds which
may bind in an unselective way to intra¬
cellular constituents and may well be
chemically toxic - eg ^ Cr, ^mTc, and ^^In.
All the above categories may be inherently toxic to cells
because of the radioactivity and such radiotoxicity depends
upon the site of incorporation of the radionuclide together
with the range of emitted energy and the dose - ie the
cellular specific activity.
'i
Against this background several compounds that have been
used for radiolabelling lymphocytes were investigated for
their suitability for tracing such labelled cells into
non-lymphoid tissues in the following general experimental
model.
Thoracic duct lymphocytes were 'labelled' either in vivo
o
with H Thymidine or most commonly in vitro culture with
one of a variety of compounds. After thorough washing to
remove unbound label the cells were injected intravenously
into syngeneic recipients which were killed 24 hrs later.
At the time of death the blood was sampled and then the
vasculature 'perfused' with a large volume of PBS to
remove intravascular label (see Methods) before tissues
were excised. Weighed samples of the tissues together
with samples of body fluids and the original injection
suspension were assayed for total radioactivity by
scintillation counting of either p or ^ emissions.
Some experiments utilized recipients with indwelling
thoracic duct cannulae to monitor the passage of label
into the lymph both associated with the cells and in the
lymph plasma.
Urine was collected semiquantitatively by collection of
the output from restrained rats without catheterization
of the bladder.
Methods
Table 3•1 summarizes the radiolabels studied with respect
to their energy of emission, category as defined in the
introduction, source of supply, labelling dose and approx¬
imate uptake efficiency - ie the proportion of the total
activity added to the culture that remains with the cells
in the final injection suspension.










































































































(a)AllsuppliedbyRadiochem calCentre,mersh m,xcept). (b)SuppliedyCISviaBritishagents-E rotopee v cL d,104trnetRNewr et,H ts. (c)Allinvitrocul ureswemediumRPMIi64oithLgl tamine+10%FCSat5x107-10 l̂ls/ l for1hat37°Cexcept(d). (d)In ium-oxineptakw si normalsalinet10°cel s/mfor0mirtemp rature.
CO
Thoracic duct lymphocytes were removed from lymph by
centrifugation and for Category (iii) labels were further
spun over Ficoll/llypaque to remove most contaminating
erythrocytes before suspension in tissue culture medium
for labelling.
After labelling the cells were washed three times by
centrifugation out of 40ml volumes of PBS and finally
spun through 5ml of 50% FCS/PBS t o exchange any surface
adherent label. The cell pellet was then resuspended to a
suitable volume and concentration for injection.
Two exceptions to this general method were used:
(a) Tdr was administered to growing rats at a dose
of 1 |iCi/g/dy i.p. for a period of three weeks to
label all cells including lymphocytes that were
synthesizing DNA during this period. A further
three weeks was allowed to elapse before labelled
TDL were collected by the establishment of a
thoracic duct fistula. This was to allow recently
formed cells time to either dilute out their label
by further cell division or to die if they had a
lifespan of less than three weeks. Thus the label
in the TDL collected during the 48 hrs after
cannulation was restricted to a population of
relatively long-lived recirculating lymphocytes.
Such cells were washed once after collection
before resuspension for injection.
(b) ^ '^In-Oxine binds avidly to protein and therefore
cells were labelled in protein free solutions.
Indium-Ill was recently developed as a cell label
by M L Thakur and colleagues with particular
application to polymorphonuclear leucocytes and
platelets because it has good physical character¬
istics for external detection and a suitable half-
life for studies in patients.
The few experiments summarized here were done with
Dr Thakur and were designed to determine whether
lymphocytes would be labelled and would migrate
normally and also to compare the tissue
distribution in non-lymphoid tissues with the
other labels.
solution of oxine in ethanol to Indium chloride
solution previously buffered to pH 5-6 by the
addition of approximately 200j_il of . 3M acetate
buffer. The complex which formed rapidly at
room temperature was extracted twice in equal
volumes of chloroform and the latter evaporated
off in a boiling water bath. The residue which
contained about 90% of the original activity
was redissolved and stored in a small volume of
ethanol. Before addition to cell suspensions
the required activity was removed and the
alcohol diluted in four volumes of normal saline.
Pilot experiments showed that uptake was most
efficient in protein free normal saline at a
cell concentration of greater than 50 x lO^ml.
Labelling was efficient at room temperature as
well as 37°C but was slower at 4°C. (Table 3-2).
Dilution of the cell suspension also reduced the
labelling efficiency (Table 3>3)> as did the use
of culture medium (Table 3-4), probably because
components of the latter competed for the binding
of ^^In and broke the relatively weak oxine
complex. This mechanism probably underlies the
intracellular binding of Indium for the oxine
does not remain within the cell. The complex
being lipid-soluble serves to carry the oxine
into the cell where binding occurs because of the
greater avidity of as yet unknown cytoplasmic
molecules (Thakur et al 1977)•
The ^*In was chelated with 8-hydroxyquinolone
(oxine) by addition of of lmg/ml
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TABLE 3-2
The effect of temperature on '^In-oxine uptake into TDL
in normal saline at 50 x 106/ml.
% uptake




60 98 O 80
90. 98 90
TABLE 3.3
The effect of cell concentration on the efficiency of
Ulln uptake in normal saline for 5 mins at 37°C.












The effect of culture medium on labelling efficiency
of ^ ^In-oxine for 5 mins at 37°C.
Medium % uptake
Normal saline 98
Phosphate buffered saline 95
RPMI 1640 60
After labelling with Indium-Ill cells were thoroughly
washed as for the other labels including the final spin
through 50% serum to exchange any contaminating surface
protein which was labelled.
7 Q
Recipients received cell doses of between 10' and 2 x 10y
in a volume of 2.0ml via the lateral tail vein. The cell
number was not found to alter the proportional distribution
and enough cells were injected to carry the requisite
radioactivity for counting.
In some experiments labelled TDL were heat-killed by
culturing for 30 mins in PBS at 56°C after which time
more than 95% of the cells failed to exclude Trypan Blue
but remained intact.
Results
Table 3 • 5 summarizes results pooled from many experiments.
Not all the parameters were measured in each recipient
and the results are standardized by expressing them as
the percentage of injected activity per whole organ or
per total volume of body fluid. The original data were
computed as % injected dose per gram of tissue from
weighed aliquots and totals were derived from organ
weights extrapolated from those measured after complete
dissection of several rats. These weight and volume
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Comparison of the values for each tissue shows wide varia¬
tions between the results in various compartments with the
different isotopes. The standard deviation about the mean
for each compartment was of the order of 50% when experi¬
ments were pooled. The variation was consistently less
between triplicate recipients within an experiment with
a SD of 10-30% suggest ing that the reproducibility is more
dependent upon individual populations of cells rather than
recipient variation.
The differences reflect the behaviour of the particular
isotopic molecules after incorporation into the cell and
also more importantly on subsequent release from labelled
cells. The major differences will be delineated and their
significance discussed with particular reference to the
likelihood of a particular isotope producing results that
reflect the labelled cell content of any compartment in
the body.
None of the markers showed total accountability by 24 hrs
after i.v transfusion of labelled cells. Even though most
tissues were sampled minor variations would be expected as
the precise total weight of each tissue was impossible to
assay in each recipient. However, £ emitters produced low
total recovery when compared to ^ emitters and this may be
partly due to the more complex counting procedures used.
^Cr produced consistent recovery and although higher than
most other labels it was not so high as that found with
***In. isotopes gave the lowest total recovery.
One maj'or point of interest was the discrepancy between
the % injected activity of as opposed to in tissues
when both isotopes had been offered to the cells on the
same carrier molecule - eg Uridine or Leucine. There was
an excess of in lymphoid tissues but the converse was
true in non-lymphoid tissues and cell free fluids. This
result was confirmed in an experiment in which TDL were
double labelled with and Udr and transfused into
duplicate recipients. The activities in the various
compartments at 24 hrs after injection were expressed as
the ratio of % injected to the % injected such that
a ratio of less than one indicated an excess of and
vice versa (Table 3-6).
For tritium isotopes with either carrier molecule there
was significant activity in the supernatant of the
perfusate fluid which was consistently in excess of the
total amount estimated in the blood. This was also
reflected in the ability of perfusion to reduce non-
lymphoid tissue concentrations by a factor of more than
two, which was not seen with eg ^Cr.
In lymphoid organs such as spleen and lymph nodes ^Cr,
111 3
In, and H Tdr gave comparable high concentrations
whilst ~*^Cr also gave the lowest concentrations in non-
lymphoid tissues usually by an order of magnitude even
3 111when compared to H Tdr. In compared very closely to
^Cr in both lymphoid and non-lymphoid tissues particular¬
ly when it was certain that no * * * In-labelled protein was
injected with the cells which could contaminate the
tissues.
Two further approaches can be made to assess whether the
label distribution reflects the behaviour of viable cells.
If the labelled cells are functioning normally they will
be able to migrate into central lymph via lymph nodes and
in recipients with thoracic duct fistula will emerge with
the lymph. The proportions of the input activity
collected either associated with the emerging thoracic duct
cells or in the supernatant lymph provides an assay of the
behaviour of the labelled cells and gives some indication
of the degree and fate of eluted label. Secondly, compar¬
ison of label distribution after injection of viable
labelled cells with that of heat-killed cells revealed
differences such that the viability of a test population
could be assumed at least in part.
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TABLE 3.6
Ratio of % inj. ^U/% inj. in tissues 24 hrs after
injection of thoracic duct lymphocytes double labelled
with Uridine.
Tissue Recip.A Recip.B
Injected cells 1.0 1.0
Spleen . 82 . 80
Lymph node .93 .88
Small intestine .89 .86
Thymus .73 •73
Liver .94 .95
Lung .85 . 82
Kidney 1 .20 1.29
Testis 4.31 5.89
Epididymis 1.81 2.90
Muscle 2. 32 2.17
Brain 4.61 8.19
Skin 1. 62 2.06
Plasma 4.7 4-7
Supernatant perfusate 18.6 19-3
C
When comparing the various isotopes the proportion of
injected label bound to cells in the recirculating pool
sampled at the thoracic duct again confirmed the differ¬
ences seen in lymph nodes. ^ ^In gave the highest total
recoveries over 24 and 48 hrs and at the other extreme
99mTc labelled cells virtually failed to appear in lymph.
In this experimental model if double-labelled cells or
mixtures of alternatively labelled cells are injected into
the same recipient the appearance of cell-bound and free
label can be measured and directly compared. The time
course of cell associated label is well established with
o
a peak of H Udr labelled cells occurring at 18 hrs after
injection. (Ford & Simmonds 1972)remembering that this
compound is preferentially incorporated by T cells.
Figs 3-1 (a) and (b) show the results of an experiment in
which TDLs double-labelled with and both followed
the normal pattern but again more was measured than
with the ratio of ^H/^C initially falling, but then
reaching a plateau after several hours. In the super-
natant lymph substantial H was found soon after cell
injection before any activity was found in the cell pellet
arguing against the elution of this label from cells after
collection into the flask as being the major source of thi
cell free label. Much less cell-free was found.
I
FIG 3 . 1
3 14
Recovery of H and C in the cells and supernatant
lymph in 90 min sequential collections of lymph
draining from a thoracic duct fistula of a rat
injected at time zero with syngeneic TDL double-
labelled with ^H-Udr and *^C-Udr.
Upper graph - percentage injected activity associated
with the cell pellet.
Lower graph - percentage injected activity associated




In a similar experiment using a mixture of ^Cr and ^^In
labelled TDL and collecting sequential 45 min fractions,
progressively more *^*In was recovered than ^Cr, but
again both curves followed the normal time course. Very
little of either isotope was found in cell free lymph.
However, the total recovery of ^Cr was greater than that
with *^C-Udr (Fig 3-2 a & b).
An indirect estimate of elution of label from cells in
vivo can be made by measuring urinary excretion of isotope
A substantial proportion of ^^mTc was found in urine
collected over 24 hrs - at least 25%- Significant
quantities of ^Cr - approx. 10% - were also found but
much less of the other isotopes. This does not mean that
label did not elute from cells but rather that such eluted
label was not excreted in urine. For example, the output
of H in urine was approximately 3% in restrained but
intact recipients. However, if such recipients also
received an intravenous infusion of saline at 2.0ml/hr
then the urinary output was sometimes over 30%>. This
agrees with results published by Goldschneider & McGregor
(1968b) who found up to 50% of injected in either cell
free lymph or urine up to 48 hrs after labelled cell trans
fusion.
The fate of eluted label may be partly discerned by exam¬
ination of the tissue distribution of label after heat-
killed labelled cell transfusion. Part of this
distribution will follow the fate of phagocytosed cells
and debris but the proportion found in cell free fluids
may indicate how such released label may behave after
viable cell transfusion. However, no direct evidence can
be adduced to decide whether the release of label after
such viable cell injection follows death of a minor
proportion of the cells or continual gradual release of
isotope from all labelled cells.
Table 3•7 shows the results of two experiments comparing
the distribution of activity after injection of live and
FIG 3-2
Recovery of ^Cr and ***In in the cells and super¬
natant lymph in 45 min sequential collections of
lymph draining from a thoracic duct fistula of a rat
injected at time zero with syngeneic TDL - half
labelled with ^Cr and the other half with ^^In-
oxine.
Upper graph - percentage injected activity associated
with the cell pellet.
Lower graph - percentage injected activity associated
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heat-killed cells labelled with ^Cr or In expressed as
% injected dose/organ.
The major proportion of heat-killed cell-associated label
localized rapidly in the liver and this high concentration
was maintained and possibly increased by 24 hrs. A
significant proportion of either label was present in the
plasma by 1 hr and these concentrations fell by 24 hrs
though for apparently different reasons. ^Cr was
excreted in the urine. ^ ^In was not excreted but rather
continued to accumulate in liver, spleen and bone marrow
probably due to presence of transferrin to which ^ ^In
binds avidly (Thakur 1977) as well as the accumulation of
labelled cell debris in the reticulo-endothelial system.
Concentrations of '^In in non-lymphoid tissues were in
some cases greater after dead cell injection than after
viable cell injection, but no meaningful correlation
between tissue levels and cell-free plasma levels occurred
in either case.
The avid binding of free ***In to protein and its
distribution may account for the somewhat analogous
results in the experiment of Table 3.8. Cells were
labelled with ***In in medium which contained a trace of
protein and from which the cells were washed only once.
Recipients of these cells together with 5Icr-labelled TDL
showed the tissue concentrations listed in Table 3.8. The
lymphoid organs had an apparent deficit of ^^In labelled
cells compared to ^Cr in contrast to the experiment
detailed in Table 3-7- However, the concentration in
lymph nodes and spleen did alter with time in the normal
way and the discrepancy appeared to be due to the high
plasma and liver concentrations evident soon after
injection hr). The bone marrow showed an early deficit
and a late excess of *^*In that is consistent with a
deficit of labelled cells and an excess of labelled protein
the latter of which could account for the continued
increase after 20 hrs. The other interpretation would be
that substantial proportion of the initial population of
***In but not ^*Cr labelled cells were dead at the time of
injection.
TABLE 3.7
TISSUE DISTRIBUTION OF RADIOACTIVITY 1 HR AND 24 HR
C<1 111
AFTER I.V. INJECTION OF EITHER ( Cr) OR (in)
LABELLED TDLs IN DUPLICATE SYNGENEIC WEIGHT MATCHED
RECIPIENTS PERFUSED AT TIME OF DEATH.
MEAN % INZJ. ACTIVITY/WHOLE ORGAN OR VOL OF BODY FLUID
111
(N.B. Great care was taken to ensure that ( In) labelling was
carried out in protein free medium with thorough
washing of the cells) *
Upper value for each tissue - Viable cells








LYMPH NODES 3.4 2.4 26.5 30.8
.06 .12 .11 .26
SPLEEN 47.7 56.2 22.0 31 .5
1.7 2.6 2.6 5.2
LIVER 11.3 10.8 9.0 9.4
37.1 39.9 38.1 53.5
KIDNEY .28 .39 .29 .30
4.8 2.0 5.6 1.8
GUT 4.3 1.9 2.9 3.6
.52 .68 .27 .75
LUNG 4.5 4.3 1 .8 1.6
22.7 23.1 1.5 2.2
BONE MARROW 14.7 18.1 2.3 2.1
3.9 3.2 7.2 10.1
OVARIES .11 .01 .05 .02
.04 .06 .03 .04
UTERUS .04 .01 .04 .02
.05 .12 .07 .16
THYMUS .06 .11 .21 .07
1 .03 .04 .02 .04
SALIVARY GLAND .02 .01 .06 .01
.03 1.2 .04 .62
SKIN .45 .47 .28 .58
2.0 2.9 1.5 3.4
MUSCLE 1 .37 1 .23 .56 1 .12







51 „ 111TCr In
WHOLE BLOOD 3.7 3.2 3.0 2.8
5.8 6.8 1.2 2.3
PLASMA .27 .44 .18 .35
4.9 5.7 1.1 1.3
BLOOD LEUCOCYTES 1.3' 1.5 1.3 2.2
.4 1.0 .2 1.1
WHOLE PERFUSATE 2.2 3.2 1.6 1.4
4.9 5.9 1.3 3.6
.SUPERNATANT PERF. .6 .5 .2 .2
3.3 3.8 1.0 2.5
CELLS IN PERFUSATE 1.5 2.5 1.3 1.2
1.0 1.6 .4 2.1
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7 5
Txssue concentrations at 24 hrs after injection of Se
labelled cells showed values in lymphoid organs and TDL
intermediate between ^Cr and but high concentrations
were found in non-lymphoid tissues and plasma. There was
7
no excess of 'JSe in the perfusate over the blood levels
and the radioactivity in plasma was associated with 5%
TCA precipitated macromolecules, confirming the observ¬
ations of Rose & Micklem (1976) in the mouse.
*^^Udr is metabolically incorporated into DNA and there-
,fore labels only those cells in S-phase. In lymph the
minority population of lymphoblasts therefore are the only
cells labelled, and since Gowans & Knight (1964) and Hall
et al (1972) showed that these cells behave differently
from the majority population of small lymphocytes in that
they (i) preferentially migrate to the small intestinal
lamina propria, (ii) are found in much lower proportions
in secondary lymphoid organs, and (iii) migrate poorly
into thoracic duct lymph, direct comparison of isotope
behaviour with labels in different cell populations can
only be made as far as the behaviour of the cell-free
portion of eluted label is concerned. The majority of
125a; in the blood was in the plasma and there was also
some excess activity dialysed out by perfusion suggesting
some degree of widespread redistribution of cell-free
label contaminating tissues similar to that seen with
tritium. The pattern of tissue distribution confirmed
published results suggesting that a major proportion of
the labelled cells were viable.
Distribution of ^^Tc non-perfused recipients showed
that a high proportion of the label was accounted for in
the liver, kidneys and urine. Very variable low con¬
centrations were found in lymph nodes and little or no
activity was found associated with cells in draining
thoracic duct lymph. All these factors are suggestive of
damage to the cells.
99m 111 r.
Tc and In are both isotopes with high outputs of
gamma photons that are efficiently detectable by external
imaging devices and as such provide potential labels for
the study of cell migration in vivo with non-invasive
techniques. Fig 3-3 and Fig 3-4 show respectively images
obtained with a gamma camera 18 hrs after the intravenous
transfer of TDL labelled with approximately 300uCi of
isotope.
Fig 3-3 shows the distribution after transfer of 1320 x
10^ TDL labelled with 320j*Ci ^^mTc. There is marked
concentration in liver, spleen, kidneys and bladder and
the cervical lymph nodes are just discernable.
Fig 3-4 shows the distribution pattern of activity 18 hrs
after iv injection of 200 x 10^ TDL labelled with 300uCi
'^In-oxine. The cervical lymph nodes are easily
discerned and several other nodes in thorax and abdomen as
well as the prominent spleen and liver can be seen. Fig 3-5
shows the cervical region of the same animal viewed with a




Gamma camera image of ventral aspect of an
anaesthetized rat injected iv 18 hrs previously with
syngeneic TDL labelled with 320jiCi ^mTc. 15 min
exposure using a multihole collimator.
The liver, spleen and kidneys are active as is the
bladder (arrowed). The cervical lymph nodes appear






Gamma camera image of ventral aspect of an
anaesthetized rat injected iv 18 hrs with 200 x 10^
syngeneic TDL labelled with 300ynCi ^^In-oxine 15 min
exposing using a multihole collimator.
Liver and spleen are very active but many lymph nodes





Same animal as Fig 3*4•
Gamma camera image using a pin-hole collimator.
15 min exposure over cervical region.






Several features of the behaviour of radioactive marker
molecules following their uptake by thoracic duct lympho¬
cytes are apparent from the results.
When a radioactive molecule passes across the cell membrane
it may be incorporated into the cell structure in a
variety of ways or it may remain in solution in the cyto¬
plasm such that it may leave the cell again unchanged at
some later time. If the latter occurs then the molecule
may be available for uptake and incorporation by another
cell and in vivo by other cell types. This true re-
utilization is one potential source of artefactual data
when total tissue activity is equated with introduced
labelled cell content.
Any molecule that is truly incorporated into intracellular
structures shares the fate of the particular macromolecule
to which it is attached and may therefore have a variable
biological half-life within the cell depending upon the
3 12 5metabolic pathways involved. For example H Tdr or lUdr
are incorporated into DNA^ a relatively stable molecule.
On the other hand uridine is a precursor of RNA which may
have a great variety of lifespans as will amino-acids
synthesized into proteins. The catabolism of the macro-
molecules may allow release of the isotopic atom from the
cell in a new molecule which will determine its ultimate
fat e.
The same principles hold true for the Category (iii) non-
metabolic labels which after uptake bind by non-specific
chemical forces rather than by biosynthetic incorporation.
However, once bound, the fate of the marked atom will then
follow that of the molecule to which it is bound depending
in part upon the relative binding activities of the mole¬
cules present in the immediate environment. Whether re-
utilization will take place on release from labelled cells
will again depend upon the type of molecule to which it is
bound or if truly free the chemical state of the ion. For
example it has been reported that ^*Cr on release from
cells is bound to molecules with characteristics of small
peptides or amino acids (Sanderson 1976, Ronai 1969).
The suitability of an isotope for tracing cells to areas
of low cell concentration by the indirect scoring method
of measuring total tissue activity depends upon the inter¬
relationship of several factors:
a- the stability of the attachment of the label to the
cells.
b the rate of elution of label from the test cells.
c the rate of uptake of eluted label by other cells
in the test tissue.
d the appearance of label in tissue fluids.
e the rate of removal of the label from the body by
excretion.
f the viability and normal behaviour of the labelled
cells.
In the ideal situation (a) and (f) would be maximal and
the remaining factors would not interfere. Given that
this ideal situation does not exist the relative




A H Thymidine in vivo
This nucleotide is incorporated into DNA and as such
should be part of a stable structural molecule in long-
lived non-dividing recirculating lymphocytes (both T
and B cells). The cells were labelled in a physio¬
logical environment and were transferred to recipients
with minimum manipulation. The results suggest normal
migratory function of such lagelled cells by the high
lymph node concentrations and substantial recirculation
into lymph. However, elution and redistribution of
does occur as shown by significant concentrations in
plasma and in the cell free perfusate. This suggestion
is confirmed by the significantly higher concentrations
1 r 1
in non-lymphoid tissues of JH as opposed to 3 Cr.
Several mechanisms may be involved in the appearance of
such cell free label:
(i) A proportion of the transferred labelled cells
may die on transfer following in vitro
manipulation or because they have reached the
end of their normal life. Catabolism could
3then release H from the DNA.
(ii) A proportion of the H in transferred cells
may not be incorporated into DNA but may
rather be of low molecular weight and in
dynamic equilibrium with the extracellular
fluid which in the original labelled donor
~\ would still contain °H. On transfer net re¬
distribution could occur with appearance of
3
cell free H in the extracellular fluid.
(iii) A proportion of the labelled DNA may have a
metabolic turnover dissociated from that of the
chromosomes as suggested by Harris et al (1973;
1976).
(iv) There may be atomic exchange of hydrogen atoms
at the surface of molecules with a net elution
3of °H in the new non-radioactive environment.
In fact a standard method of tritiating com¬
pounds involves such an exchange in the presence
o
of excess JH and a catalyst.
There is no evidence which would exclude any of these
factors' and all may operate.
Tritiated DNA is usually considered stable as measured
by autoradiographic grain counts over samples of a
cell population over long time periods (Theml et al 1973)-
The present results raise the possibility that low mole¬
cular weight activity may be washed out during process¬
ing even of cell semears which would prevent the detect¬
ion of total intracellular radioactivity.
The source of eluted tritium is less important in the
present circumstances than its fate which appears to be
widespread contaminatory redistribution. The advantages
of this label for autoradiographic studies of cells of
known age in areas of reasonably high frequency make
the expense in terms of isotope and time worthwhile for
certain studies, but the advantages of using a non-
traumatized closely defined (by age) population are
nullified when quantitating non-lymphoid tissue cell
content by assaying total radioactivity as over-
estimation will occur.
Uridine
In the rat this precursor of DNA is more efficiently
incorporated by T cells than B cells (Howard et al
1972b). This differential uptake must be taken into
account when the activity associated with a mixed cell
population such as TDL is being followed. In addition
not all of the radioactive uridine that is absorbed
during culture may be incorporated into RNA immediately
as suggested by the finding of Gowans & Knight (1964)
that an increase in macromolecular TCA resistant
activity detected by grain counts over cells labelled
2with H adenosine more than 27 hrs after iv trans¬
fusion as compared to the starting population
immediately after labelling. This low molecular weight
activity, if not subsequently incorporated, may be
released into the environment - ie the recipient animal
Avoidance of such contaminatory eluted label might be
attempted by assaying only RNA from tissues. This may
not be as helpful as expected for the following reasons
Extraction of RNA is unlikely to be total and
efficiency may vary between tissues - eg attempts to
extract macromolecular radioactivity with TCA from
homogenized renal tissue gave total yields of only 60%
of that measured in raw digests even when the precip¬
itate and supernatant fractions were combined. In
addition the amounts of label incorporated into RNA
within the cell may vary with time. Measurement of
specific activity of RNA in various tissues is also
open to the inherent variation in RNA concentration in
different tissues.
The variation in total tissue concentrations between
and when the same cells were double-labelled
with these isotopes on the uridine molecule must
reflect the fates of different parts of uridine mole¬
cule. Thus tritium eluted from labelled cells to a
greater extent than as shown by the relative
3deficit of H lymphoid tissues and thoracic duct lymph
<K
cells. The converse was true in areas of expected low
3cell concentration and cell free fluids. The excess H
released by perfusion with the corresponding fall in
tissue activity is not seen with other labels. That
this label is available for excretion in urine under
conditions of high fluid intake from an iv saline
infusion suggests that the tritium moves with the body
water pool.
The elution from uridine could be due to those factors
3
already suggested for JH Tdr but the observation that a
similar pattern of elution still occurs (28% in per¬
fusate and 11% in plasma) when labelled cells are
double passaged through an intermediate recipient
suggests that the elution is gradual and continuous and
cannot be accounted for my non-incorporation of low
molecular weight uridine alone. The relative intra¬
cellular conservation of also argues against the
non-incorporation idea as this should also affect the
*^C form of the molecule. This conservation of
could occur if catabolic products of RNA separate the
5-H from the 2-C or if the tritium exchanges at the
surface of the intact molecule. The low total account¬
ability of however argues that does also elute
although at a slower rate but the failure to detect
such eluted is unexplained. One possibility is that
the was excreted via the lungs as . In a not
totally satisfactory experiment all expired CO2 from a
recipient of *^C Udr labelled TDL was collected from a
gas-tight box for 24 hrs by precipitation as Barium
carbonate. The precipitate failed to show significant
counts when it was dissolved with tetrasodium EDTA and
added to a liquid scintillation cocktail.
The widespread redistribution of low molecular weight
3
H could provide an alternative explanation of the
observed increases in TCA insoluble/TCA soluble ratio
3of radioactivity in lymphoid tissues with time after H
labelled cell injection when no increase in this ratio
was measured in non-lymphoid tissues. (Goldschnieder &
McGregor 1968b, Ellis & de Sousa 1974)- These observ¬
ations have been cited as evidence that lymphocytes
continue to synthesize RNA from labelled precursors
only in lymphoid tissues. However, such alterations in
this ratio would also be produced by net elution and
redistribution of TCA soluble label from areas of high
cell content to all other areas including those of low
cell content. Thus the TCA insoluble fraction of
lymphoid tissue would increase with time because of
cell accumulation and at the same time the eluted TCA
soluble activity would show a net efflux and both
factors would push the ratio in the same direction.
However in non-lymphoid tissues containing few labelled
3cells and thus little TCA insoluble H the net inflow
3of TCA soluble H would tend to stabilize or even
reduce the ratio. The ability of lymphocytes to
continue RNA synthesis from radioactive precursors is
suggested by the increase in RCA resistant grain counts
3in H adenosine labelled cells with time as already
stated (Gowans & Knight 1964) but there is no evidence
in favour of a restriction of this ability to lympho¬
cytes within lymphoid tissues.
Thus uridine because of its rapid rate of elution and
particularly because of contamination of tissues with
cell free label is unlikely to give accurate estimates
of labelled cell content using indirect methods.
Nevertheless is likely to give more realistic
3results than H.
Leucine
This amino-acid does not show the differential uptake
between T and B cells but otherwise shows the same
range of problems experienced with Uridine - ie elution




The incorporation of this analogue of the sulphur
containing amino acid methionine into lymphocytes with¬
out impairing their function was reported by Rose &
Micklem (1976) and Bainbridge (1976). It has the
potential advantage of emitting y rays but the biological
behaviour as shown by these results suggests that
elution is substantial and this may occur unevenly
between lymphoid organs as suggested by Bainbridge (1976).
The eluted label binds to plasma proteins and may also
be re-utilized by other tissues as shown by the higher
non-lymphoid concentrations than ^*Cr and the failure
of perfusion to dialyse out more activity than could be
accounted for in the blood.
O 0 m
E Sodium Tc Pertechnetate
The work of Barth et al (1974) using murine lymphocytes
suggested that high cell specific activities with
stable labelling could be achieved with this label
although such potentially toxic compounds as stannous
chloride were used in the labelling method. Preliminary
studies suggested this step was indeed excessively toxic
and sodium chromate also used as an adjuvant for label¬
ling did not improve the situation. A wide range of
labelling conditions was investigated with great vari¬
ability in the performance of labelled cells; these
never produced high lymphoid tissue localization but
consistently showed much activity in liver, kidneys and
urine. The ability of such labelled cells to recirc¬
ulate into thoracic duct lymph was severely impaired.
Thus the potential advantages of achieving greater
detectability in non-lymphoid tissues by having a high
cell specific activity and of being able to visualize
labelled cells with external scanning devices were not
realized. A recent report of the distribution of ^^mTc
labelled peripheral blood lymphocytes in the rabbit
measured by radioassay of dissected tissues or by
external scanning with a gamma camera gave similar data
to that shown here (Gobuty et al 1977)- However these
authors interpreted their results in terms of cell
distribution which seems most unlikely.
F Sodium Cr Chromate
This radionuclide has had widespread use in labelling a
variety of cell types including TDL, after the original
description of the method by Bainbridge et al (1966).
Like other non-metabolically incorporated labels it is
taken up by all cell types thus necessitating great
purity of the starting population. Because of the low
efficiency of uptake (2% of isotope added to the culture)
low cell specific activities are achieved and this can
only be safely counteracted by injecting more cells as
increasing the labelling cell dose may introduce two
potentially toxic factors: (i) the concentration of
chromate ion may be chemically toxic; (ii) radio-
toxicity is likely to be dose dependant. Thus the
ability of ^Cr-chromosome marked murine lymphocytes to
survive in vivo and proliferate on subsequent exposure
to lectins was reduced compared to non-radiolabelled
similarly chromosome marked cells (Doenhoff & Davies
1976). Also rat TDL labelled at 100|iCi/ml showed
significant impairment of activity in a local graft
versus host assay whereas the same dose of cold
chromate or labelling at 25^-iCi/ml showed no consistent
impairment (B Rolstad personal communication). In one
experiment TDL labelled at 10jjiCi/ml ^Cr showed slight
impairment of GVH activity in a similar rat popliteal
node GVH assay.
On the other hand the ability to proliferate may be too
stringent a test of normal function as far as migratory
behaviour is concerned. The proportional distribution
of the same population of TDL labelled at lOynCij 30yaCi,
or 100|iCi/ml showed no significant differences in either
tissue distribution or draining thoracic duct lymph
cells as shown in Table 3.9.
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TABLE 3-9
Effect of Labelling Dose c 51 rof Cr on Tissue Distribution
and Migration of Labelled Cells into Thoracic Duct Lymph
after IV Injection









Spleen 34-3 35.6 38.8
Liver , .89 .55 1 . 2
Kidney .86 .60 .68
Bone marrow .19 .19 .36
Thymus .08 • 03 .12
Skin .01 .008 .008
Muscle .008 .011 . 008
Brain .001 .001 .001
TDL cells (0-21 hrs) 9.7 10.0 8.6
TDL sup " " • 75 1.0 .95
Urine 7-4 9.1 12.8
Blood 6.2 4.8 5.3
Plasma .23 .16 .27
Perfusate (whole) 2 . 6 1.8 1.4
Perfusate (cells) 3-2 1.5 1 . 2
However, a routine dose of lOjaCi/ml was used throughout
the remainder of the project.
The non-specific uptake into all cell types necessit¬
ated the removal of contaminating erythrocytes as these
could amount to ten percent of the population of TDL
without obvious bleeding or discolouration of the lymph.
The activity in blood was not due to reutilization in
vivo but to prelabelling. Autoradiographs of smears of
^Cr labelled TDL showed labelled red cells as long as
Haematoxylin and eosin rather than Unna-Pappenheim
stains were used. Erythrocytes are not well stained
with the latter preparation and are therefore easily
overlooked. Centrifugation over Ficoll/Hypaque was
found to be the most efficient method of removing this
low level contamination.
Uptake of ^Cr by cells is not uniform but tends to
depend upon cell size. Large cells incorporate more
isotope than small (Eyre et al 1970). As the larger
cells in TDL are immunoblasts and behave differently to
small lymphocytes, it is inherently difficult to
apportion accurately the contribution of the sub-
populations to the total concentration of radioactivity
in any tissue at a given time, even if the proportion
of the total label associated with this minority
population was known precisely.
However, the results suggest that ^Cr labelled cells
are most likely to reflect the physiological distrib¬
ution of cells in non-lymphoid tissues because activity
was the lowest recorded of all the labels used. This
is almost certainly due to the efficient excretion of
any eluted label with little evidence of redistribution
or reutilization. However some elution does occur,
since ten percent of the injected activity was found in
urine and also recovery in thoracic duct cells was
lower than that of *^In labelled cells (Fig 3-3) •
Elution was also seen in culture where by 3 hrs there
was 30% spontaneous release of ^Cr. In comparison
only 5% of ***In was released from TDL cultured at
5 x 106/ml in RPM1 + 1056 FCS at 37°C in vitro.
These advantages outweigh the disadvantages of the non¬
uniform uptake but poor results in autoradiographs of
tissue sections (probably due to loss of activity
during processing) preclude the use of this technique
to confirm directly how differences in total tissue ^*Cr
activities reflect differences in cell content.
111 t n •In-Oxme
The preliminary results of labelling lymphocytes with
this compound confirmed the findings of Thakur et al
(1976 a & b; 1977) when labelling other cell types
(leukocytes and platelets) and suggest that this label
may be extremely useful in both experimental and
clinical investigations. The rapid uptake, high cell
specific activity obtainable, and low rate of elution
taken together with the normal migratory behaviour,
establishes this method as a useful alternative to ^Cr
labelling for experimental situations with the added
advantage of being more efficiently detected by external
scanning devices. In addition the ability to label
cells heavily should allow a greater degree of detect-
ability in areas of low cell concentration particularly
if the number of cells available for labelling is
limited. A possible disadvantage of ***In is the bind¬
ing of this ion to transferrin on elution from dead or
living cells. It is therefore not excreted and may
contaminate some tissues.
With well washed labelled cells the concentrations of
^ ^In in non-lymphoid and lymphoid tissue were slightly
higher than with ^Cr, perhaps due to the greater
elution of ^Cr.
Assay of heavily labelled TDL in a local GVH assay did
show an abolition of proliferative activity but this
again may be too stringent a test of normal function
for migration studies.
H I-Iododeoxyuridine
As a label for DNA synthesizing lymphoblasts this
analogue of Tdr has the advantages over tritiated Tdr
of being a gamma emitter and therefore allowing examin¬
ation of larger samples and also of having slightly
better elution characteristics. However elution does
occur and at least part of the free label is widely
distributed as shown by whole body perfusion which
yields more in the perfusate than can be accounted for
12 5
by the blood. Also I has a greater radiotoxicity in
DNA as shown by reduced growth in labelled tumour cell
cultures (Hofer & Hughes 1971) and by alterations in
migration characteristics of murine "activated T.TDL"
12 5when increasing labelling doses of Udr reduced
splenic localization probably reflecting increasing
cell damage (Sprent 1976a). Thus l^uCi/ml is an upper
limit of acceptable in vitro labelling dose for 1 hr in
culture.
Non-lymphoid tissue concentrations are thus likely to
over estimate lymphoblast cell content but this arte¬
fact does not completely vitiate the use of this label
to gain some insight into the migratory behaviour of
such labelled cells in most sites.
CONCLUSIONS
The wide variations in tissue distribution of radioactivity
measured after iv injection of TDL labelled with a variety
of radionuclides was shown to depend upon the fate of the
various isotopes after incorporation and more importantly
after subsequent dissociation from the cells.
Contrary to one's expectations metabolically incorporated
labels were least suitable for marking cells; the binding
was temporary and release was faster compared with the
non-specific chemically bound metallic ions. Tritium was
found to be particularly unsuitable for measuring cell
content in non-lymphoid tissues by assaying total radio¬
activity because of large scale contamination by cell-free
label.
^*Cr was found to elute from cells at a slower rate than
Uridine, Leucine or Methionine markers and had the major
advantage of being efficiently excreted in urine after
release thus minimizing contamination of tissues. It was
therefore considered the isotope of choice to approximate
the actual cell content of tissues.
^In-oxine was found to be an efficient and potentially
very useful label for lymphocyte migration studies both in
animals and man. It was not available for the bulk of the
work to be reported and has the one potential disadvantage
of not being excreted on elution. However the close com¬
parison between the results obtained with ^^In and ^Cr
supports the thesis that both isotopes reflect physio¬
logical cell behaviour. Cell-free forms of each label
follow different pathways.
12 5Udr has several disadvantages because of toxicity and
elution but was found to be the most useful available
label for the assay of lymphoblast content in tissues by
measuring total tissue activities.
CHAPTER FOUR
The Kinetics of Tissue Localization of Radioactivity after
Labelled Cell Injection - an approach to the measurement of
thoracic duct cell migration in various tissues.
Introduction
The behaviour of constituent members of a population that
is mobile and distributed through a multicompartmental
system can be examined by tracer techniques, provided:
(l) the introduction of "labelled" members does not of
itself disturb the system; (2) mixing within the whole
population occurs after introduction of the tracer; and
(3) several compartments can be examined simultaneously
after various times.
Data derived from several experimental approaches have
suggested that the model of the recirculating lymphocyte
pool is such a multicompartmental system, comprising
mainly small long-lived lymphocytes that are in dynamic
equilibrium between the blood, the secondary lymphoid
organs, and the central lymph.
The model further envisages migration pathways that
involve differing proportions of the population and
transit times through different compartments of varying
duration. i
The model was built up from the following observations:
i the output of lymphocytes from the major lymph¬
atic ducts into the blood was sufficient to
replace the total blood content several times a
day (Mann & Higgins 1950).
ii removal of this central lymph output via a
thoracic duct fistula resulted in a profound fall
in the cell output in lymph and also depleted the
cell content of the blood, the white pulp of the
spleen, and the paracortical areas of lymph nodes
(Mann & Higgins 1950, Gowans 1959).
iii only a small proportion of such cells in lymph
had labelled DNA after continuous administration
of H Thymidine for five days and therefore the
majority were relatively long-lived (Everett et al
1964).
iv reinfusion of the draining cells into the venous
circulation corrected the tissue deficits and the
thoracic duct output as long as the injected cells
were viable (Gowans 1959).
v if these reinfused cells were "labelled" the same
marked cells were found in the thoracic duct lymph
after a period of hours (Gowans 1959? Shorter &
Bollman I960, Gowans & Knight 1964).
Identification of the two major traffic areas in lymph
nodes and splenic white pulp by depletion studies and then
by positive identification of large numbers of radio-
labelled cells in autoradiographic preparations of histo¬
logical sections (Gowans & Knight 1964) raised the
questions of the precise anatomical pathways and time
courses involved.
Information relating to lymph nodes came from two experi¬
mental approaches. Firstly, examination of histological
autoradiographs a few minutes after iv injection of radio-
labelled cells revealed a close association between these
cells and the post-capillary venules in the paracortex -
vessels which normally have a prominent lymphocytic cont¬
ent in their walls (Gowans & Knight 1964? Goldscheider &
McGregor 1968a). Secondly, measurement of the cell
content of afferent lymph and efferent lymph draining into
and from a single lymph node in the sheep revealed a much
higher lymphocyte concentration in the latter, together
with a shift in differential cell counts such that afferent
lymph contained higher proportions of large lymphocytes
and macrophages, while efferent lymph was enriched in
small lymphocytes and contained very few macrophages
(Hall & Morris 1965^ Smith, Mcintosh & Morris 1970a). Thus
a net addition of small lymphocytes to the lymph in the
node was indicated which was too great to be accounted for
by new cell production within the node as determined by
incorporation of tritiated thymidine (Hall & Morris 1965).
A direct blood-lymph node-lymph pathway was thus establish¬
ed and the time taken to make this journey was measured by
sequential collection of labelled cells in efferent lymph
after their introduction into the blood. The results from
both sheep and rats indicated a modal transit time of the
order of 18 hrs (Ford & Simmonds 1972, Hall et al 1976,
Frost et al 1975).
In the spleen the entrance to the white pulp was found by
autoradiography to be via the marginal zone by direct
emigration from the blood through the walls of the margin¬
al sinuses. The use of an isolated perfused spleen
preparation showed that the major exit was directly into
venous blood and that the modal transit time through this
compartment was approximately five hours (Ford 1969a).
Study of the distribution of radio-labelled lymphocytes
within the intact animal and removal of these major sites
of lymphocyte migration at various times after iv injection
and assaying them for labelled cell content, either direct¬
ly by autoradiography or by total tissue radioassay, showed
that the content of these tissues changed with a time
course that is consistent with such transit times and also
gave information about the relative proportions of injected
population in each compartment. (Gowans & Knight 1964,
Goldschneider & McGregor 1968 a & b, Heslop & Hardy 1971,
Shorter & Bollman I960, Freitas & de Sousa 1975> Ellis &
de Sousa 1975) •
It is therefore reasonable to expect that examination of
other compartments within the system in such kinetic
distribution experiments would provide information about
the quantity and time course of lymphocyte traffic through
other tissues. Several factors must be taken into account
before this direct interpretation can be made without the
ultimate check of examination of each tissue in isolation.
The main conditions that should be operative to allow
interpretation of results in terms of cell migration
through tissue are : (a) the cells labelled must be part
of the total population under study - ie the recirculating
lymphocyte pool - and should mix freely within that pool;
(b) the "label" should be uniformly distributed among the
labelled cells which should behave as a homogeneous
mixture; (c) the label should be as near 'ideal' as
possible in terms of elution and lack of toxicity (as
discussed in the previous chapter); (d) the radioactivity
assayed should be associated with viable cells which
should be extravascular if true migration is to be assumed
(e) mixture within the initial compartment entered should
be thorough and rapid.
The choice of thoracic duct lymphocytes for distribution
studies of this type has two inherent advantages. Firstly
the population comprises virtually pure lymphocytes that
are physiologically destined to enter the venous circ¬
ulation, and secondly, the great majority of the cells are
known to be part of the recirculating pool. However, two
drawbacks are also apparent. The minority population of
immunoblasts also traversing this route may not be part of
the true recirculating pool and are known to have migra¬
tion characteristics that differ from recirculating small
lymphocytes (Gowans & Knight 1964* Hall, Parry & Smith
1972). If the whole population is labelled the contrib¬
ution of this minority may influence the overall distrib¬
ution of radioactivity. The contribution of this
population may be to some extent evaluated by studying it
alone, utilizing the specific uptake of DNA precursors by
such cells. The other major complicating factor is the
heterogeneity within the recirculating pool. Thus both
T and B cells are known to recirculate but it is apparent
that the routes and time course through secondary lymphoid
organs differ with B cells, tending to longer modal
transit times (Howard 1972, Freitas & de Sousa 1976,
Niewenhuis & Ford 1976). Again, non-specific labels will
reflect the behaviour of a mixture of these cell types as
TDL comprise very approximately 70% T cells and 30% B
cells (Howard 1972, Crum & McGregor 1976). Previous
studies employing uridine as a carrier for the radiolabel
examined mainly T cell behaviour, as these cells take up
some 10-15 times the amount of label as B cells in the rat
(Howard 1972). However, the use of this label to study
non-lymphoid tissue distribution is precluded by the
significant contaminatory elution detailed in the previous
chapter.
Because of the characteristics of the various labels
available, ^Cr was considered to be the most suitable
even though all cell types were labelled. To gain a rough
assessment of the contribution of lymphoblasts, which were
probably somewhat more heavily labelled than small lympho¬
cytes with ^Cr (Eyre et al 1974), such cells were
IOC
labelled in vitro with JI Udr. Furthermore, a population
relatively depleted of labelled lymphoblasts was obtained
by 'passaging' labelled TDL from blood to lymph in a
host with an established thoracic duct fistula. Lympho¬
blasts recirculate into lymph poorly (Gowans & Knight 1964)
It is possible that such 'passaged TDL' collected from 2-
24 hrs after iv injection may also be somewhat enriched
for T cells as their modal transit is somewhat shorter
than that of B cells, but this possible enrichment was not
quantitated.
Attempts to prepare purified populations of B or T cells
were not made because of the lack of techniques available
that would yield large enough numbers of cells to allow
adequate labelling for distribution studies in multiple
recipients. Such studies would be more feasible using
^^In-oxine, as much higher cell specific activities could
be achieved which in turn would allow the use of many fewer
cells per recipient.
Experiments were designed to measure changes in the
proportion of injected radioactivity in various tissues
at various times after iv injection of labelled TDL.
Recipients were always subjected to whole body vascular
perfusion to minimize contamination of the tissues by
intravascular label. Clarification of the interpretation
of the results of such experiments was provided by a
series of supplementary studies. The effect of intravenous
injection of cells upon that part of the recirculating
population already present within the tissues of the host
was studied by looking for changes in the distribution of
labelled cells, that had been allowed to equilibrate with
the RLP over a period of 24 hrs, upon subsequent iv
J
injection of a large number of unlabelled cells. The use
of splenectomized recipients allowed higher blood con¬
centrations to be maintained for longer, as such an
operation removes a tissue which normally accepts half of
bie injected cells from the circulation very quickly. It
was hoped that such a manoeuvre would enable more cells to
emigrate at other sites and therefore accentuate any
fluctuations seen in tissue levels as suggested by the
early increased lymph node localization noted in such
recipients (Bradford & Born 1973) •
Intra-arterial injection of labelled cells was used in an
attempt to provide a known concentration of cells to
peripheral tissues avoiding the systemic factors that are
all working to reduce the concentration of injected label¬
led cells in the blood compartment so rapidly.
Autoradiographs of histological sections of all tissues
studied were examined to provide qualitative confirmation of
the extravasation of labelled cells at various times after
14 3 3
iv injection. For these experiments C or H Udr or H Tdr
were employed as they provided much better preparations,
and elution of some label does not matter in these circum¬
stances. Very large doses of cells were sometimes used to
counteract the great dilution effect within non-lymphoid
tissues and increase the chances of detecting labelled
cells in the very small samples that could be examined.
METHODS
Particular techniques not included in the general methods
chapter.
1 'Passaged ~*^Cr TDL 1
This population of labelled cells was included among
thoracic duct cells collected during a period from
2-24 hrs after iv injection of *Cr labelled TDL
into a syngeneic cannulated intermediate host. Approx¬
imately 10% of the initial dose of label was collected
and the cells were washed once in PBS before resuspens-
ion in medium RPMI 1640 + 10% FCS at a concentration
suitable for iv injection.
2 Splenectomy
Recipients, under ether anaesthesia, underwent splen¬
ectomy or a sham laparotomy via a left subcostal
incision. The vascular pedicle of the spleen was
isolated by blunt dissection and the spleen removed
after a single ligature had been tied around the
pedicle. The wound was closed with continuous
ligatures in two layers. The operation was performed
either immediately or twelve days prior to labelled
cell transfer.
3 Intra-arterial Infusions
Labelled cells suspended in medium RPMI I64O + 10% FCS
or modified rat blood comprising 20% by volume syngeneic
erythrocytes in plasma were infused by syringe or roller
pump via a polythene cannula (PP10 Portex Ltd) with or
without a 27g needle into an exposed femoral artery at
the mid-femoral level in a peripheral direction. The
cannulation of an artery was performed under ether
anaesthesia and the vessel was ligated at the end of
the infusion to prevent the otherwise inevitable
haemorrhage as a relatively large incision through the
arterial wall was necessary to allow introduction of
the cannula. The pressure of the infused fluid was
monitored with a mercury filled U-tube manometer
connected via a saline filled tube and a T connector to
the infusion cannula. For experiments of short
duration the anaesthesia was maintained, while for
experiments with periods of 1 hr or more elapsing
between the end of the infusion and tissue examination
the wound was closed and the animal allowed to recover
from the anaesthetic.
RESULTS
Table 4*1 summarizes the results of many experiments in
which the distribution of radioactivity in most tissues of
the body was examined half an hour, two hours or twenty-
four hours after injection of labelled cells belonging to
one of three populations:
L'
51
(i) Cr labelled whole TDL.
(ii) Passaged ^Cr labelled TDL.
(iii) 125j udr labelled lymphoblasts.
The results are expressed as the percentage of the injected
dose per whole organ determined as described in the
previous chapter by radioassay of weighed samples obtained
by di ssection after whole body perfusion and calculation
with reference to standard organ weights. The variation
between results in triplicate recipients was much smaller
within an experiment than between experiments. In the
former case a standard deviation of ten percent of the
arithmetric mean was usually found, but when experiments
were pooled this standard deviation was nearer 50% for
most tissues.
Examination of the data for "^*Cr whole TDL" reveals a
distribution pattern in the secondary lymphoid organs
similar to those reported by others (Gowans & Knight 1964,
Shorter & Bollman I960, Heslop & Hardy 1971? etc).
)









































































































































































































































































































































































































































































































































































































Initially the major localization was in the spleen, which
often accounted for half of the injected activity at 2 hrs.
The concentration of label then fell from this peak value
by a factor of two to three by 24 hrs. There was also an
initial rapid localization in lymph nodes amounting to
approximately 8% per hour over the first half hour in
superficial nodes. This was followed by a short period
of relatively slow accumulation between ^ and 2 hrs and
then by a steady and prolonged increase in activity
reaching peak values around 18-24 hrs. Most lymph nodes
showed very similar concentrations per unit weight with
perhaps a slight tendency to higher concentrations in
superficial as opposed to mesentric nodes. A notable
exception was the hepatic node which almost invariably
showed higher concentrations particularly at 2 hrs and 24
hrs. The extent of this increase is shown in Table 4-2.
Table 4.2
% Inj.dose/gm + SD of Lymph Node following iv Injection
of ^Cr whole TDL (perfused). (n) No. of recipients/group.
■_ . ,_L.

























Autoradiographs of lymph nodes removed one hour after iv
o
injection of JH-Udr labelled TDLs confirmed this increased
concentration in the hepatic lymph node and showed that
many of the labelled cells were in the subcapsular sinus
of this node. Cells in this compartment of lymph nodes
draining other anatomical regions were very much fewer
with a slightly greater frequency noted in the mesenteric
node compared to superficial cervical, axillary or pre-
femoral nodes (see Figs 4.1> 4-2, 4>3).
>
FIG 4■1
Autoradiograph of a section of mesenteric lymph node
of a rat injected iv 2 hrs previously with 500 x 10^
syngeneic TDL labelled with ^H-Udr.
Many labelled cells are present in the deep cortex
(lower centre field) where some are associated with
specialized post-capillary venules (dilated by
vascular perfusion at the time of sampling). However
labelled lymphocytes are also present in the sub¬
capsular sinuses and in the superficial cortex
between the lymphoid follicles. Labelled cells were
absent from germinal centres.





Autoradiograph of a section of Hepatic Lymph Node of a
rat injected iv 2 hrs previously with 500 x 10^
■7
syngeneic TDL labelled with H-Udr. Labelled lympho¬
cytes are present in the subcapsular sinus, super¬
ficial cortex and particularly the deep- or para¬
cortex .




Autoradiograph of a section of Hepatic Lymph Node of a
rat injected iv 2 hrs previously with 500 x 10^
syngeneic TDL labelled with ^H-Tdr (in vitro).Labelled
lymphoblasts are present in the subcapsular sinus and
were noted sparsely distributed in the superficial and
deep cortex.
Mag x 350. Methyl Green + Pyronin; green filter;
6 weeks exposure.
 
These results in lymph nodes and spleen act as a positive
control for the techniques used and suggest the 'normal'
behaviour of the injected cells. They also confirm that
the choice of times at which tissues were sampled was
appropriate and likely to show tissue concentrations under
conditions when levels in the spleen, lymph nodes and
blood were substantially different. Thus levels at half
an hour will reflect the initial rate of extravasation
from the blood, those at two hours will be associated with
minimal blood levels and maximum spleen concentrations,
while the results at 24 hrs will reflect the distribution
when equilibration of the injected cells within the re¬
circulating lymphocyte pool is almost complete. Confirm¬
ation of this latter assumption was obtained by examining
tissues in triplicate recipients perfused 24, 48, or 72
hrs after injection of aliguots of the same suspension of
^Cr labelled TDL. Table 4-3 summarizes the results which
show very little fluctuation between tissue concentrations
at these times, allowing that some of the late decreases
may be due to non-specific elution of label.
The results in other tissues showed various patterns of
distribution. The small intestine excluding the organized
lymphoid tissue of Peyers Patches showed significant early
localization of radioactivity with a small degree of
further accummulation between 2 and 24 hrs.
The thymus showed a pattern similar in shape to lymph
nodes but 3 orders of magnitude less in quantity. Thus
there was significant early localization by ^ and 2 hrs
(Fig 4-4) but a five fold further increase by 24 hrs,
resulting in concentrations that were consistently higher
than in most non-lymphoid tissues. Autoradiography of
sections of thymus prepared 36 hrs after intravenous
injection of or ^C-Udr labelled TDLs showed such
labelled cells located in the medullary parenchyma (see
Fig 4.5, 4-6). These cells were most readily visualized
after injection of large numbers (up to 3 x 10^) of
labelled cells but the proportional distribution of label
TABLE 4.3
Late Time Course of Tissue Radioactivity following iv
Injection of Normal ^Cr TDL into Syngeneic Recipients
(Perfused).
3 recipients of the same cell suspension at each time
point.
% Inj Dose Per Gram of Tissue
Tissue 24 hrs 48 hrs 72 hrs
Spleen 42.5 26.5 28.9
Superficial lymph nodes 6 5.5 53.9 49.6
Mesenteric lymph node 52.9 55.3 41.9
Small intestine .65 • 70 • 51
Thymus • 37 . 26 • 30
Bone (marrow) • 78 •53 • 49
Liver 1.4 1 . 2 1.4
Kidney .33 • 33 .38
Muscle .044 .006 .007
Brain .003 .0008 . 0004
White blood cells • 153 .070 .086
Skin .011 .010 .010
FIG 4-4
Autoradiograph of a section of thymus medulla of a
rat injected iv 2 hrs previously with 500 x 10^
3
syngeneic TDL labelled with H-Udr. Labelled lympho
cytes are present attached to the wall of a venule,
dilated by vascular perfusion, and also in the inter
stitial parenchyma.
Mag x 350. Methyl Green + Pyronin; green filter;
4 weeks exposure.
FIG 4-5
Autoradiograph of a section of thymus of a rat
injected iv 36 hrs previously with 3000 x 10^
3
syngeneic TDL labelled with H-Udr. Numerous
labelled lymphocytes are present in the medulla but
not in the cortex.
Mag x 50. Methyl Green + Pyronin; green filter;
6 weeks exposure.
FIG 4-6
Same section as Fig 4-5. High power view of labelle
lymphocytes in thymic medulla.
Mag x 500. Methyl Green + Pyronin; green filter;
6 weeks exposure.
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per whole thymus did not vary with the dose of cells
injected.
The bone marrow accumulated substantial proportions of
radioactivity with peak values seen at 2 hrs followed by a
decrease in concentration between 2 and 24 hrs of some
five fold. Autoradiography of decalcified histological
sections showed frequent JH-Udr labelled cells in all
areas of the parenchyma with perhaps a slight tendency to
an early accumulation in areas near the bone surfaces.
Such labelled cells were extravascular and were very much
less frequent by 24 hrs after iv injection (see Fig 4-7,
4.8). This pattern of distribution has many features in
common with that seen in the spleen.
In blood a very rapid fall in concentration was character¬
istic. This observation and that of initial levels that
are never as high as might be expected confirm those of
many other workers (eg Bunting et al 1963)-. Bunting et al
also described minimum concentrations found at around 2-4
hrs after iv injection with some small increase by 24 hrs
and this observation was confirmed. The early fall in
blood levels was associated with high concentrations in
the lung which show rapid falls between ^ and 2 hrs as
previously reported (eg Weisburger et al 1951, Gowans &
Knight 1964, Scollay & Smith 1976).
The liver accounted for about ten per cent of the injected
activity at all time intervals and this lack of fluctuation
was also apparent in the kidney.
The other non-lymphoid tissues studied consistently showed
low total amounts of radioactivity but the concentrations
were significantly above background and in general showed
highest values at ^ hr with a fall by 2 hrs and little
change thereafter. However in individual experiments in
which all time periods were studied with the same cell
suspension a slight rise in concentrations - eg in skin -
was often seen between 2 and 24 hrs. Such slight changes
FIG 4-7
Autoradiography of a section of decalcified bone and
marrow from a rat injected 2 hrs previously with
6 7.
500 x 10 syngeneic TDL labelled with H-Udr. Many
labelled lymphocytes are present in the marrow
parenchyma particularly in areas close to bone
surfaces. The sinuses are widely dilated by
vascular perfusion at the time of sampling.
Mag x 200. Methyl Green + Pyronin; green filter;
4 weeks exposure.
FIG 4-8
Autoradiograph of a section of a 'plug' of bone
marrow expelled from the femur of the same animal
as Fig 4-7. Numerous labelled lymphocytes are
intimately mixed with unlabelled marrow cells.
Mag x 240. Methyl Green + Pyronin; green filter;
4 weeks exposure.
 
cannot be seen in the pooled data from multiple experi¬
ments, because of the wider interexperiment variation.
At equilibrium non-lymphoid tissues had concentrations
approximately ^/l0,000 of those in lymph nodes. Extensive
searches of histological autoradiographs confirmed the
presence of labelled cells in all tissues; Figs 4-9, 4-10
4-11j show examples of interstitial labelled lymphocytes
in brain and testis.
'Passaged Cr TDL' produced a distribution pattern that
was usually very similar to that of the whole population
labelled with ~^Cr. It was noteworthy that there was
significant localization of radioactivity in the small
intestine and thymus which both also showed some late
accumulation.
The bone marrow again showed substantial but temporary
early localization, as did the spleen. Non-lymphoid
tissues showed if anything a more pronounced 'peak' at 5
hr, partly as a result of more substantial falls by 2 and
24 hrs. The minimum blood leucocyte concentration at two
hrs was consistently absent with this population.
Udr-labelled lymphoblasts
The tissue distribution pattern following the iv injection
of this population differed markedly from that of the othe
two populations, as expected. The proportionately smaller
localization in the spleen and lymph nodes confirmed the
observations of others (Gowans & Knight 1964; Hall, Parry
& Smith 1972), as did the substantial localization in the
small intestine at both early and late intervals. An
increased concentration in the mesentric lymph node when
compared to superficial nodes (eg cervical) was noted at
2 hrs but not at 24 hrs. As with the other populations,
significant activity was found in the thymus. The bone
marrow accounted for a large proportion of the injected
activity with a similar time course as seen with *Cr.
Concentrations in lung and blood both fell rapidly from
their initial levels and it was noted that the majority of
FIG 4-9
Autoradiograph of a section of brain of a rat
injected iv 24 hrs previously with 1080 x 10^
syngeneic TDL labelled with -Udr. Two
labelled lymphocytes are present in the interstitium
and the dilated capillary shows the effect of
vascular perfusion at the time of sampling.
Mag x 450. Methyl Green + Pyronin; green filter;
6 weeks exposure.
FIG 4- 10
Same animal as Fig 4-9- A labelled lymphocyte in
the interstitium of the cerebellum.
Mag x 550. Methyl Green + Pyronin; green filter;
6 weeks exposure.*
FIG 4-11
Autoradiograph of a section of testis from a rat
injected iv 24 hrs previously with 215 x 10
syngeneic TDL labelled with ^C-Udr. The recipient
was perfused at the time of sampling. A labelled
lymphocyte is seen in the interstitial connective
tissue.
Mag x 150. Methyl Green + Pyronin; green filter;
6 weeks exposure.
 
the activity in blood was in the cell free plasma fraction.
The liver accounted for a considerable proportion of the
lhbel initially but this level fell steadily over 24 hrs
unlike the ~**Cr activity. However, the total account¬
ability of was also much lower than for ~^Cr by 24hrs.
12 5The consistent excess of I in the supernatant perfusate
over that in the total plasma volume showed that some
contamination of tissues by eluted label was likely. Non-
lymphoid tissues which showed maximum levels at 5 hr with
subsequent falls by 2 hrs and 24 hrs consistently showed
proportional concentrations that were several times
greater than those seen with either ^Cr population.
In an attempt to accentuate these possible early fluctu¬
ations in non-lymphoid tissue concentrations the distrib¬
ution of labelled cells in splenectomized recipients was
studied at similar time intervals.
Data pooled from several experiments is shown in Table 4-4,
in which the results are expressed as tissue concentrations
- ie arithmetic mean percentage injected dose/gram of
tissue perfused at 2 or 24 hrs after iv injection of
~**Cr labelled cells. The results which confirm those of
Bradfield & Born (1973) showed at least double intact
control activities in lymph nodes of splenectomized
recipients at \ and 2 hrs but little difference at 24 hrs.
This extent of increase was measured in most tissues, being
most obvious in blood, lungs and bone marrow, and least
noticeable in non-lymphoid tissue such as skin.
Table 4•5 shows the results of experiments in which the
recipients had been allowed 12 days to recover from the
effect of the surgical trauma of splenectomy or sham
laparotomy. The distribution of label at 2 hrs and 24 hrs
confirms the results shown in Table 4-4* showing that the
differences are due to the lack of the spleen which acts
to remove large numbers of lymphocytes from the circulation
soon after injection, rather than a non-specific effect
/
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following surgery. As this "sink" only removes about ten
1 2 c
percent of I Udr labelled lymphoblasts in normal
recipients, the effect of such an operation on this
population is likely to be less pronounced, there being
fewer cells made available for redistribution. This
prediction is confirmed by the results shown in Table 4-6,
which shows the distribution of a mixture of passaged ^Cr-
labelled TDL and Udr-labelled lymphoblasts in
recipients one hour after iv injection. Not only are there
smaller differences between tissue concentrations of ^ ^ 5 j
in intact and splenectomized recipients but also the ratio
of 125I/51 Cr in each tissue tends to be smaller in the
1 2 c
splenectomized animal. Similar results for were
found at 2^ hrs (Table 4*7)• In general the gut showed
the greatest increase in an(j as with ^*Cr differences
in non-lymphoid tissue were least dramatic.
The most important observation from these experiments was
the correlation between the increased blood leucocyte
concentration at \ and 2 hrs in splenectomized recipients
with a similar increase in lung concentrations. Previous
interpretations of the initial high localization of
labelled cells in the lung of normal animals had suggested
a mechanism involving sequestration or embolization of
cells in lung vessels as a result of possible changes to
the lymphocytes due to in vitro manipulation (Gowans &
Knight 1964, Hall Scollay & Smith 1976). The present
results make such an explanation untenable as there is no
way in which the removal of the spleen could slow the rate
of decline in lung levels without the cells being mobile
within the blood circulation and not sequestered. This
pattern of distribution in the lung would however result
if lymphocytes normally traversed the lung capillary bed
relatively slowly so that the localization is apparent
rather than real and follows the rapid return of labelled
cells (which have made a circuit with the blood during
which they failed to extravasate elsewhere) to this
capillary bed.
TABLE 4.6
THE DISTRIBUTION OF RADIOACTIVITY ONE HOUR AFTER I.V. IN3ECTI0N
C s\ <1 O C
OF PASSAGED Cr TDLs AND IUDR LABELLED TDLs INTO INTACT OR
SPLENECTOMIZED RECIPIENTS.
% IN3 DOSE/GM OF TISSUE AND RATIO OF % IN3 125l/$ IN3 51Cr.^
TISSUE INTACT SPLENECTOMIZED
P51Cr 125 R n51rP Cr 125 R
SPLEEN 131 .1 24.3 .18
SUP. LYMPH NODES 33.0 1 .8 .05 55.5 2.03 .04
MES. LYMPH NODES 21 .6 3.3 .15 28.0 2.9 .10
SMALL INTESTINE .32 1 .94 6.0 .67 2.7 4.0
THYMUS .29 .22 .7 .09 .27 3.0
BONE MARROW 1.3 1.8 1 .4 3.9 2.3 .6
BLOOD LEUCOCYTES .27 .09 .33 .86 .07 .1
LUNG 8.9 32.8 3.7 32.7 41 .2 1.2
LIVER .78 2.7 3.5 1.7 3.26 1.9
KIDNEY .26 .55 2.0 .73 .79 1.1
TESTIS .02 .05 2.5 .01 .05 6.0
EPIDIDYMIS .05 .16 3.0 .09 .18 2.0
BRAIN .016
1
.026 1.6 .06 .05 .8
SKIN .03 .21 6.9 .05 .20 4.3
TABLE 4.7
THE DISTRIBUTION OF 125I 2-J HOURS AFTER
I.V. INOECTION OF 125IUdr LABELLED LYMPHO-
BLASTS IN TDLs INTO INTACT OR SPLENECTOMIZED
RECIPIENTS.
% INO DOSE/GM OF TISSUE
TISSUE INTACT SPLENECTOMIZED
SPLEEN 17.6
SUP. LYMPH NODES CDCD• 1.3
MES. LYMPH NODES 3.5 3.7
SMALL INTESTINE 2.9 4.2
THYMUS .27 .26
BONE MARROW 1.1 2.1
BLOOD LEUCOCYTES .014 .027
LUNG 5.3 6.2







The initial precipitous fall in labelled leucocyte
concentration in the blood after injection of a bolus of
cells might suggest that there is a homeostatic mechanism
regulating the lymphocyte content of blood. If such a
mechanism existed it should act upon the lymphocytes
within the host as well as any artifically added to the
blood compartment. Experiments designed to detect such a
mechanism were carried out by preloading recipients with
~**Cr labelled TDL which were allowed 24 hrs in which to
equilibrate within the recirculating pool. Such recipient
were then "challenged" with a large 'bolus' of unlabelled
TDL, an equivalent volume of cell free fluid or left
untreated as controls. Half an hour later the recipients
were subjected to whole body perfusion as before and the
proportional distribution of the original ^Cr labelled
cells was measured with particular emphasis on tissues
where such homeostatic mechanisms might exist - viz lung,
spleen and bone marrow.
Table 4•8 shows the results of such an experiment
expressed as the arithmetic mean (of duplicate recipients)
percentage injected ^Cr/organ.
Allowing for the inherent variation between recipients, no
differences can be detected with any of the treatments,
suggesting that the injected cells behave independently
and do not interact with those already present in the host
This further suggests that the rapid lowering of blood
concentration of labelled cells is simply a reflection of
the rapid rate of extravasation and therefore short half-
time within the blood compartment. Support for this hypo¬
thesis comes from the lack of difference seen in the
proportional distribution of label carried on a wide range
of cell doses (10 x 10^ - 3 x 10^) which might otherwise
be expected to have a variable effect upon any putative
homeostatic control.
The distribution following intra-arterial injection of
labelled cells into a peripheral artery allowed further
/



























































examination of the initial localization of labelled cells
in non-lymphoid tissues, to define whether the early 'peak'
was real and not just an artefact resulting from
incomplete wash-out of labelled cells from the intra¬
vascular compartment. Under these conditions some
peripheral tissues could be supplied with a known con¬
centration of labelled cells maintained over a period and
information relating to the rate of extravasation could
become available. The complete removal of interacting
factors can be achieved only in isolated perfused organ
models but such isolation is not feasible with diffuse
tissues such as skin.
Table 4•9 summarizes the results of several experiments in
which ^*Cr labelled cell suspensions were infused into the
arterial circulation. Interpretation of the results must
take into account the necessity of ligating the artery
used for infusion to prevent inevitable haemorrhage upon
removing the cannula. This implies a reliance upon
collateral circulations both during the period of the
experiment and for the saline perfusion.
Experiment 101 involved the measurement of tissue distrib¬
ution after whole body perfusion at several times after a
seven minute infusion of ^Cr labelled TDL into one femoral
artery at the mid-femoral level. The concentration, rate
of administration and pressure were approximately physio¬
logical. The results in the tissues of the directly
perfused leg show highest concentrations ten minutes after
the end of the infusion with decreasing concentrations at
1 and 2 hrs except in the marrow, which showed a higher
value at 2 hrs than at 1 hr. A similar pattern is seen in
the tissues of the contra-lateral leg but with lower
concentrations. Even lower concentrations were measured
in similar tissues from the trunk of the animal with much
less time dependent variation. It was notable that the
variation between the concentration in bone marrow from
various sites was not great. The lung consistently showed
high concentrations soon after ia injection of the same
/































































































































order of magnitude as after iv injection, confirming the
observations of Weisburger et al (1951)- The spleen also
contained substantial radioactivity soon after injection.
Experiment No.100 also showed relatively small differences
between the concentrations in tissues of the directly
perfused and contralateral limbs, and in Experiment No.88,
in which tissues were sampled half an hour after injection
into the lower abdominal aorta, there was again little
difference between skin and muscle in the legs or from the
flanks of the upper half of the body, which were presumed
not to receive the infusion direct. The highest absolute
values in peripheral tissues were found immediately after
the end of an hour-long infusion of a labelled cell
suspension. These results all suggested that the rate of
extravasation in non-lymphoid tissues was low and that the
concentrations of labelled cells supplied directly was not
much, if any, less than after iv injection, supporting the
idea that in the latter situation thorough mixing in the
blood pool did occur quickly and all the injected cells
were available to the systemic circulation.
The possible inefficiency of wash-out by whole body per¬
fusion may still be raised as a criticism, particularly at
very short intervals after injection, and this factor can
never be completely removed. Evidence in support of the
idea that the remaining intravascular cells are unlikely
to account for all the tissue activity measured is (i) the
ability to perfuse some highly vascular tissues - eg brain
- to an extent that they give lower concentrations than
elsewhere - eg skin - even at early intervals when the
blood activity is high; (ii) by 2 hrs the concentration
125.of I was increased in irritated skin but that due to
^Cr in the same animal decreased between 5 and 2 hrs. In
the blood the concentration of both isotopes was
decreasing over this time period; (iii) most of the
activity estimated for the total blood volume can be
accounted for in the blood sample and total perfusate;
(iv) previous reports using ^Cr labelled red cells show
very low residual red cell content of tissues after simple
"bleeding out" - eg Skin 2.2ul rbc/gram, and Muscle 3•6ul
rbc/gram, in 200 gm rats (Meulheims et al 1959). If the
total red blood cell volume was 4-4ml, then for skin .05%
of the total blood activity would be present per gram of
skin, which, if the ^Cr leucocyte data at 24 hrs are con¬
sidered, would result in a figure of approx. * x 1.88 =
.0009% of the initial dose of ^*Cr labelled TDL. In an
experiment of similar design ^Cr labelled red cells were
injected iv into syngeneic recipients. 24 hrs later two
recipients were exsanguinated by section of the abdominal
aorta while two others were subjected to whole body
perfusion. The results of tissue distribution (Table 4*10)
expressed as mean percent inj.dose/gm, show that the
exsanguination gives results that are comparable to those
reported by Meulheims and in most tissues "perfusion"
lowers the residual activity by a further factor of approx¬
imately 50%. Thus if the total blood ^*Cr. activity'is
taken as the equivalent of the total injected red cell
dose in experiments using labelled lymphocytes, the
maximum activity that can be accounted for by residual
bl ood is likely to be, eg in skin, .001% inj.dose/gm. This
is in fact less than ^/lOth of the activity measured and
assuming that lymphocyte behaviour within the circulation
is somewhat similar to that of erythrocytes, it suggests
that the activity measured reflects true extravasation.
This is supported by the results of an experiment in which
the "perfusate" of a normal animal was collected in
sequential 20ml fractions and each fraction was analysed
for total leucocyte count. The total leucocyte output
fell steeply and then more gradually in successive
fractions and the total found approximated the estimate
made of the total blood content from counts made on a
cardiac blood sample (Table 4-11)-
The other possible way of measuring interstitial lympho¬
cyte flux directly is to collect the output of afferent




DISTRIBUTION OF RADIOACTIVITY 24 HR AFTER Cr LABELLED ERYTHROCYTES
INUECTED I.V. INTO SYNGENEIC RECIPIENTS. COMPARISON OF EXSANGUINATION
AND WHOLE BODY PERFUSION.
MEAN % IN3 DOSE/GM OF TISSUE - S.D.
























































































TOTAL RECOVERY -Oz. 55;i 80^
109
TABLE 4.11
The Effectiveness of Whole Body Perfusion in the Removal
of Intravascular Nucleated Cells.
Sequential 25ml Collections of Vascular Perfusate - Total
Nucleated Cell Count in Zaponim Treated Samples Measured
in Coulter Electronic Particle Counter.
Sample No. Cell Count x 10^
1 ' 42.6
2 6.9

















Total Recovered 122.5 x 10
Total Estimated in Blood l6l x 10^
(57% lymphocytes)
% Recovery 76%
the rat because the ducts are too small to cannulate. A
much less satisfactory approach is to examine autoradio¬
graphy of tissues and lymph nodes for labelled cell
content in extravascular sites and in afferent lymphatic
channels. The only place to be sure of identifying the
latter structures is at their entrance to lymph nodes - ie
the subcapsular sinuses.
Tissues were examined at 5, 1, 2, or 24 hrs after iv
injection of large doses of Udr or Udr labelled TDL
or H Tdr in vitro labelled lymphoblasts.
At one hour after injection of labelled small lymphocytes
many labelled cells were found in the paracortical areas
of all lymph nodes with many cells associated with the
post-capillary venules. Labelled cells were also seen in
the subcapsular sinus of some nodes. This occurrence was
most frequent in the hepatic node, common in the mesent¬
eric node, and infrequent in superficial cervical,
axillary or prefemoral nodes. In addition, labelled cells
were also found in interstitial lymphatic ducts in the
immediate vicinity of the hepatic node at this time. Exam¬
ination of similar tissues at one hour after injection of
3
the same total number of cells containing H Tdr-labelled
lymphoblasts showed a much lower frequency of lymphoblasts
in the paracortex of all nodes. These were most frequent
in the mesenteric node in which many labelled blasts were
also found in the subcapsular sinuses. It was impossible
to decide whether the total increase in frequency could be
accounted for by the entrance of cells from the afferent
lymph or whether some degree of specificity of entry
according to tissue of origin was also operative at the
post-capillary venule. The hepatic node again showed a
high overall frequency with many labelled cells in the
subcapsular sinus. The peripheral nodes contained only
infrequent labelled cells.
At ^ hr, all nodes showed labelled cells only in associa¬
tion with post-capillary venules in the paracortex. By 24
hrs the distribution within nodes was much more diffuse and
occasional cells could be found in the subcapsular sinus
of all types of node.
3 14At 24 hrs occasional cells labelled with either H or C
Udr were identified in the interstitium of all tissues by
autoradiography of tissue sections including brain after
large numbers of labelled cells had been injected. As
already mentioned, labelled cells were found in thymic
medulla and bone marrow at frequencies that confirmed the
distribution pattern seen with whole organ radioassay.
In the small intestine labelled cells were found in the
interstitium of the lamina propria as expected. The
frequency was greater at the base of the villi compared to
the tips and occasional cells were also found in the
position of 'theliolymphocytes' between epithelial cells.
With or Udr labelled cells those labelled cells
seen extravasated in the lamina propria comprised obvious-
ly pyroninophilic blast cells and small lymphocytes. H
Tdr in vitro labelled TDL showed a particular propensity
for extravasation in this site as is well established (see
Fig 4-12) (Gowans & Knight 1964; Hall, Parry & Smith 1972).
3
However, long lived in vivo H Tdr labelled cells were also
found in the intestinal lamina propria.
Labelled cells were found frequently in lung at 2 hr and
with decreasing frequency at later times. At no time was
there evidence of embolization, the cells always being
separate and widely distributed throughout the vasculature.
Both here and in the liver where labelled cells were found
associated with sinusoids and the interstitium of portal
tracts, it was very difficult to determine whether many of
the cells were in the lumen of vessels or not, even after
vascular perfusion with saline and fixative. No evidence
of engulfment of labelled cells by Kupffer cells was found.
FIG 4-12
Autoradiograph of a section of the wall of the small
intestine of a rat injected 2 hrs previously with
500 x 10^ syngeneic TDL labelled with ^H-Tdr (in
vitro). Labelled lymphoblasts are present both in
the interstitial lamina propria and between epithel¬
ial cells (theliolymphocytes). Recipient underwent
vascular perfusion at the time of sampling; the
small vessels are therefore widely.dilated.






The interpretation of the data revealed by distribution of
radioactivity depends upon the factors enumerated in the
introduction. The results of the experiments involving
splenectomy and intra-arterial injection, together with
the apparent independence of behaviour of the injected
cells, all suggest that following intravenous injection
the labelled cells mix in the blood and are all available
to the peripheral circulation immediately. The major
localization in lung after intra-arterial and intravenous
injection originally described by Weisburger et al (1951)
was at that time interpreted as a mechanism for the perm¬
anent removal of cells. The later 'emigration' was not
apparent as the tissues were only examined at short
intervals after injection. The most reasonable inter¬
pretation is that the lymphocytes take a relatively long
time to traverse the lung capillaries but that they are
mobile and not 'sequestered' as suggested by others
(Gowans & Knight 1964; Hall Scollay & Smith 1976).
The similarity between the results reported relating to
secondary lymphoid tissue and those of various other
workers supports the contention that the cells are
behaving 'normally'. Thus the major pathways through
lymph nodes and spleen were confirmed for small lympho¬
cytes (Gowans & Knight 1964; Goldschneider & McGregor
1968a), as were those through lymph nodes, spleen and
small intestine for the lymphoblasts in thoracic duct
lymph (Gowans & Knight 1964; Griscelli, Vassali &
McCluskey 1969; Hall, Parry & Smith 1972).
In addition to these well defined migratory routes the
present data suggest that a further major pathway is
through the parenchyma of the bone marrow. As early as
1951j Farr reported the presence of many fluorescently
labelled isologous lymph node cells in the bone marrow of
rabbits at early intervals after iv injection with a
disappearance from this site by twelve hours. These
results were interpreted at that time as being suggestive
of transformation into other cell types rather than re-
migration which was not considered. Shorter & Bollman
(i960), using ^Cr labelled lymphocytes in rats, reported
maximum bone marrow localization of \% of the injected
dose, but the size of the sample was not published. The
presence of some interchange of long-lived lymphocytes
between blood and bone marrow has been suggested by the
presence in bone marrow suspensions of cells with similar
functions - eg GVH activity (Yoshida & Somond 1971) and
f «
SRBC helper cells - to those of mature T cells which could
be removed by prolonged thoracic duct drainage (Howard &
Scott 1972). This interchange has always been assumed to
be relatively small, but it seems that a substantial flux
of such cells occurs. The estimate of roughly a quarter
of the injected cells being temporarily localized in the
bone marrow was made assuming that the total bone marrow
organ was contained in bones totalling 5% of body weight
in similar proportion to the tibiae and femora. The total
skeleton weighs slightly more than this but some bones
contain very little marrow. The large size of this flux
has not been appreciated for two main reasons. Firstly,
the tissue is diffusely spread throughout the skeleton and
is perhaps more difficult to examine than other tissues
and, secondly, the rapid flux means that the maximal
localization is soon after cell transfer. In the
equilibrated state the proportion of recirculating cells
within the marrow lymphocyte population is very small, as
shown by the very high labelling index in this population
3
after only a few days H Tdr administration (Everett et al
1964) • Chapter 6 will discuss experiments related to the
importance of this particular migratory pathway.
The evidence relating to the efficiency of perfusion wash¬
out of the vasculature suggested that a maximum of ten
percent of the activity in most tissues could be accounted
for by remaining intravascular label. This low value of
intravascular contamination together with the histological
evidence of labelled cells in the interstitium of tissues
and particularly in the subcapsular sinus of lymph nodes,
even at early intervals after in injection, support the
hypothesis that the bulk of the total activity measured in
each tissue is related to the extravascular content of
labelled cells.
If this is the case estimations of the proportional
distribution after equilibrium has been achieved within
the recirculating pool, will provide some measure of the
relative size of the many compartments of the total pool,
remembering always that the degree of accuracy will be
limited by a tendency to over-estimation because of some
intravascular label and also a tendency to under-estimation
following elution of label.
With a knowledge of the size of the total pool, these
proportions within various compartments can be converted
to actual numbers of lymphocytes. Furthermore, if the
modal transit time through a compartment can also be
estimated, then tissue fluxes in numerical terms can also
be calculated. Allowing that equilibration is virtually
achieved by 24 hrs, by which time some ten percent of ^Cr
has been secreted in the urine, the proportions at this
time interval for the passaged ^Cr TDL population can be
used to estimate numbers of accredited recirculating cells
in each compartment. The total numbers in the whole pool
were estimated using the assumption of Gowans (1959) that
the total output in the thoracic duct lymph over the period
of about four days, by which time low plateau levels of
cells were draining reflected the number of readily mobil¬
ized cells of the recirculating pool. In the rat strains
9used for these experiments average values of 2 - 2.5 x 10
cells were collected over a period of four days continuous
drainage.
Another source of error when estimating total organ
proportions is the variation in weight of each tissue. The
degree of error introduced is likely to be greater for
organs with high concentrations of label such as lymph
nodes, especially as multiple small organs are difficult
to dissect out totally with certainty. In large diffuse
organs such as skin or muscle, because of the low label
concentrations, relatively large errors in the weight
estimation will make relatively little difference to the
total organ content of labelled cells.
With the use of the 24 hr ^*Cr passaged cell data, the
standard organ weights in a 200g rat and the value of 2.5
9
x 10 for the total pool content, values for lymphocyte











Spleen 427 .0 1070.0
Sup.lymph nodes 650.0 1300.0
Mesenteric node 160.0 1060.0
Small intestine 38.5 7-7
Thymus .65 2 . 2
Bone marrow 60.0 6.0
Blood leucocytes 42.5 2 . 8
Lung 55.0 46.0
Liver 232 . 0 23-2
Kidney 13.0 8.0
Ovary / .075 .75
Uterus .10 .25
Muscle 9.5 .09




These figures can only be regarded as approximate and it
is noted that the total accountability is only about two
thirds of the estimated total pool. The majority of this
shortfall is likely to be due to inaccuracies in lymph
node weight estimates. However, artefactual results may
obtain for tissues such as liver and kidney, as these are
known to be organs involved in disposal of label associated
with dead cells. The same may also be true in salivary
gland, for no labelled cells were found in this organ in
histological sections and it is a secretory organ that
might be expected to act in the excretion of cell free
label. The values relating to the lung are after per¬
fusion and were measured in peripheral pulmonary tissue.
The degree of extravascular label is unknown, but a major
proportion in this situation may still be intravascular.
The results suggest that at least half of the total cells
in the circulation are in the pulmonary vasculature and
therefore might escape being counted in systemic blood
samples. Put another way, the total blood leucocyte count
measured by systemic blood samples may largely under¬
estimate the true total intravascular complement of such
cells.
The results for spleen and lymph nodes compare closely
with those of Ford & Gowans (1969). Estimates of tissue
fluxes from these results require also an estimate of the
modal transit time. Deriving values for this parameter
from the shape of the distribution curves (the time of
peak localization and the rate of subsequent decline) and
assuming uniformity in the behaviour of the cells within
the injected population tissue flux can be calculated using
the formula:
No. of lymphocytes/gm
Transit time in hrs
Using direct evidence relating to the transit time in
spl een of 5-6 hrs (Ford 1969a) and lymph nodes 18 hrs
(Ford & Simmonds 1972) as approximate calibrations for the
other curves, transit times are suggested in Table 4-13-
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TABLE 4-13
Est.Transit Time Lymphocyte Fiux
Tissue Hrs (approx) /gm/hr /Organ/hr
Spleen 4-6 214 X 106 86 X 106
Sup.lymph nodes 18 72 X 106 36 X 106
Small intestine ? 12 .64 X 106 3.2 X 106
Thymus 18 .12 X 106 . 04x 106
Bone marrow 3-5 1.2 X 106 12 X 106
Blood leucocytes .3 9-3 X 106 140 X 106
Lung ?? mins -
Liver 7 -
Kidney 7 -
Ovary 1-3 .25 X 106 .02 5 X 10
Uterus 1-3 .083Ix 106 •03 3 X 106
Muscle 1-3 .03 X 106 3-0 X 106
Salivary gland 1-3 .40 X 106 . 12x 106
Brain 1-3 .01 X 106 .015 X 106
/
Skin 1-3 • 05 X 106 1.5 X 10
Apart from the histoiogical evidence of labelled cells in
lymph node subcapsular sinuses of draining lymph nodes
within one hour, support for the contention that modal
transit times through non-lymphoid tissues are more rapid
than through lymph nodes, comes from experiments in the
sheep, in which *Cr labelled efferent lymph cells were
injected iv and collected from both afferent and efferent
lymph duct fistulae. In these experiments activity was
consistently found in afferent lymph within the first hour
and the activity curve in afferent lymph lead that in
efferent lymph by several hours (Hall, Scollay & Smith
1976). A transit time of approximately ten hours was
suggested and if this was so the present fluxes for the
rat could be reduced by a factor of about three. The
presentation of the results in this report as specific
activities precludes detailed quantitation of the kinetic data.
The results of experiments of Smith et al (1970a) which
examined cell outputs in afferent lymph from several
tissues in the sheep give precise quantitation of cell
numbers but no estimate of the weight of tissue drained
was reported. For discreet organs, where the total lymph
output can be reasonably assumed if organ weights are also
estimated then fluxes can be computed. Hourly outputs in
afferent lymph of 2.0 x 10^ from the kidney, 5-0 x 10^ for
the testis and 75 x 10^ for the liver, were quoted (Smith
Pederson & Morris 1970). If weights for these organs of
lOOgm, 250gm and lOOOgm are assumed, then flux values of
.02, .02 and .075 x 10^/gm/hr are suggested. These values
are of the same order of magnitude as those calculated for
non-lymphoid tissues in the present experiments. Fig 4-13
shows a schematic view of the compartments of the re¬
circulating lymphocyte pool with possible rates of flux.
The finding of a substantial afferent supply of small
lymphocytes to hepatic node from the liver in the sheep
which amounted to about half of the efferent output of
this node, provides evidence for a substantial migration
pathway through liver. This is also suggested by the early
increased concentration of label in this node compared to
others and the very frequent finding of labelled cells in
subcapsular sinuses in this node as has also been described
for and ^H-Tdr-labelled lymphocytes (Fichtelius &
Groth 1963)- However bee ause of the lack of fluctuation
in tissue levels in the liver, a modal transit time cannot
be suggested.
A very indirect method of estimation of this hepatic flux
can be made by assuming half of the activity in the
hepatic node to be the result of this afferent flow. The
hepatic node weighing approximately O.Olgm would therefore
contain some 15 x 10^ cells as a result of afferent flow
at equilibrium. If the hepatic weight and transit time
were lOg and 3 hrs respectively, then a flux of .5 x 10^/
gm/hr through liver is suggested. This is greater than
that found in the sheep and little reliance can be placed
121
FIG 4• 1 3
Lymphocyte Recirculation
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upon it. However, this result suggests that the ten per¬
cent of the injected dose measured in liver considerably
over-estimates the true extravascular content of viable
cells.
If these values for lymphocyte flux are reasonable then
the total flux through non-lymphoid tissues excluding liver
amounts to about 10 x 10^/hr. This is in agreement with
the hypothesis that the majority of lymphocyte traffic
into efferent lymph comes directly from the blood in lymph
nodes and not via the tissues and afferent lymph, rather
than the other way round as originally suggested (Sjovall
1936). The latter theory was also supported by St Marie
(1967) who examined arteries and veins at the hilum of
lymph nodes in rats quick frozen in liquid nitrogen for
their lymphocyte frequency per unit area in tissue
sections. He reported an increased frequency in the veins
and interpreted this as being due to a net addition of
lymphocytes to the blood from the lymph node in direct
contradiction to the idea that the blood lymphocytes
showed net entry into the node. He further suggested that
the autoradiographic evidence in the rat and kinetic data
in the sheep could be due to experimental artefact and that
the afferent input of lymphocytes into nodes was quantit¬
atively more important (St Marie 1975)• The present
results suggest rather that the maximum figure for the
afferent input of most nodes is 20% of the total output
necessitating a net flux from the blood to the efferent
lymph. The clearance factor from blood flowing through a
node cannot be estimated accurately without a reliable
estimate of the actual blood flow but recent studies using
radioactive microsphere embolization to measure blood flow
to lymph nodes suggested that about one lymphocyte in five
may leave the blood and enter the node (Hay & Hobbs 1977;
Herman et al 1976).
The suggested rate of flux through non-lymphoid tissues is
of significant size and is presumed to be of functional
significance. Whether the supply of antigen reactive
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cells is large enough to allow for 'peripheral sensitiz¬
ation' to antigens without the necessity of also invoking
antigen transport to lymph nodes remains open to doubt but
the efferent arm of the immune response, particularly for
cell mediated responses, takes place in the peripheral
tissues and must therefore be mediated by cells within the
normally migrating population. The important step is the . -
triggering of the inflammatory response which then
produces an increased cell emigration. This step is anti¬
gen specific and cell mediated and unless antigen is
present upon vascular endothelium must rely upon extra¬
vasation of 'specific' lymphocytes within the total
population.
Thymus
The accumulation of label in this primary lymphoid organ
after injection of labelled cells from all three
populations studied suggests that the barrier to re¬
circulating cells in this organ is far from complete.
Gowans & Knight (1964) reported the failure of JH-adeno-
f
sine labelled TDLs to localize in adult thymus, but did
find labelled cells in the thymic medulla of new-born rats
and these data might be explained as a dose effect as the
detection of cells in autoradiographs of this tissue was
much easier when large cell inocula were used. Consider¬
able numbers of newly-formed lymph node cells labelled in
situ with H Tdr by application of the isotope to
ischaemic antigen activated lymph nodes were found in the
thymic medulla (Werdelin et al 1971)- These cells are
likely to have been T-blasts and raise the possibility that
only lymphoblasts can enter this tissue. The finding of
accumulation of ^Cr-passaged TDLs in the thymus suggests
that recirculating lymphocytes also have this capability.
This raises the question of how much of the activity of
cortisone-resistant thymocyte populations is due to re¬
circulating cells that have migrated from blood and how
much is due to maturation of thymocytes in situ to a
degree of similar functional competence as suggested by
Jacobsson et al (1972). The ability of the thymus to
provide an adoptive plaque forming response particularly
in primed animals with large booster doses of SRBC iv
argues strongly that memory B cells also have the ability
to migrate to the thymus. (Benner et al 1975)- Plaque
forming cells to hen lysozyme protein have also been found
in this organ in secondary responses (Hill 1976).
Immunoblasts
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Interpretation of the kinetics of distribution of I
12 3
after I Udr-labelled blast cell injection must be even
more tentative than for ~^Cr because of the contaminatory
elution and progressively poor total recovery. Difficultie
also arise in autoradiographic studies, as the numbers
available for labelling are small because only a minority
of thoracic duct cells belong to this population. In
normal thoracic duct lymph the majority of the lympho-
blasts are likely to have been formed in gut-associated
lymphoid tissue which provides the major drainage area for
this duct below the diaphragm. The cells comprise approx¬
imately 70% B-blasts and 30% T-blasts (Crum & McGregor
1976) .
The pattern of distribution revealed in these studies
agreed closely with that described by others (Gowans &
Knight 1964; Hall, Parry & Smith 1972; Griscelli,
Vasalli & McCluskey 1969) and suggested that large lympho¬
cytes have a greater propensity than small lymphocytes to
leave the circulation in all sites. This increased
tendency has been described for inflammatory exudates
(Koster & McGregor 1971; Koster et al 1971) and cellular
immune tissue inflammatory reactions (Werdelin et al 1972)
Comparative proportional distributions of ^Cr-passaged
12 3and I Udr-labelled cells in the same recipients reveal
^^i/^Cr ratios of up to 10.1. Also subtracting the
contribution of passaged ^^Cr-labelled cells from ^Cr
whole TDL and allowing that ^*Cr-labelled blasts may have
a higher cell specific activity than small lymphocytes
(Eyre, Rosen & Perry 1970), then approximately equal
numbers of each cell type are present in most tissues
including the small intestine. Support for this idea in
experimental autoimmune lesions comes from the experiments
of Werdelin & McCluskey (1971) who counted labelled cell
frequencies in lesions by autoradiography after injection
of equal total numbers of lymphocytes labelled with either
^H-adenosine or Tdr in vitro. Only slightly greater
concentrations of adenosine-labelled cells were found
3
despite the very much lower labelling index for the H Tdr
population.
That this propensity to extravasate is general even though
much lower proportions of immunoblasts localize in lymph
nodes and spleen in vivo is suggested by the finding of a
2:1 excess of proportional extravasation of JH Tdr in vitro
labelled TDL over Udr labelled TDL in the isolated
perfused lymph node preparation (Sedgley & Ford 1976).
Thus in vivo the deficit in secondary lymphoid organs must
be the result of competition by other tissues, the most
important of which is no doubt the small intestine.
The question of specificity of recognition of tissues by
lymphocytes particularly in lymph nodes (Griscelli,
Vassali & McClusky 1969) may be particularly relevant to
lymphoblasts (Rose, Parrot & Bruce 1976 a & b; Hall et al
1977) •
12 5
The finding of an increased concentration of I Udr
labelled TDL in the mesenteric node compared to super¬
ficial nodes at 2 hrs after injection may be cited as
evidence in support of positive recognition of tissue of
origin as most blasts in TD lymph will have been produced
in this node. Another explanation, however, derives from
the autoradiographic evidence of many such labelled cells
in the subcapsular sinuses of the mesenteric node even by
one hour and an afferent supply of the magnitude of that
from the gut lamina propria would not be available from
other tissues to superficial nodes. Thus if recognition
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does occur it may be at the level of the peripheral tissue
vasculature as much as at the level of the lymph node (Rose,
Parrot & Bruce 1976).
CONCLUSIONS
The evidence suggested that labelled cells could be used
as tracers in the analysis of the recirculating pool as a
multicompartmental system. Rough estimates of tissue flux
of lymphocytes through non-lymphoid tissues of the order
of 10^ - 10^/gm/hr were suggested. Such figures were
derived for accredited recirculating lymphocytes but may
be similar for lymphoblasts.
A major recirculation pathway through the parenchyma of
the bone marrow was described which involved a consider¬
able proportion of the injected cells with a time course
similar to spleen.
The other primary lymphoid organ, the thumus, was also
found to be part of the recirculating pool with a through¬
put pattern like that of lymph nodes but at very much
lower concentrations.
The total flux through non-lymphoid tissues was suggested
to be of low volume but rapid and to amount to not more




The Migration of Thoracic Duct Lymphocytes to Sites oF
Inflammation
Introduction
Since the recognition of the central importance of lympho¬
cytes as mediators of immune responses (reviewed by Gowans
& McGregor 1965)? the accumulation of this cell type in
interstitial infiltrations characteristic of many
inflammatory lesions has been taken to reflect an immuno¬
logical component of such responses. In the 'cell-
mediated' type of chronic inflamation, in which sensit¬
ivity to a particular antigen cannot be adoptively trans¬
ferred to a naive recipient by serum, the direct inter¬
action of specifically committed lymphocytes with antigen,
in the peripheral tissue site of antigen deposition, is
presumed to be essential for the triggering of the
inflammatory response. Many studies involving the
adoptive transfer of hypersensitivity to antigens with
lymphocytes support this view but the exact site of cell-
antigen interaction and the mechanisms involved in the
subsequent accumulation of lymphocytes in inflammatory
lesions remain unclear.
A net accumulation of lymphocytes within a tissue could
arise if the outflow of lymphocytes was halted or reduced
or if the influx of cells was increased. A slowing of the
modal transit time of lymphocytes through the tissue would
also lead to an apparent accumulation of cells within the
interstitial compartment even if the net flux remained
constant. The observations of increased lymphocyte out¬
puts in the afferent lymph draining (i) a chronic sub¬
cutaneous granuloma in the sheep (Smith, Mcintosh & Morris
1970b), (ii) a site of subcutaneous injection of partic¬
ulate antigen in the rabbit (Kelly R H 1970), (iii) an
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allogeneic kidney graft in the sheep (Pederson & Morris
1970 & 1974) j argue that there is no reduction in the
numbers of lymphocytes leaving the tissues under these
circumstances and by inference that extravasation from the
blood must be increased. This increased flux of lympho¬
cytes into sites of inflammation has been measured using
isotopically labelled lymph node cells usually 24 hrs
after iv injection. Asherson & Allwood described the
increased localization of ^Cr labelled normal lymph node
cells in ears painted with contact sensitizing agents or
croton oil and also showed an increased ability of
recently divided lymphocytes produced in response to a
variety of immunogenic stimuli to localize in both
specific and unrelated lesions (Asherson & Allwood 1972).
More recently the particular subclass of lymph node cell
from immunized mice that shows the highest localization in
contact sensitivity lesions has been characterized as a
thymus derived lymphoblast (Allwood 1975)- Increased
accumulation of ^Cr normal lymph node cells in both
actively immunized and passively transferred contact
sensitivity lesions in mouse ears has also been reported
(Sabbadini et al 1974)-
Other reports have suggested that immunoblasts have an
increased ability to enter inflammatory exudates in the
peritoneum (McGregor et al 1971) and in experimental auto¬
immune diseases (Werdelin 1972). The particular import¬
ance of the T-blast in contact sensitivity lesions has
been stressed (Rose et al 1976).
This propensity of activated T cells to enter inflammatory
lesions may explain at least in part the development of
the skin lesion several days after primary sensitization
of an animal with an agent such as Picryl Chloride. There
are however situations in which delayed type hypersensit¬
ivity responses develop when such T blasts would not be
expected to be present if it is true that they are relat¬
ively short-lived and not part of the true recirculating
pool as the evidence suggests (McGregor et al 1971,
Allwood 1975) • The tuberculin reaction is of this type
and develops within 24-48 hrs after antigen administration
in animals immunized many months previously. Memory for
this antigen is carried by long-lived small recirculating
lymphocytes (Lefford et al 1973)- The speed of onset of
this reaction probably precludes the activation of memory
cells in draining lymph nodes and subsequent initiation of
the lesion by migration of lymphoblasts.
Whatever the type of lymphocyte involved the precise site
of interaction with antigen and the mechanism whereby this
triggers the inflammatory response are unknown. The
difficulty encountered in experiments designed to detect
any preferential localization of specific antigen reactive
cells within inflammatory infiltrates (reviewed by
Werdelin 1972) suggests that the extravasated lymphocytes
are a random selection of those in the blood with respect
to antigen sensitivity although selection with regard to
other non-antigen related factors such as size, thymus
dependency or tissue of origin may be operative. This
non-selection by antigen argues against specific
attraction of reactive lymphocytes from the blood, but if
the normal flux of cells through the tissue is not great
enough to allow emigration of enough specific cells
depending upon their frequency in the blood) to account
for the time course of triggering of the lesion, then some
mechanism allowing interaction of antigen and lymphocytes
within the blood vessels must be considered.
The vascular changes entailed in inflammation almost
certainly permit an increased extravasation of lymphocytes.
Two mechanisms are possible: release of vasoactive com¬
pounds could increase the blood flow locally and provide
more lymphocytes to the vasculature which would allow
increased extravasation without any alteration in the
individual lymphocyte-endothelial cell interaction - the
'clearance factor'. On the other hand a qualitative
change in the endothelium could be envisaged which would
render lymphocyte adhesion and extravasation more efficient.
These two possibilities are not mutually exclusive and
both could operate.
The increase in blood flow to cell mediated lesions, as
measured by embolization of radiolabelled microspheres,
was considered to be great enough to account for the
increase in lymphocyte extravasation (Hay et al 1977). On
the other hand the emigration of lymphocytes through
venules in the lesions of experimental autoimmune neuritis
as studied with phase contrast and the electron microscope
had many similarities to that seen in lymph node post¬
capillary venules which is specific for lymphocytes. Also
if no qualitative change in the endothelium occurs then
increased lymphocyte extravasation should follow any form
of vasodilation - even mild heat - and this does not occur
The observation of morphological change, in some venules
in the centre of dense infiltrations of small lymphocytes
in muscle in some patients with polymyositis, so that the
endothelial cells are cuboidal and pyroninophilic (Ball J
pers.comm.) suggests that some 'specialization' can occur
but this change is rarely pronounced in most inflammatory
lesions.
The experiments to be described were designed to examine
the kinetics of localization of normal thoracic duct cells
in various inflammatory lesions. These lesions were
designed to have different immunological components and to
be relatively constant, as far as intensity was concerned
over the period of study, to minimize distortion of the
results following changes in the lesions themselves. The
experiments closely followed the design of those described
for normal tissues and the relative contribution of lympho
blasts and small recirculating lymphocytes was again
assessed.
In addition, the localization of in vitro trypsin-treated
TDL was studied. Such cells have a greatly reduced
ability to enter lymph nodes via the post-capillary
venules but an unaltered ability to migrate across the
splenic marginal sinus endothelium, both of which sites
normally support lymphocyte traffic at a high rate and
with efficient selection. This altered behaviour is
temporary with the cells showing total recovery and normal
distribution by twenty four hours (Woodruff & Gesner 1968,
Ford et al 1976). This effect can provide a tool to
investigate other sites in which a lymph node like lympho-
cyte-endothelium interaction may operate.
METHODS
1 Cell Labelling
~*^Cr whole TDL, ^Cr passaged TDL, and Udr in
vitro labelled TDL were produced as before.
All recipients underwent whole body perfusion at the
time of death at various times after intravenous
injection of normal syngeneic labelled TDL.
2 Production of Inflammatory Lesions
a Skin sensitization to chemical agents
Table 5-1 shows the agents used together with the
dilutions and diluents.
Rats were sensitized by application of 0.1ml of
agent to the clipped abdominal skin. Secondary
lesions were elicited by application of 0.1ml of
the appropriately diluted agent to a circular area
( - 1.5cm in dia.) of clipped skin on the back 12
days later. Similar areas were also painted with
0.1ml of dilute solutions of the other agents at the
same time. Thus recipients were sensitized with one
agent and challenged with all four compounds,
enabling contact hypersensitivity lesions and direct





1, Chloro 2,4' Dinitrobenzene(a) 5%(c) 0.5%(c)
(DNCB)
Picryl Chloride(a) (TNCB) 7%(c) 1.0%(c)
4 Ethoxymethylene-2-Phenyl Oxaz- 5%(c) O.S%(c)
olone (OXAZ)(a)
Croton Oil(b) 10^(d) 10£(d)
(a) BDH Chemicals Ltd, Poole, Dorset.
(b). Sigma Chemical Co, PO Box 14508, St Louis, USA.
(c) Dissolved in absolute ethyl alcohol.
(d) Dissolved in Di-n-butylphthalate-(a).
Specific contact sensitivity was elicited in primed
animals following challenge with a low dose of TNCB,
DNCB or OXAZ. Clinically the lesion was an area of
erythema with little obvious induration. Histo¬
logically a moderate mixed mononuclear cell
infiltrate was seen throughout the dermis (see Fig.
5-1) with occasional superficial foci of polymorpho¬
nuclear leucocytes. Lymphocytes were present as a
minority cell type. Maximum intensity of the
inflammation was seen by 24-48 hrs and the lesion
remained roughly the same for a period of 48 hrs.
Skin painting with Croton oil produced a mild acute
inflammatory reaction with erythema, slight oedema
and a mild acute inflammatory cell infiltrate. No
evidence of sensitization was found, with a second
application producing a lesion of similar severity
as the first.
Primary application of challenge doses of TNCB, DNCB
or OXAZ, produced no obvious lesion at any time.
Granuloma
Subcutaneous granulomata were produced by intra¬
dermal injection of 0.1ml of an emulsion of equal
volumes of Freund's complete adjuvant (Difco) and
PBS at several sites on the flanks of potential
recipients three weeks before labelled cell inject¬
ion. Histologically the lesions comprised droplets
of oil surrounded by an infiltrate of macrophages,
fibroblasts and relatively few lymphocytes (see Fig
5-2) .
Tumour
A mammary carcinoma, which arose spontaneously in a
rat of the DA strain, was passaged by serial sub¬
cutaneous implantation of small fragments of tumour
tissue in females of either DA or PVG/c x DA F^
hybrid strain. Potential recipients of labelled
FIG 5-1
Histological section of skin from a rat sensitized
12 days previously with DNCB, showing the edge of
an area challenged by painting with DNCB 48 hrs
previously. A diffuse mononuclear cell infiltrate
which includes lymphocytes is present in the deep
dermal connective tissue and muscle; in addition
there are superficial foci of acute inflammatory
exudes in which polymorphonuclear leucocytes
predominate.
Mag. x 70. Haematoxylin + Eosin.
FIG 5-2
Autoradiograph of a granuloma in the deep dermis of
a rat injected i.d. with an emulsion of Freund's
complete adjuvant and PBS 21 days previously and iv
2 hrs previously with 300 x 10^ syngeneic TDL labelled
3
with H-Tdr (in vitro). Large globules of lipid are
surrounded by macrophages, lymphocytes and fibro¬
blasts. Two labelled lymphoblasts can be seen in the
interstitial cellular infiltrate.
Mag. x 450. Methyl Green + Pyronin.
6 weeks exposure.
 
cells received up to four subcutaneous fragments
at separate sites on the flanks and the tumours were
allowed to grow to approximately one centimetre dia¬
meter nodules. At this size the tumour comprised
solid masses of malignant epithelial cells with
relatively little fibrous stroma or interstitial
infiltrate but a well defined capsule. The tumours
were well vascularized and only showed necrosis +
haemorrhage when larger than 1.5 diam. No meta¬
static spread was encountered.
d Trypsin Treatment of Lymphocytes
Radiolabelled TDL were washed in PBS and resuspend-
g
ed at 10 /ml in protein free PBS to which was added
0.02mg/ml final concentration of Trypsin (Difco).
The cells were incubated at 37°C for 10 mins, after
which FCS was added to a final concentration of 10%
to inhibit further trypsinization. The cells were
then filtered through cotton gauze and washed twice
before resuspension for injection. Control cells
were treated in parallel but incubated in protein-
free PBS without trypsin.
Very few cells were lost with this procedure and the
viability of the final suspension as assessed by
Trypan Blue dye exclusion was always greater than
95% as for the control cells.
e Autoimmune Inflammations
This type of inflammatory lesion has the potential
advantages of using normal tissue as antigen and
therefore avoiding traumatic administration of anti¬
gen at the site of study. This is particularly true
in adoptively immunized animals in which the time
course of the lesion is also under precise control.
However, several attempts to elicit this type of
reaction in various strains of rat all failed to
produce significant or reproducible clinical disease
or histological lesions. Antigens used were Guinea-
pig Myelin Basic Protein, and crude saline extracts
of rat brain, kidney, muscle, testis and epididymis
emulsified in varying doses with Freund's Complete
Adjuvant. The tubercle bacillus content of this
adjuvant was also varied.
Possible reasons for the failure to induce experi¬
mental autoimmune encephalitis (EAE) or analogous
lesions in other tissues include: (i) Nonsuscept-
ibility of the strains of rat used which were AO
(AgB2); PVG/c (AgB5); DA (AgB4); PVG/c x DAF^
(AgB4 +5); AS (AgBj). Most work on EAE has been
carried out using Lewis strain rats (AgBl) but no
more success was encountered with AS rats of the
same AgB type. Variation in susceptibility has
been linked to AgB type by Gasser et al (1975) who
found both Lewis and DA strain rats to be suscept¬
ible and by Hughes et al (1973) who found AS
susceptible but PVG/c not. (ii) Inappropriate
immunization technique, dose or adjuvant compos¬
ition. (iii) Failure to use pertussis vaccine
as an extra simultaneous adjuvant. This has been
reported to increase the frequency and severity of
autoimmune diseases induced in this way (Werdelin
1972) .
RESULTS
Experiments were carried out in which the localization of
^Cr TDL in skin lesions 24 hrs after iv injection was
measured in recipients that had been pre-sensitized with
one of the agents listed in Table 5-1 and challenged with
all four agents. The results summarized in Table 5-2 show
the factor of increase of ^Cr measured in the skin lesions
over the concentration measured in normal unpainted skin.
It is apparent that the second application of TNCB, OXAZ
or DNCB in specifically immunized recipients produced a
higher factor of increase than areas challenged with
irrelevant agents. Thus antigen specificity of the
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TABLE 5.2
THE LOCALIZATION OF 51CR IN SKIN LESIONS 24 HRS AFTER I.V. INOECTION
OF 51CR TDLs INTO SYNGENEIC RECIPIENTS 'PERFUSED' AT TIME OF DEATH.
Each recipient had been sensitized to one agent some days previously
and challenged with all four agents at the time of labelled cell injectior











FACTOR OF INCREASE OVER
NORMAL SKIN IN LESIONS
TNCB OXAZ DNCB CROTi
57.1 A AO 7 - .0120 1.9* 0.8 1.5 2.5
B .0248 0.7 1 .9* 0.9 1.5
C .0150 1.6 1.3 7.0* 3.9
D .0193 1.8 1.7 2.1 3.2*
57.2 A 8 .0120 1.6* 1.0 1 .6 2.5
B .0178 1 .4 2.2* 1 .6 2.2
C .0116 2.0 1 .3 4.9* 2.8















C .0138 2.9 1.1 11.7* 7.7
D .0142 1 .9 1.0 1 .9 8.9*
59.2 A
/ ■ -
12 .0128 17.7* 0.6 1 .6 9.5
B .0109 4.4 22. 8* 2.2 15.9
C .0122 2.7 2.8 7.8* 11.8
D .0118 3.6 0.9 2.1 12.4^
sensitivity lesions was confirmed. The factor of increase
in the area of skin painted with Croton oil was however as
large on primary as secondary application, suggesting that
there is little or no element of hypersensitivity in this
lesion.
Table 5.3 confirms these results and shows the pooled
results of several experiments in which the 24 hr local¬
ization of 5*Cr XDL was measured in inflammatory lesions
including those following primary and secondary applica¬
tion of skin paints and also the subcutaneous granuloma
and tumour.
It is therefore reasonable to assume some immunological
component in the specific recall contact sensitivity lesion
while the lesions following primary application of
challenge doses of these sensitizing agents provide
controls for the direct irritation produced by skin paint¬
ing; the Croton oil lesion also reflects non-specific
irritation but of greater magnitude.
The kinetics of localization of radioactivity following
injection of labelled TDL was studied in recipients that
had been sensitized to DNCB twelve days previously and
challenged with all four agents 24 hrs previously. This
early challenge was to allow the lesions time to develop
fully before cell injection.
Table 5-4 shows the results of experiments in which ^Cr
was measured at 2, and 24 hrs after ^Cr whole TDLs
were injected iv. The activity in normal skin followed
the pattern described in the previous chapter with an early
peak at ^ hr. Concentrations then fall and the 2 hr value
was often fractionally below that measured at 24 hrs. A
very similar pattern was seen in skin painted with sensit¬
izing agents in non-sensitized recipients (TNCB and OXAZ).
In specific recall contact sensitivity lesions (DNCB*) a
considerably increased concentration of ^*Cr was already
present by 5 hr after injection and this concentration
usually showed a slight fall between 5 and 2 hrs and then
TABLE 5-3
Localization of ^Cr in Inflammatory Lesions
Arithmetic mean percent inj . activity/gm tissue +_ SE in
recipients of ^lcr XDL perfused 24 hrs after iv injection.
1 indicates recipients had previously been immunized with
the same agent.
Tissue No. of samples % Inj. activity _+ SE
Skin TNCB 36 .0265 + .0022
Skin TNCB1 6 .0984 + .0327
Skin OXAZ 38 .0154 + .0015
Skin OXAZ1 4 .1122 + .0485
Skin DNCB 18 .0266 + . 0019
Skin DNCB1 30 .0688 + .0069
Skin Croton 40 .0819 + .0072
Skin Croton* 4 .0922 + .0263
Normal skin 50 .0130 + .0005
Granuloma 12 .2364 + .0231
Tumour 4 .0736 + .0078
TABLE 5-4
The Kinetics of Localization of ^Cr in Skin Lesions
in recipients 'perfused' at intervals after iv injection
of ^*Cr whole TDLs.
Arithmetic mean percent inj.activity/gm of tissue +_ SE
(pooled data from experiments in which each time period
was studied with the same cell suspension).
Tissue 2 Hr 2 Hr 24 Hr
TNCB .0200 + .003 .0134 + .003 .0151 + .001
(8)2 (9) (9)
OXAZ .0200 + .003 .0153 + -002 . .0167 + .003
(8) (10) (10)
DNCB1 .0416 + .003 .0360 + .005 .0689 + .011
(20) (11) (11)
Croton .0342 + .004 .0281 + .003 .0391 + .008
(11) (13) (11)
Normal .0272 + .003 .0122 + .001 .0137 + .001
(13) (10) (10)
indicates recipients were specifically sensitized with
this agent 12 days previously.
r\
() indicates no. of samples.
some late accumulation by 24 hrs. The increased concentr¬
ation over normal skin in the Croton oil lesion was also
present by \ hr and again a slight trough was seen at 2 hrs
with a little further increase by 24 hrs.
In one experiment (Table 5-5) in which the late time course
of 51Cr TDL 1 ocalization was studied in animals which were
challenged three hrs after labelled cell injection, when
the blood concentration would have been minimal, the usual
pattern of accumulation was present by 24 hrs and little
difference was seen between these values and those
measured at 48 or 72 hrs, by which time some fluctuation
in the intensity of the inflammation may have influenced
the results.
In order to assess the contribution of the minor popula-
12 5tion of lymphoblasts in TDL the distribution of I was
12 5studied in recipients of TDL labelled in vitro with I
.Udr.. With this population a somewhat different kinetic
distribution pattern emerged. Table 5-6 summarizes data
from experiments similar to those in Table 5-4 but using
125 125
I Udr labelled TDL. The concentrations of I in
normal skin were highest at 5 hr with a subsequent
progressive fall. As in the previous experiments the
1 9 r
absolute proportion of X^->J found in normal skin was
higher than with ^Cr whole TDL at all times. In contrast
to this latter situation the areas, painted with challenge
doses of sensitizing agents to which the recipients had
not been previously exposed, showed an increase in local-
125 ,
ization of I between 5 and 2 hrs, and then a marked
decrease to 24 hr values. Specific recall lesions showed
a similar increase at these early periods but showed less
decrease by 24 hrs so that by this late time there was an
obvious difference between 'primary' and 'secondary'
lesion concentrations. Croton oil irritant lesions showed
considerable increase over normal skin at ^ hr with an
increase to 2 hrs and if anything still further increases
by 24 hrs.
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The difference in the pattern of distribution of I
TABLE 5-5
Late Time Course of Localization of ^Cr in Skin Lesions
Recipients 'perfused' 24,48 or 72 hrs after iv injection
of ^Cr whole TDLs and challenged with all four agents 3
hrs after labelled cell injection.
No. Mean % Inj.Act/gm tissue _+ SE
of
Samples 24 hr 48 hr 72 hr
Skin TNCB 2 .014 + .009 . 014 + .015 .015 + .003
TNCB1 1 .040 • 045 • 049
OXAZ 2 .008 + .001 .015 + .006 .008 + .002
OXAZ1 1 .010 .015 .013
DNCB 2 .029 + .007 . 018 + .002 .023 + .02
DNCB1 1 .113 . 110 .117
-Croton 3 .157 + .029 . 102 + .024 • 095 + .018
Normal 3 .011 + .004 .010 + .004 .010 + -003
indicates specifically immunized recipient.
TABLE 5-6
125
The Kinetics of Localization of I in Skin Lesions
in recipients 'perfused' at intervals after iv injection
of udr-in vitro labelled TDLs.
Arithmetic mean percent inj . activity/gm of tissue _+ SE
(pooled data from experiments in which each time period
was studied with the same cell suspension.
Tissue | Hr 2 Hr 24 Hr
Skin TNCB .282 + .060 •333 + .055 .121 + .009
(5)
OXAZ .321 + .017 .424 + .025 .154 + . 012
(5)
DNCB1 .392 + .039 .426 + .074 .296 + OOO-O
(5)
Croton .495 + .055 .541 + .054 . 641 + . 337
Normal .175 + .0.5 .111 + .006 • 073 + .004
n = 4 except where stated.
*
indicates specific immunization of recipient
with this agent.
compared with suggests that the activities measured
with the latter isotope associated with the whole popula¬
tion of TDL cannot be due only to the lymphoblasts. Two
approaches to the estimation of localization of small re¬
circulating lymphocytes in skin lesions were made.
r 1 o
•Passaged' J Cr labelled TDLs and long-lived in vivo °H
Tdr labelled TDL were used but the production of either of
these populations in sufficient quantities to allow
adequate 'counts' to accumulate in non-lymphoid tissues in
multiple recipients within an experiment was difficult.
Table 5-7 shows the pooled results of two experiments in
which recipients bearing skin lesions were 'perfused' and
sampled at each time period after passaged -^Cr TDL
injection. Again all areas of skin showed peak values of
-**Cr at half an hour after iv injection of passaged ^lcr
TDL and at this time no difference was seen between
painted + non-painted areas. The fall by two hours and 24
hrs was greater than for ^Cr whole TDL and was only
slightly less steep for the specific recall sensitivity
lesion and the Croton oil lesion which did both show
slight evidence of increased concentration over normal
skin at 24 hrs.
Table 5.8 shows the factor of increase in concentration of
in skin lesions over unpainted skin in recipients per¬
fused 24 hrs after iv injection of long-lived Tdr in
vivo labelled TDL. There was an obvious increased con¬
centration over normal skin in the specific recall contact
sensitivity lesion to DNCB^ but no increase in other areas
including that painted with Croton oil. The absolute con¬
centration of tritium in skin may be artefactually high
because of the likelihood of contamination with non-cell-
associated isotope.
Another way of comparing the distribution of the lympho¬
blasts in TDL with that of the whole population is to
examine the ratio between the proportions of each popula¬
tion in each tissue. This comparison is perhaps most
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TABLE 5-7
The Kinetics of Localization of ^Cr in Skin Lesions
in recipient s ' perfused' at intervals after iv injection
of 'passaged 51 Cr TDLs'.
Arithmetic mean percent inj.act/gm tissue + SE
Tissue No. K3|>-> a 2 Hr 24 Hr
Skin TNCB 2 .0293+•0036 .0088+.0017 .0055+.0016
OXAZ 2 .0284+.0019 .0069^.0011 . 0069+•0025
DNCB1 2 .0295+.0014 .0125+.0025 .0090+.0011
Croton 3 .0226^.0021 .0074+.0008 .0095+.0032
Normal 3 .0319+.0032 .0089+.0014 .0067+.0028
No. = number of samples
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meaningful when carried out in the same recipient of a
mixture of labelled cell types but comparisons between
groups of results can also be made if the scatter of these
values is not too great. In recipients of both ^Cr and
12 5
I labelled populations at 24 hrs after iv injection the
i25i/5l£r rati0 in the DNCB^ recall lesion was similar to
that in normal skin. A similar result is shown in Table
5-9 in which the ratio of percent ^^i/gm/percent ^^Cr/gm
is calculated from the pooled data in Tables 5-4 and 5.6.
The similarity between the ratios of *^l/ Cr in the
•recall' lesion and normal skin suggest that there is no
marked change in the rate of extravasation of the lympho-
blast subpopulation into this lesion but the increased
ratios in the irritant lesions supports the idea that
newly formed cells may have a particularly increased
propensity to leave the circulation under these circum¬
stances.
The effect of trypsin treatment of lymphocytes on their
ability to localize in inflamed skin was studied using
^Cr whole TDL. Table 5*10 summarizes the results of
three experiments in which the kinetics of localization of
^^Cr associated with normal or trypsin-treated TDL were
compared. The results are expressed as the mean percent
injected activity/gm of tissue for each population in
separate groups of recipients. The localization of lympho
cytes in normal skin was clearly not impaired by trypsin;
radioactivity associated with trypsin-treated TDL found in
the skin at ^ and 2 hrs after injection was equal or
slightly greater than radioactivity associated with un¬
treated cells, possibly reflecting the marginally higher
numbers in the blood.
The spleen and liver showed no decrease in isotope local¬
ization following trypsinization of TDL at early times
especially when compared to the blood levels confirming
the observations of others (Woodruff & Gesner 1968, Ford
et al 1976). A similar picture is seen in most non-lympho
TABLE 5-9
and 5 • 6
i Hr 2 Hr 24 Hr
Skin TNCB 14-1 24-8 8.0
OXAZ 16.1 27.7 9.2
DNCB1 9.4 11.8 4.3
CROTON 14-5 19-3 16.4
NORMAL 6.5 9.1 5-3
)



















































































































































































































































































































'l)n=16-differencebetw encontrol&trypsisig ificant;P*C.02-Mann-WhitneyUt t. '2)n=7-forcontrola dtrypsingroups.
tissues suggesting that migration of lymphocytes into non-
lymphoid tissues in general may be trypsin-resistant. By
contrast the localization of ^^Cr in lymph nodes was
reduced to 1-2% by trypsin at \ and 2 hrs with complete
recovery by 24 hrs.
The most striking result was that trypsin treatment did
impair the capacity of ^*Cr TDL to migrate into establish¬
ed recall contact sensitivity lesions. Although at ^ and
2 hrs in these experiments the localization of ^Cr in
DNCB1 1 esions with control cells was only about 2.5 times
greater than in normal skin this increase was highly sig¬
nificant (P = .02) and consistent. With the trypsin-
treated populations little or no increase over the normal
skin values occurred at these early times and the differ¬
ence in absolute values in the lesion due to control and
trypsin-treated cells was also significant (P .02). No
inhibition of migration of trypsin-treated cells was
measured in the sites of primary application of sensit¬
izing agents and this was probably also true for the
Croton oil lesion but the increases in this latter lesion
with control cells were very small in this particular
series of experiments.
This inhibition of migration of trypsin-treated ^Cr TDL
into the cell mediated immune lesion is most strikingly
seen if the increase in activity that could be attributed
to the immune inflammatory component of the lesion is
taken to be the excess localization over normal skin
values. Table 5-11 shows the concentration of ~^Cr/gm of
inflamed skin minus the concentration of ^^Cr/gm of normal
skin for each animal. The mean of these differences + SE
are shown. Again a clear effect is seen in the DNCB^
lesion particularly at 5 hr but still obvious at 2 hrs but
no differences between the localization of control or
trypsinized cells in the Croton oil or other irritant
lesions are seen.
Examination of another chronic inflammatory lesion similar
/































to that which in the sheep was associated with an increased
flux of lymphocytes - Smith, Mcintosh & Morris (1970)
revealed a pattern of localization of normal ^Cr TDL that
was similar to the DNCB* lesion although the early peak at
5 hr was somewhat more obviously increased compared to
normal skin and the element of late accumulation by 24 hrs
was also consistently greater. The nadir at 2 hrs was how¬
ever also a consistent feature. The localization of
trypsin-treated ^Cr TDL was again significantly impaired
in this lesion at 5 and 2 hrs (Table 5.12) with consider¬
able recovery seen by 24 hrs. An absolute difference was
still measured between localization of activity associated
with control and trypsin-treated cells at this time but a
parallel disparity in blood leucocyte ^Cr activity in
these particular recipients may explain this result. It
was also noted that some degree of inhibition of local¬
ization of trypsin-treated lymphocytes was measured in gut,
thymus and bone marrow.
In a preliminary experiment the mean concentration of ^Cr
in the subcutaneous mammary carcinoma nodule was .077% inj.
act./gm at 24 hrs after iv injection of ^Cr whole TDL
which was considerably above that in normal skin. It was
therefore decided to study the kinetics of localization of
passaged ^Cr tdl and 1^5j udr labelled lymphoblasts in
this model system. The main reasons were that tumour nod¬
ules could be removed at biopsy allowing more than one
time to be studied in each recipient, which is advantage¬
ous when the number of labelled cells that can be made
available for injection is limited, as is the case with
both these populations. Also the tumour is an abnormal
tissue and therefore there is no true normal control with
which comparisons can be made; thus no loss accrues to
the failure to sample other tissues at the time of biopsy.
Table 5-13 summarizes the results of two experiments in
each of which duplicate recipients received a mixture of
->^Cr passaged TDL and Udr in vitro labelled TDL, and
after ^ + 2 hrs subcutaneous tumours were excised. At 24
hrs after cell injection the animals were killed with whole
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body perfusion as normal. With the passaged ^Cr TDL
population, peak values were measured at \ hr and at this
time the blood level was still high. Levels in both these
compartments fell with time but the fall in tissue was
12 5
less marked than in the blood. With the I-labelled TD
lymphoblasts the fall in the blood level was much quicker
IOC
and more profound. Concentration of JI in the tumour
showed a slight increase with time. This pattern of local¬
ization of both isotopes was similar to that seen in both
DNCB* and croton oil lesions with these populations.
The results of an experiment comparing both these popula¬
tions with similarly labelled but trypsin-treated TDL
(Table 5-14) suggested that there might be a slight degree
of inhibition of localization of trypsinized lymphocytes
in the tumour at 2 hr, particularly if the blood concentra¬
tions were taken into account. This was most noticeable
for the passaged ^Cr TDL population. In order to assess
if this inhibition was significant another experiment
involved duplicate recipients of control or trypsin-treated
^Cr passaged TDL each bearing several tumour nodules all
of which were assayed after whole body perfusion at i hr
after iv injection of cells. In this experiment (Table
5.15) the blood levels of control and trypsin treated
cells were similar and if one spuriously high control
tumour value was discounted no difference was seen between
the localization of either population in the tumour. Lymph
nodes of these animals did show significant inhibition of
localization of isotope associated with trypsin-treated
passaged ^*Cr labelled lymphocytes, but little reduction
12Cin lymph node levels of I was apparent.
Experiments of this type should be more easily carried out
with ^ ^In-oxine labelled TDL as the higher cell specific
activities obtainable would allow significant count rates
with many fewer labelled cells and therefore more recip¬
ients could be studied with a given cell population.
Examinations of autoradiographs of tissue sections of
y













































Localization of ^Cr in Tissue 5 hr after iv Injection of
^Cr-passaged TDLs (Perfused)





excluding one high value




4-7 + 1.0 25 + .02
Blood
Leucocytes
4.2 + 3.8 + .4
s
inflammatory lesions following skin painting, or injection
of adjuvant, and of the tumour, showed occasional labelled
cells after injection of either tritiated uridine or
tritiated thymidine in vitro labelled TDL but the frequency
was too low to allow meaningful quantitation.
DISCUSSION
Examination of the kinetic localization data in a way
similar to that for normal tissues suggests that there is
a net increase in the proportion of the total lymphocyte
pool at equilibrium in specific recall contact sensitivity
lesions, and areas of inflammation following application
of croton oil, or injection of Freund's adjuvant. The
shape of the distribution curve for ^^Cr whole TDL
suggests that in inflammatory sites the peak is still very
soon after injection with usually some degree of trough at
2 hrs and only relatively small further increases by 24 hrs
The observation, that the bulk of any increased localiza¬
tion occurs so early, is consistent with the idea that
accumulation of lymphocytes follows an increased rate of
extravasation rather than a decreased rate of exit. The
slight trough at the time of lowest blood concentration
suggests that at least a proportion of the extravasated
cells have already left the tissue by this time and there¬
fore have a rapid transit time. However the slight degree
of late accumulation in specific recall DNCB lesions may
reflect some degree of increase in the modal transit time
through the tissue in a way analogous to lymph nodes. A
similar pattern holds for the croton oil irritant lesion
while for the 'primary' lesion following painting with
sensitizing agents little change from normal skin can be
discerned.
In the granuloma following injection of Freund's complete
adjuvant the degree of late accumulation is even greater
than for the contact sensitivity lesion and can be inter¬
preted as suggesting both an increased 'clearance factor'
of lymphocytes across the endothelium and a prolongation
of the modal transit time.
These results for contact sensitivity lesions are similar
to those of Sabbadini et al (1974)- Their results also
showed that the bulk of any increased localization of ~^Cr
lymph node cells in mouse ears specifically challenged
with Picryl chloride was present by 3 hrs after iv inject¬
ion provided that the lesion was 24 hrs old. On the other
hand no increased localization over normal skin was pres¬
ent 3 hrs after injection if the challenge was given at
the same time as the cells, but a normal degree of local¬
ization was present by 24 hrs under these conditions. This
latter observation was confirmed in the experiment shown
in Table 5-5 in which normal degrees of increased accumul¬
ation were present at 24 hrs and later even though the
challenge was not given until three hours after the
labelled cells were injected. This argues strongly
against the idea that the early extravasation of cells
following injection of a 'bolus' of cells with consequent
artificially high blood levels for a short period could be
the cause of the late accumulation. In the experiment
described the blood level of labelled cells at the time of
skin challenge would be minimal and therefore such a
mechanism of early localization could not operate. It is
very likely therefore that there is a flux of lymphocytes
through inflammatory lesions of increased magnitude but of
a similar rapid time course to that in normal non-lymphoid
tissues.
As in the case of normal tissues, the question arises of
whether this increased flux is due to the minority popul¬
ation of lymphoblasts contained in normal TDL. Several
pieces of evidence combine to suggest that this subpopul-
ation is not entirely responsible for the activity
measured even though many workers have reported that
'activated' lymphocytes have a particular propensity to
accumulate in inflammatory exudates and infiltrates
(Werdelin 1972, Allwood 1975, Rose et al 1976, Moore &
Hall 1973, Koster et al 1971)* Firstly, the difference
in shape of the kinetic distribution curves (data summar-
1 o c
ized in Fig 5-3) obtained with I Udr-lymphoblasts and
5*Cr whole TDLs, particularly between 5 and 2 hrs in skin
painted with irrelevant antigens suggests that all of the
-*^Cr activity cannot be accounted for by the cell type
1 o qthat is also labelled with I Udr. The observation of
some increased localization of ^Cr associated with
passaged ^Cr TDL at 24 hrs suggests that some accredited
recirculating lymphocytes can enter recall contact sensit¬
ivity lesions and those induced by croton oil. Localiz¬
ation of long-lived recirculating cells in a cell-mediated
immune lesion is also suggested by the increased concentra¬
tion of tritium associated with long-lived ^H-Tdr in vivo
labelled TDL in DNCBl lesions but with this label no
increase was measured in the non-immune irritant lesion
with croton oil. Also the reduction of localization of
trypsin-treated ->*Cr labelled cells in skin lesions and
lymph nodes is not paralleled by the behaviour of ^^I-Udr
labelled lymphoblasts in either situation.
The similarity in the ratio of % xnj inj.^Cr in
recipients of both populations in the DNCB* lesion and
normal skin also suggests that the increased flux through
the cell-mediated immune lesion includes all cell types
and if the considerations taken into account in the last
chapter are true then approximately equal numbers of small
recirculating lymphocytes and lymphoblasts may comprise
the infiltrate.
The general impression that emerges is, therefore, that in
simple irritant lesions following painting with croton oil
or contact sensitizing agents in non-sensitized animals
there may be a small increase in lymphocyte flux with a
higher proportion of lymphoblasts than in normal tissues,
but in fully developed cell-mediated lesions small long-
lived lymphocytes are also present and the total flux is
increased several-fold.
The inhibition of localization of trypsin-treated lympho-
FIG 5.3
The distribution of radioactivity in normal and
inflamed skin at intervals after iv injection of
syngeneic labelled TDL. Summary of data given
in Tables 5-4? 5-6, 5-7-
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cytes in contact sensitivity and granuloma lesions is
almost total if it is acceptable to take normal skin con¬
centrations as relevant background values. This result
strongly suggests that the increased extravasation in cell
mediated immune lesions follows some qualitative change in
the endothelium that increases the efficiency of extravas¬
ation of lymphocytes and possibly makes the endothelium
appear more like the specialized post-capillary venular
endothelium of lymph nodes to the lymphocytes in the blood.
It is therefore unlikely that the increase in extravasation
results solely from hyperaemia even though the extent of
this change in blood flow has been reported to be great
enough to account for the increase in lymphocyte influx
into the tissues without any increased efficiency of the
extravasation mechanism (Hay et al 1977) •
Until the precise mechanisms of interaction between lympho¬
cyte and venule endothelium in post-capillary venule and
in sites of cell-mediated inflammation are discovered, it
is impossible to say that they are identical but they do
both appear to be trypsin sensitive. In the 24 hr old
recall contact sensitivity lesion no morphological
evidence of venular endothelium specialization was seen
although cuboidal change in this type of vascular endo¬
thelium has been reported (i) in parts of longstanding
subcutaneous granulomata following injection of virus +
Freund's complete adjuvant in the sheep (Smith et al 1970),
(ii) in the thymus of some myasthenia gravis patients
(Bradfield 1973) , (iii) in areas of dense small lymphocyte
infiltration of muscles in some patients with polymyositis
(Ball J, pers.comm.) and associated with lymphocyte
infiltration of a human medullary carcinoma of breast
(Ahmed A. pers.comm.), (iv) in an experimental arthritis
in rabbits injected repeatedly with horseradish peroxidase
(Graham & Shannon 1972), (v) in experimental chronic in¬
flammatory lesions in the chicken and rheumatoid arthritis
lesions in humans (Miller J J 1969)-
These observations suggest that some change does occur in
the function of vascular endothelial cells in areas of
inflammation and that there could possibly be a morpho¬
logical change that occurs if the stimulus is maintained
for long enough. An extension of this idea suggests that
the specialization of the post-capillary venules in lymph
nodes followed some change that rendered this 'inflammatory
modification non-reversible in certain areas around which
organized lymph node structures evolved. Support for this
theory comes from the fact that organized lymph nodes
developed later in phylogeny than lymphocytes, lymphocyte
recirculation, or cell-mediated immune inflammatory
reactions, and are in fact only present in mammals.
This idea that chronic inflammatory areas behave as lymph
node analogues is supported by the results pertaining to
the adjuvant granuloma which showed an increase in flux
and also some lengthening of the interstitial transit time.
The afferent lymph output in the sheep draining such a
lesion had the magnitude and differential cell count that
would normally be expected for the efferent lymph draining
a lymph node of the same weight as the granuloma (Smith et
al 1970).
The situation as far as the subcutaneous nodule of mammary
carcinoma is concerned is less clear. The limited series
of experiments suggests that such tissue had a greater
flux than normal skin but this may not be a relevant com¬
parison. The equivocal results obtained with trypsin-
treated lymphocyte localization suggest that this flux does
not depend upon a trypsin sensitive mechanism and may
therefore suggest that there is not a cell-mediated immune
inflammatory component to the lesion. This may indeed be
the case as the tumours grow freely in syngeneic and Fj
hybrid female recipients with no evidence of rejection.
The questions that still remain unanswered are: Is
peripheral sensitization an important mechanism of initiat¬
ing immune responses? Which cell types are the most import
ant for triggering immune inflammation and where is the
precise location of interaction with antigen? The
relatively greater ability of recently formed lymphocytes
to extravasate in all tissues could perhaps provide a
great enough frequency of antigen reactive cells if these
were confined to this minority population in the blood. In
primary immune responses 'virgin' B lymphocytes may belong
to this subpopulation (Strober 1969? 1972) and if the
irritant action of any antigen administration preferent¬
ially allows increased entry of this cell type into the
tissues then peripheral sensitization might be expected
(de Sousa & Parrott 1969, Macher & Chase 1969) - This type
of effect will also explain the direct development of
delayed type hypersensitivity reactions (eg 4-5 days after
sensitization with TNCB) in the mouse in the site of
primary application of antigen that is almost certainly
mediated by activated T lymphoblasts generated in the
draining lymph node (Allwood 1975)-
However, as mentioned already, the triggering of this type
of cell-mediated response in long-term immunized subjects
can only be explained by interaction of antigen with long-
lived memory cells that will be of the classical small re¬
circulating type. A precise knowledge of the frequency
of these various cell types that can react to a given
antigen would help to clarify whether fluxes of the order
suggested are great enough to account for the development
of the reactions.
CONCLUSIONS
Lymphocyte fluxes through skin were increased by eliciting
cell-mediated immune responses and this flux probably com¬
prised the same mixture of cell types as in normal non-
lymphoid tissues.
The increase in flux through irritant lesions may have an
increased proportion of lymphoblasts.
In cell-mediated immune inflammation the increased entry
of lymphocytes is trypsin-sensitive and from this point of
view is similar to the very efficient entry of lymphocytes
into lymph nodes. The entry into irritant lesions is
possibly not trypsin-sensitive.
The tumour model studied probably showed no evidence of a
cell-mediated immune reaction.
CHAPTER SIX
The Bone Marrow - A Secondary Lymphoid Organ
Introduction
The bone marrow is the major site of haemopoiesis in the
adult mammal. The generation in this tissue of erythro¬
cytes, polymorphonuclear leucocytes, monocytes and plate¬
lets (from megakaryocytes) are all well established
phenomena. In addition, bone marrow populations contain
small round cells with the morphological appearance of
lymphocytes. Following studies using systemic and local
administration of tritiated thymidine it is clear that
many of these bone marrow lymphocytes arise by cell
division at this site (Everett et al 1964, Brahim &
Osmond 1970). With the development of surface markers
for sub-populations of mature lymphocytes it was shown
that only a small minority of bone marrow cells contained
surface 0 antigen in mice. That such mature T cells
though needing the thymus for inductive maturation were
ultimately derived from bone marrow precursor cells was
shown by re-population studies after lethal irradiation,
in which this latter source was essential for the full
recovery of T cell populations (Claman 1974)- Also fully
mature B cells with dense surface immunoglobulin (ig)
comprised only a small proportion of bone marrow lympho¬
cytes (Osmond & Nossal 1974a). Using timed administration
of H Tdr and also scoring cells for surface Ig (Osmond &
Nossal 1974b) showed that there was indeed a maturation of
newly formed bone marrow lymphocytes with accumulation of
surface Ig in increasing density. The time of release of
such developing B cells into the blood appeared random
with respect to an individual cell's maturity as assessed
by surface markers.
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Because of these results of a high labelling index of
marrow lymphocytes with Tdr after only 3 days admin¬
istration, showing that most cells are newly formed, and
the low proportion of cells having surface markers typical
of mature long-lived lymphocytes, it was considered that
there was only a minor interchange between the blood and
marrow of recirculating lymphocytes. This idea was rein¬
forced by the relatively low immunocompetence of bone
marrow cell populations. However, the presence of some
functional activity known to require T cells or memory B
cells in this compartment and the ability to reduce this
functional activity by prolonged thoracic duct drainage
argued in favour of some recirculation through this tissue.
Such functional markers were (i) the graft-versus-host
(GVH) activity of rat marrow cells (Yoshida & Osmond 1971)
that was shown to be carried by small lymphocytes by cell
size fractionation and is established to be almost
exclusively the property of small T cells in the rat
popliteal lymph node assay used (Ford et al 1970, Rolstad
& Ford 1974). Similarly the GVH activity of mouse marrow
cells was abolished by treatment with anti-9 serum (Cantor
1972); (ii) the adoptive primary antisheep erythrocyte
haemolysin response of bone marrow cells (Howard & Scott
1972)measured in irradiated recipients challenged with
antigen was much reduced in donors subjected to prolonged
thoracic duct drainage; (iii) mature T cells were notably
absent in the bone marrow of nude mice and were markedly
diminished in neonatally thymectomized mice (Claman 1974).
Indirect evidence supporting this blood-marrow interchange
of immuno-competent lymphocytes comes from the observation
of increased functional activity of marrow populations
with increased proportions of mature T cells as shown by
surface markers or ^Cr labelling in mice treated with
hydrocortisone. These same animals showed a deficit of
immuno-competence in the blood and lymph nodes at the same
time (Moorhead & Claman 1972). Similar results obtained
in the guinea pig (Fauci 1975)-
The observations of Gordon et al incidentally provided
more direct evidence of both release from and uptake into
the bone marrow of lymphocytes in an isolated rat femur
preparation. The experiments were designed to measure
the kinetics of polymorph release under the influence of
releasing factors but the differential counts of the input
and output perfusates showed (i) a deficit of lymphocytes
in the output if lymphocyte rich blood was used as per¬
fusing fluid, but (ii) if cell free plasma was used then
lymphocytes were found in the outflow perfusate and these
must have derived from the marrow. Histological exam¬
ination showed no disruption of the marrow architecture
that would account for artefactual release of cells under
the conditions used (Gordon et al 1964)-
Histological examination with the electron microscope also
revealed lymphocytes in transit between blood and marrow
parenchyma between sinusoidal endothelial cells, but the
direction of movement could not be deduced from these
static preparations (Hudson & Yoffey 1966).
The data presented in Chapter 4 suggested that there is a
substantial flux of lymphocytes between blood and bone
marrow. Labelling with ^Cr or supported the
thesis that both large and small lymphocytes could use
this pathway with a modal transit time similar to or
shorter than that in the spleen. The size of this flux
had not been appreciated previously because of the diffuse
nature of the organ and also because early time intervals
when peak values are found were not studied.
The experiments to be detailed in this chapter were
designed to investigate further the relationship between
immuno-competent lymphocytes and the bone marrow.
Functional markers were used to follow the migration of
thoracic duct lymphocytes thus avoiding the potential
toxicity associated with radioactive labelling. The
capability of the marrow organ to act as a lymphoid tissue
was assessed by measuring the localization of labelled
particulate antigen, and by investigating the behaviour of
injected parental strain lymphocytes in Fj hybrid
recipients in which a systemic graft versus host reaction
would develop, in order to determine whether this site
could produce specific antigenic retention of reactive
lymphocytes with blast-transformation and proliferation as
is known to occur in the spleen (Gowans 1962, Ford et al
1975)•
Methods
1 Bone Marrow Cell Preparation
Both femora, tibiae and humeri were removed immediately
after death and placed in PBS containing a final
concentration of 5 niM EDTA and 15% FCS on ice. The
marrow was flushed from the marrow cavity, after
perforation of the epiphyseal plate using a 19 or 21g
needle, with approximately 10ml of the EDTA/PBS/FCS per
bone, as soon as possible. The fragemnts of marrow
parenchyma were broken by repeated aspiration with a
pasteur pipette followed by sieving through a sterile
stainless steel wire mesh. The resulting suspension
was allowed to stand in 35ml conical tubes held vertic¬
ally on i ce for at least 10 mins. Large particles
sedimented quickly and the supernatant single cell
suspension was aspirated with a pasteur pipette, taking
care to avoid the inevitable surface debris. The cell
were then washed once by centrifuging at 350g for 10
mins at 4°C and resuspended for counting and injection
at suitable concentrations in PBS. Troublesome clump¬
ing of cell suspensions after washing was avoided by
maintaining the cells on ice at all times. EDTA was
used as an anticoagulant, as bone marrow is rich in
tissue thromboplastins and also in the hope that it
might encourage dissociation of reactive cells from
their antigenic tissue in a way analogous to the detach
ment of cytotoxic effector cells from specific target




Whole body irradiation was used to greatly reduce the
immune competence of final recipients in the adoptive
memory antibody response assay for memory B & T cells.
The dose usually of 750 rads was administered to rats
restrained in 4•4cm wide space within perspex cages
with 12 Mev electrons from a horizontally directed linear
accelerator (pulse width 50 ji sec repetition rate 50 Hz
current 3 amps peak). Recipients in the adoptive anti¬
body assay received transferred cells on the day of
irradiation.
Radiation of intermediate recipients with up to 1000
rads was used in attempts to reduce the background GVH
reactivity of bone marrow.
Assay for the adoptive transfer of memory to Human
Serum Albumin (HSA).
The transfer of lymphocytes from rats, primed by the
injection of alum-precipitated HSA together with 8 x 10^
Bordetella pertussis organisms at least 3 months
previously, to irradiated syngeneic recipients which
were then challenged with 10 ^ig soluble HSA 24 hrs
later, allowed the production of a secondary antibody
response whose magnitude was directly related to the
number of lymphocytes transferred (Bell & Shand 1975)•
The antigen binding capacity of serum taken on days 14
and 21 after challenge was measured using a modified
Farr-type radio-immuno-assay.
Serum samples were assayed for antigen binding capacity
(ABC jig antigen bound/ml of neat serum) and relative
affinity ( T S') by the ammonium sulphate precipitation
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test using I-HSA monomer as described by Bell & Shand
(1975). Dilutions of antisera, in duplicate, were made
with a Micromedic automatic pipette (Micromedic System
Inc, Phila, Pa) and ABC determined both at 0.1 ^ug and
10 jig HSA monomer/ml. However, when the ABC was 2.0,
the sample was also tested at 1.0 jig HSA/ml . A
computer programme was written to calculate the
relative affinity and when necessary to extrapolate the
ABC at 1 jig/ml.
51
4 Cr Labelling of Sheep Erythrocytes
Sheep erythrocytes (Tissue Culture Services, Slough)
were washed twice in PBS and resuspended at a con¬
centration of 5 x 10^/ml in RPM1 + 10% FCS and incubated
with Na£ ^Cr 0^ at 50 ^iCi/ml at 37°C for 1 hr. The
labelled cells were washed three times in 40ml vols of
PBS and resuspended for injection. The dose of cells
administered iv was adjusted to give adequate total
activity.
5 Popliteal Lymph Node Assay of Graft versus Host Activity
The method of Ford Burr & Simonsen (1970) was used, in
which graded doses of cells were injected subcutaneously
into the footpads of young (less than 8 weeks old) F^
hybrid rats. Each population was assayed in quad¬
ruplicate at two doses. For bone marrow suspensions
where large cell doses were required an injection
volume of 0.2ml was usually employed and if this was
the case all populations within the experiment were
injected in this volume rather than the standard 0.1ml
volume. Seven days later the draining popliteal lymph
nodes were removed, dissected clear of adherent fat and
weighed to _+ O.lmg.
Results
A Localization of Particulate Antigens
Tables 6.1 and 6.2 show the results of kinetic
distribution studies of ^^Cr-labelled xenogeneic
erythrocytes and heat-killed syngeneic thoracic duct
lymphocytes respectively. Comparison of the local¬
ization of radioactivity expressed as the percentage
injected dose in animals perfused at 1 or 2 and 24 hrs
after iv injection of labelled cells showed that the
TABLE 6.1
The Distribution of Radioactivity in Recipients 1 & 21 Hrs
after i v injection of 8 x 10^ 51cr-labelled sheep erythro¬
cytes .
(Triplicate recipients 'perfused' at time of sampling)
Mean % injected activity per whole organ ± S E.
Tissue 1 Hr 21 Hrs
Spleen 1.3 1 03 2.7
+
. 1
Bone marrow 3.5 ± 3 4 . 2 + .3






Skin 3.7 ± 53 1.8 + .08
Small intestine 1.1 - 11 .62 .08
Lung 1.1 ± 21 .4
+
. 002
Blood leucocytes 1.7 1 4 • 13
+
.01




Tissue Distribution of Radioactivity 2 Hrs & 24 Hrs after
i v Injection of 130 x 10^ ^Cr-labelled Heat-Killed
Syngeneic TDL
Mean % injected activity per whole organ - S E (n = 2)
Tissue 2 Hr 24 Hr
Spleen 1.9 - .17 2.7 - .18
Bone marrow 6.1 i .16 11.1 — .9
Liver 57•1 - 1.0 58.6 - 2.6
Lymph node .06 ± .002 ' .11 ± .02
(superficial)
Skin 3.0 - .2 2.2 ± .02
Small intestine .81 - .06 .42 - .06
Lung 34-9-12.5 2.4 - .16
Blood leuco¬
cytes
.62 - .3 .36 - .07
Plasma 7.6 - .06 1.6 - .17
majority of the injected activity was in the liver at
both times. The high early level in the lung had
fallen by 24 hrs and presumably reflects continued
clearance of cells from the blood. The cell-free
label in the plasma showed a similar pattern, as did
the activity in most non-lymphoid tissues as exempli¬
fied by skin values. Lymph nodes accumulated very
little activity at any time. In contrast to these
tissues the spleen and bone marrow showed significant
localization at two hours but also showed increased
activity by 24 hrs. These results are consistent
with an interpretation that the activity in these sites
is due at least in part to the phagocytic activity of
the rich population of macrophages lining the blood
sinusoids and therefore supports the idea that the
marrow could be a site of antigen concentration.
B Migration of TDL to Syngeneic Bone Marrow
Fig 6.1 and Table 6.3 summarize the results of experi¬
ments in which the migration of syngeneic cells into
and out of the marrow was assessed with functional
markers.
The protocol for these and several subsequent experi¬
ments was to inject groups of intermediate recipient
rats intravenously with thoracic duct lymphocytes
either two or twelve hours before making single cell
suspensions of the bone marrow of these and uninjected
controls. These marrow populations and the original
TDL were then used in functional assays using
appropriate final recipients.
Using GVH reactivity of parental strain lymphocytes in
Fj hybrid recipients as a measure of T cell function,
triplicate groups of parental HO B2 strain rats were
injected with 350 x 10^ syngeneic TDL. The marrow
populations were taken after intervals of zero, 2 and
12 hrs and assayed in HO B2 x PVG/c F^ hybrids using
the popliteal lymph node assay. It is clear (Fig 6.1)
FIG 6.1
Ex 103. 350 x 106 HO.B2 TDL were transferred to each
member of groups of three intermediate
normal rats by iv injection either 2 or 12
hrs before death. Bone marrow cell
suspensions were prepared from the six major
long bones of each recipient and the
suspensions from each group of syngeneic or
HO.B2 x Pvg/C hybrid intermediates were
pooled for each time period. These
suspensions together with those made from
matched but uninjected control groups of
rats and a sample of the HO.B2 TDL were then
assayed for GVH activity in HO.B2 x Pvg/C Fj
hybrids using the popliteal lymph node assay.
Fig 6.1 shows the dose response relation¬
ships of each population for the parental
strain syngeneic groups of rats.
1-5-
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Geometric Mean Antigen Binding Capacity (- SE) of Sera
of Groups of Five (750 RAD) Final Recipients 21 Days
after I.V. Injection of Bone Marrow Cells derived from
Duplicate Intermediate Normal or 800 RAD Irradiated Rats
which had received Syngeneic TDL from HSA-Primed Donors,
2 or 12 Hrs Previously.
(Each final recipient received */5 of the total cells
collected from 6 long bones of both intermediates).
2 Hrs 12 Hrs
Normal 750 rad Normal 750 rad
2.2 (- .06) 4-6 (± -15) 0.3 (± .16) 0.8 (± .16)
o>
/
that the potency of bone marrow cells, though much
lower than pure TDL, is significantly raised 2 hrs
after a bolus injection of TDL compared to uninjected
bone marrow, but has dropped almost to background
levels by 12 hrs.
Also using TDL from HSA-primed donor PVG/c rats which
include memory B and T cells and assaying the bone
marrow of intermediate syngeneic recipients for the
ability to produce an adoptive secondary antibody
response to a standard dose of soluble antigen in
irradiated final syngeneic recipients, a similar
pattern occurred. The antigen binding capacity of day
21 sera of the group of rats receiving bone marrow from
intermediates injected with TDL 2 hrs previously was
much greater than that measured in final recipients of
bone marrow cells from intermediates injected with TDL
12 hrs previously. Normal and irradiated intermediates
were both used in case there was significant suppression
of the adoptive response by normal bone marrow cells.
The presence of suppressive activity in the marrow could
explain the slightly higher response in irradiated
animals, but another explanation is suggested by the
results shown in Table 6.4, in which the distribution
of ^*Cr-labelled syngeneic TDL was compared in similar
pairs of irradiated and normal recipients. In the
irradiated recipients the concentration of label
associated with blood leucocytes dropped much more
quickly than in intact controls and remained at lower
levels even by 24 hrs. There was a considerable
excess of activity in the bone marrow of irradiated
recipients at 2 hrs and this coincided with a deficit
in the spleen. This reciprocal imbalance had dis¬
appeared by 24 hrs. There was no difference between
lymph node localization on a whole node basis, although
an increase in concentration (counts/gm) was noted in
the nodes 1 day after irradiation as the nodes were
very shrunken by this time. The same shrinkage was
TABLE 6.4
Tissue Distribution of Radioactivity 2 & 24 hrs after
iv Injection of 120 x 10^ 51^r-labelled TDLs into
Duplicate Normal or 750 RAD Syngeneic Rats (perfused at
time of sampling).
Percent Injected Dose per Organ (SE for most tissues was
less than 10% of the mean and has been excluded for the
sake of clarity).
Tissue 2Hrs 24Hrs
Normal 750 rad Normal 750 rad
Spleen 37-0 22 . 5 17-5 16.6
Bone marrow 25.2 35.0 4.7 5.6
Lymph node
(superficial 2.3 2 . 6 6.0 8.0
cervical)
Intestine 19.5 23.8 15.2 18.4
Thymus .03 .13 • 07 . 14
Lung 5.2 5.8 2.3 1.6
Liver 10.0 10.1 10.1 9.0
Skin • 3 .3 • 31 .31
Muscle .6 • 55 .6 .6
Brain .049 .013 .007 .005
Blood leucocytes .69 .18 1.5 . 17
Plasma .38 .23 .40 .26
seen in the thymus but here the increased concentra¬
tion was still noted on a whole organ basis and may
reflect some degree of inflammatory change associated
with the massive cell death in this tissue. The splenic
activity was reduced overall but showed normal con¬
centrations on a weight basis. The net redistribution
of activity at 2 hrs from spleen to bone marrow could
be the result of two factors. Firstly, the shrunken
spleen may have a reduced total blood flow, which with
a normal clearance factor would result in a net deficit
- a partial splenectomy that would allow more cells to
be available for extravasation elsewhere. One observ¬
ation against this suggestion is the concurrent deficit
in the blood that argues more in favour of competitive
removal of labelled lymphocytes from the blood by other
tissues of which the most important is obviously the
bone marrow. That this might be likely is suggested
by the histological appearande of bone marrow 24 hrs
after irradiation; at this time there is marked loss
of parenchyma and wide dilation of the blood sinuses.
The latter may simply be due to compensatory dilation
because of the tissue shrinkage within a rigid bony
case, but would result in an increased blood supply of
lymphocytes and therefore increased extravasation even
in the absence of any increase in clearance factor.
Thus on a per whole organ basis, which was used to
assay the HSA-memory response, higher values would be
expected at 2 hrs in irradiated compared to control
bone marrow simply as a reflection of the greater
number of extravasated lymphocytes.
The pattern of localization in syngeneic bone marrow
was essentially similar when measured with functional
markers as that seen with radiolabels. Precise quant¬
itation in terms of the proportion of the injected dose
localized in the tissues was impossible with these
functional assays for several reasons. The injected
TDL populations, although from the same panel of donors
was collected over different periods to allow staggered
injections and therefore simultaneous preparation of
bone marrow cell suspensions. The potency of the
populations could therefore differ slightly and
calibration against the TDL starting population has
only limited accuracy. Perhaps more important was the
likely variation between the localization in individual
recipients and also the inconsistency of efficiency of
removal of bone marrow for preparing single cell
suspensions.
C Migration of TDL to Semiallogeneic Bone Marrow
The behaviour of injected parental strain TDL in Fj
hybrid recipients was studied in several ways. Ford et
al (1975) and Atkins & Ford (1975) showed retention of
specifically reactive parental lymphocytes in the
spleens of Fj hybrids by (i) using alternative radio-
labelling techniques which allowed comparison of the
distribution of responsive and non-responsive popula¬
tions in the same recipient and (ii) showing a retention
of H-Udr labelled parental TDL with blast transform¬
ation in histological autoradiographs of the spleen.
This antigen-reactive cell retention occurred within 24
hrs and was associated with complete removal of the
relevant GVH activity from the recirculating lymphocyte
pool as sampled in the thoracic duct. In the spleen
the GVH reactivity of single cell suspensions made 24
hrs after injection of parental TDL did not show the
expected increase in potency of GVH reactivity (Atkins
& Ford 1975). It was suggested that this may have
been at least partly attributable to the failure of
transformed cells to enter the suspension.
The size of retention in the spleen and the relatively
less marked retention seen in lymph nodes was entirely
consistent with the idea that the reactive lymphocytes
remained in the tissues in which they first extra-
vasated. It was therefore considered likely that a
similar phenomenon would take place in the bone marrow
if this tissue could be recognized as antigenic and
could support immunological blast transformation and
cell division.
Table 6.5 shows the result of an experiment in which
parental AO TDL were labelled with ^H-Udr in vitro and
injected into irradiated syngeneic or AOXDA hybrid
recipients which were killed 2 or 24 hrs later. The
recipients were perfused with PBS and then 1% Glutar-
aldehyde as a tissue fixative. The cleaned fixed long
bones were then decalcified and prepared for routine
histological sectioning.
Autoradiographs were then prepared and the total number
of labelled cells and the proportion of pyroninophilic
blast cells per unit area of cellular marrow paren¬
chyma were assessed. The recipients were irradiated
to reduce the resident proliferative population to
facilitate scoring of labelled cells. This procedure
incidentally may also have accentuated the early local¬
ization as suggested by Table 6.4-
At 2 hrs after injection similar numbers of labelled
cells were found in both strains of recipient but by 24
hrs there was not only significant retention of labelled
cells but also a marked increase in the proportion of
blast cells in the hybrids. Occasional mitoses of
labelled cells were also noted in the Fj hybrids. Thus
by 24 hrs there was a seven-fold increase in blast
transformation in the Fj hybrid confirming the ability
of parental strain TDL to instigate a systemic GVH
reaction in the bone marrow and also showing that the
bone marrow can provide a suitable environment for such
cellular activity.
The next approach was to use the same experimental
design as that described for syngeneic animals to assay
the GVH reactivity of F^ hybrid bone marrow populations
after iv transfer of parental strain TDL in an attempt
to measure any functional retention of specifically
TABLE 6.5
The Distribution of ^H-Udr Labelled AO TDL in AO or AO x
DA Fj Hybrid Bone Marrow 2 Hrs & 24 Hrs after iv Injection
(Frequencies derived from counts of approx. 1000 labelled
cells at 2 hrs and 200 labelled cells at 24 hrs in
sections of six bones from duplicate recipients of each
type at each time period).
Strain 2 Hrs 24 Hrs
Labelled Labelled
Cells/Unit % Blasts Cells/Unit % Blasts
Area Area
AO (syngeneic) 39 2.4 2.4 10




reactive cells. The demonstration of such positive
selection has proved more difficult than showing the
absence of a reactive population. Thus as mentioned
no increase in potency of GVH reactivity was found in
Fj hybrid spleens. Similar difficulties were also
encountered when specific retention of sheep erythro¬
cyte reactive cells were looked for in the spleens of
mice soon after antigen injection (Sprent & Miller
1973)- Explanations for these failures included the
possibilities that transforming cells were not well
represented in single cell suspensions or that even if
they were they either did not migrate normally or were
refractory to further antigenic challenge in the final
assay recipients. In attempts to obviate these factors
12 hrs was chosen as a 'late' time because morphological
blast transformation is not apparent as early as this
but most of the cells initially present in marrow have
emigrated again by this time. Also EDTA was included
in the medium used to isolate bone marrow cells both as
an anticoagulant and as an agent that is known to cause
the detachment of cytotoxic effector cells from mono¬
layers of their specific target cells and which may
therefore allow dissociation of antigen-reactive cells
from the antigenic stroma.
The first experiment using hybrid intermediates in
the assay of migration of GVH reactive cells was in fact
the same experiment as that for which the syngeneic
intermediates were shown in Fi<j6 . 1 . Fig 6.2 shows the
results of the parallel F^ hybrid recipients whose bone
marrow was assayed in the same strain of F^ hybrid. A
similar degree of increase of bone marrow GVH reactivity
was seen in the Fj hybrid as in the syngeneic inter¬
mediate at 2 hrs but at 12 hrs this activity had not
fallen but if anything was increased still further.This
result was entirely consistent with the idea of reten¬
tion of antigen reactive cells at the site of their
first interaction with antigen and argues in favour of
FIG 6.2
Ex 103. 350 x 1C>6 HO.B2 TDL were transferred to each
member of groups of three intermediate
normal rats by iv injection either 2 or 12
hrs before death. Bone marrow cell
suspensions were prepared from the six major
long bones of each recipient and the
suspensions from each group of syngeneic or
HO.B2 x Pvg/C Fj hybrid intermediates were
pooled for each time period. These
suspensions together with those made from
matched but uninjected control groups of
rats and a sample of the HO.B2 TDL were then
assayed for GVH activity in HO.B2 x Pvg/C Fj
hybrids using the popliteal lymph node assay.
Fig 6.2 shows the dose response relation¬
ships of each population for the Fj hybrid









positive selection of the minority population of
reactive cells. Absolute enrichment over the starting
TDL population would require purification of the marrow
cells to yield only parental strain lymphocytes.
Experiments were then carried out to test the antigen
specificity of this retention. The results were less
clear cut and several factors that make precise inter¬
pretation of the results difficult were immediately
obvious. The main difficulty was knowing whether the
small inherent bone marrow GVH reactivity should be
taken into account. It was argued previously that
injected cells and resident host cells probably do not
interact to any significant degree and therefore it
could be said to be reasonable to use the uninjected
marrow activity as a meaningful background control. In
experiments examining antigen specificity each popula¬
tion must be assayed in both relevant and third party
•Fi hybrids. This requires therefore, that Fj hybrid
marrow cells are injected into other semi-allogeneic F^
hybrids with the production of a mixture of background
GVH and HVG responses. In this popliteal lymph node
assay the peak of the HVG reaction is however much
realier at 4 days (Dorsch & Roser 1974) than that of
the GVH at 7 days and is also much lower on a cell for
cell basis so that interference should not be too great.
However, it was consistently observed that background
responses of F^A into F^B were greater than F^A into F^A.
Attempts to increase the sensitivity of the system by
increasing the initial localization in the marrow by
splenectomizing the intermediates probably did not
improve the situation as the decrease by 12 hrs in
syngeneic recipients was not so great as in intact
recipients. Similarly irradiation of the intermediates
in an attempt to recuce background activities had the
unexpected result that although the total cell number
removed from bones was decimated the GVH reactivity
increased by a factor of ten on a cell for cell basis
resulting in exactly the same total background activity
per bone.
To compare several experiments which had many differ¬
ences in detail the GVH activities were transformed by
using the TDL response for each experiment as a standard
calibration curve. Thus using the midpoint of each
experimental dose-response line (thus ignoring the
differences in slope), each population's response was
expressed in TDL equivalents and this number of cells
was then expressed as a proportion of the initial
injected dose per whole bone marrow sampled (6 long
bones) after subtraction of background TDL equivalents.
This rather complex transformation of the data allowed
the easiest comparison of results between experiments
in which the absolute GVH assay results varied
considerably. It also allowed very rough comparison
with quantitative data derived from labelled cell
studies.
Fig 6.3 shows a representative graph of the dose
response relationships of bone marrow populations in
relevant and third party assays.
Table 6.6 summarizes the data of five experiments
comprising various strain combinations and treatments
of the intermediate recipients. The behaviour of
parental TDL in syngeneic recipients is consistent in
the three experiments in which it was measured, two of
which were assayed in two types of hybrid. The
results of the activities in F^ hybrid intermediates
showed a general trend towards increased retention in
Fj hybrids at 12 hrs compared to parental strain rats
but the specificity of this retention was far from
complete. In some strain combinations the apparent
retention of GVH reactivity to third party antigens was
at least as great as the reactivity to the specific
antigen. There \vas also some variation between the
degree of retention at 12 hrs compared to 2 hrs.
Although this was always greater than in syngeneic
FIG 6.3
Ex 107. In this experiment triplicate groups of
Pvg/C rats or Pvg/C x AO or Pvg/C x XDA Fj
hybrid rats were splenectomized and received
either no cells or 500 x 10^ Pvg/C strain
TDL 12 hrs before death. Bone marrow
suspensions from these groups of animals and
the original Pvg/C TDL were assayed for GVH
activity in both Fj hybrid strains.
The graphs show the dose response relation¬
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parental controls it was not always as complete as in
Ex.103 and 110. In Ex.ll5> ^Cr labelled parental TDL
were used so that an attempt could be made to calibrate
the final GVH response against the radioactivity of the
sample as a measure of the injected cells. In this
experiment no detectable difference was seen between
the radioactivity at 12 hrs in parental or hybrid
intermediates.
To examine this question of absolute retention in the
bone marrow of semi-allogeneic recipients kinetic
distribution studies were undertaken using ^^Cr-labelled
parental TDL in various strain combinations. The
results are summarized in Table 6.7 and again only show
obvious retention in bone marrow in one experiment
which was incidentally the same AgB combination (A0->DA)
as the ^H-Udr labelled TDL experiment which had also
shown 24 hr retention in marrow at about twice that
in the parental strain recipients.
A final group of experiments studied the activity of
bone marrow populations of syngeneic and F^ hybrid
recipients of parental strain TDL from HSA-primed
donors. The aim was to investigate whether retention
of GVH reactivity in an F^ hybrid intermediate host was
accompanied by retention of memory cell activity for a
conventional protein antigen. The experimental design
used was as previously detailed and bone marrow popula¬
tions from irradiated intermediates were assayed in
irradiated final parental strain rats for their ability
to produce a secondary antibody response to soluble HSA.
The results are summarized in Table 6.8 which shows the
mean Day 21 serum antigen binding capacity for groups
of up to five assay animals which had received bone
marrow cells collected 2 or 12 hrs after iv injection
of primed TDL. The values of ABC are not directly
comparable between experiments as the starting TDL
populations had different potencies and also different
proportions of the total bone marrow cells collected
TABLE 6.8
Recovery and transfer of HSA primed TDL migrating through
the B M of syngeneic and hybrid intermediate rats. The
day 21 ABC values are geometric means of 5 recipients each,






Time of B M collection
after injection of HSA
primed TDL
2hr 12hr
ABC (± SE)* ABC (± SE)
T95 Syngeneic parental
PVG/c intermediates 4-6 (- .15) 0.8l(i .16)
800 rads
T96 Semiallogeneic PVG/c





PVG/c intermediates 4.5 (- .16) 2.7 .34)
1000 rads
Semiallogeneic PVG/c
x DA Fj hybrid inter 2.7 (- >25) 7-7 (- .10)
mediates
1000 rad
•'""Geometric mean ABC (- SE of mean log^Q ABC).
■^'""Tested at 0. Ijig sHSA/ml.
were used.
It is again clear that in syngeneic recipients a marked
fall in activity occurs between 5 and 2 hrs and 12 hrs
after iv injection. However, in the Fj hybrid
recipients this fall is much less marked or even
reversed.
All the experiments using this HSA antibody assay were
done in collaboration with Dr E B Bell.
Discussion
The results of the migration studies using functional cell
markers in syngeneic animals confirmed the findings using
radio-labelled lymphocytes and although quantitation could
not be as accurate the proportions of the injected activity
found in the bone marrow at the different time intervals
were in the same range as measured with ^^Cr. In addition
these functional assays showed that both recirculating T
cells (GVH activity) and memory recirculating B and T
cells (HSA adoptive secondary response) used this pathway.
Whether B cells migrate more slowly through this tissue as
has been suggested for spleen and lymph nodes (Nieuwenhuis
& Ford 1976) cannot be decided from these results, as the
fall in the adoptive antibody response between 2 hrs and
12 hrs could simply reflect the emigration of helper T
cells specific for the antigen as these helper cells limit
the size of final antibody response in this assay (Bell &
Shand 1975). Thus at 12 hrs memory B cells could still
be present but have insufficient 'help' to allow their
full functional potential to be demonstrated.
The ability of the bone marrow environment to support
lymphocyte activation by antigen with subsequent cellular
proliferation was clearly demonstrated by the retention
and blast transformation of parental ^H-Udr labelled
lymphocytes in the bone marrow of F^ hybrid recipients
whose tissues were antigenic to the injected cells.
The results of increasing localization of radiolabelled
particles in the bone marrow and in the spleen but not
elsewhere suggest that macrophages lining bone marrow
sinusoids are able to concentrate antigenic particles and
therefore the bone marrow has both necessary prerequisites
for functioning as a secondary lymphoid organ in the
initiation and propagation of immune responses. A rough
estimate of the likely efficiency of this site, in terms
of initiation of an immune response when compared to the
spleen, can be made if it is assumed that the limiting
factor for immune reactions would be the likelihood of
interaction between antigen reactive cells and macrophages
suitably primed with antigen. If it is assumed that the
marrow weight is approximately half of that of the bones
containing marrow, then this organ would be ten to fifteen
times as large as the spleen, yet it supports a lymphocyte
flux of seven-fold less per whole organ and has a total
antigen localizing capacity of only four to five times as
great. Thus the total efficiency is likely to be of the
order of 0.2% of that of the spleen/unit weight or 3-0%/
whole organ.
This functional capability is entirely consistent with the
growing body of evidence that the bone marrow is an import¬
ant site of plaque-forming cell localization, particularly
in secondary responses as well as late in primary
responses (Benner et al 1974a)- It would also explain
the observation that the bone marrow is only important in
primary antibody responses in the absence of the spleen if
an approximately 40 times greater antigen dose is injected
iv (Benner et al 1975)- The high rate of lymphocyte flux
could explain the distribution of plaque-forming cells or
their precursors in this site as such cells would be
likely to migrate randomly from the blood into the tissues
and might find the marrow an ideal site for maturation
into relatively sessile plasma cells especially in the
presence of antigen.
The thorough studies of Benner et al (1974 a,b & c,1975)
on the generation of memory B and T cells and plaque-
forming cells in mouse bone marrow and other tissues,
showed that IgM, IgG and IgA secreting cells could be
detected in the bone marrow of normal animals under
appropriate conditions and also showed that this site
provided the majority of such cells in the body late in
secondary responses. However, their conclusion that
priming in splenectomized recipients after large antigen
doses occurred in the mesenteric lymph node or Peyer's
patches following localization of small amounts of antigen
in those sites is less likely than the alternative
explanation of priming in the bone marrow which they
viewed with less favour.
The importance of the idea of lymphocyte flux rather than
a simple seeding of peripheral organs including the bone
marrow for plaque-forming cells, their precursors ana
associated helper T cells, is suggested by the finding of
greater numbers of plaque-forming cells in the bone marrow
of mice splenectomized between priming and secondary
challenge with sheep erythrocytes compared to intact
controls (Benner + Oudenaren 1975). In the splenecto-
mized animals the flux of lymphocytes through all tissues
is likely to be increased (Bradfield & Born 1973; this
thesis Ch.4). Conversely in intact recipients the spleen
would compete with the bone marrow for the recirculating B
and T memory cells present in the blood.
During a primary response to sheep erythrocytes plasma-
blasts, the activated precursors of antibody secreting
cells are produced in the periphery of the splenic peri-
arteriolar lymphoid sheath and migrate via the marginal
zone bridging channels (van Ewijk 1977). This is a
normal exit pathway of recirculating lymphocytes which
enter venous blood in the red pulp sinuses (Mitchell 1973)-
The major distribution of plaque-forming cells in the
sple en is in the red pulp cords and if entry into this
site entails passage via the blood rather than by direct
interstitial migration from the white pulp it is to be
expected that the spleen would be in direct competition
with the rest of the body and that the proportional
distribution throughout the body would reflect the flux of
lymphocytes through tissues as well as the distribution of
antigen. This process would explain the widespread
distribution of antibody secreting cells including the
significant bone marrow localization late in primary
immune responses to intravenous antigens that begin in the
spleen. This holds for both T independent antigens such
as LPS (Benner et al 1976), and thymus dependent antigens
such as sheep erythrocytes (Benner et al 1974), or hen
lysozyme protein (Hill 1976).
Functional studies of bone marrow cell populations also
show that many lymphocyte sub-populations are represented;
mature T cells:
(i) GVH reactivity (Yoshida & Osmond 1970)
(ii) adoptive primary haemolysin response to
sheep erythrocytes (Howard & Scott 1972)
(iii) sheep erythrocyte memory helper cells
(Benner et al 1974)
(iv) hen lysozyme memory helper cells (Hill 1976)
(v) cells protective against lb leukaemia in
C58/wm mice (Lukasewyvz et al 1976)
and immunologically active B cells:
(i) IgM, IgG, and IgA plaque-forming cells to
sheep erythrocytes (Benner et al 1974a)
(ii) plaque-forming cells to LPS (Benner et al 1976)
(iii) memory precursors of plaque-forming cells to
sheep erythrocytes (Benner et al 1974b)
These functional attributes are confirmed by surface marke:
The true
shown by
thymic dependency of bone marrow T cells has been
the absence of 9-bearing cells in the bone marrow
of congenitally athymic nude mice and also by their reduced
frequency in thymectomized normal mice (Claman 1974) thus
indicating that such T cells enter from the blood.
Further reported observations are readily understandable
if a substantial lymphocyte flux through the bone marrow
is recognized. There is a net redistribution of both B
and T cells to the marrow in mice (Moorhead & Claman 1972)
and guinea pigs (Fauci 1975) following systemic cortico¬
steroid administration. This phenomenon is rapid, as is
the recovery following metabolism of the hormone and could
follow a change in transit time of lymphocytes through
this and other compartments of the recirculating pool as
is suggested by the rapid decrease that also occurs in
thoracic duct output of rats (Spry 1972).
Recovery of B cell numbers in irradiated fetal liver cell
reconstituted mice that are also given Strontium-89 which
localizes in bone and therefore continuously irradiates
the neighbouring marrow, is incomplete (Rozing et al 1976,
Kincade et al 1975)- In this model designed to show that
B cells are able to mature in a micro-environment other
than the haemopoietic bone marrow, mature B cells and
possibly their precursors released from the spleen into
the blood are likely to migrate into the marrow and there¬
fore a proportion may succumb to irradiation damage. If
this were true, depletion of the recirculating pool should
89also occur in normal animals given Srin a way analagous
to local irradiation of the spleen (Ford 1968) or extra¬
corporeal irradiation of blood (rev. by Cronkite 1968).
After iv injection of Newcastle disease virus into rats
there was acute lymphocytopenia and also depletion of cell
numbers in the periarterial lymphoid sheath in the spleen
and the deep cortex of lymph nodes. This situation
developed quickly and the recovery 24 hrs later was also
rapid without evidence of new cell production as shown by
•5
low labelling indices after H-Tdr administration in these
populations. Thus the depletion of recirculating lympho-
cytes must result from a net redistribution as could occur
if tissue transit times were altered. It is significant
that no excess of injected ^Cr labelled cells in this
situation was measured in liver or lungs and also that
normal levels of label were found in the spleen even in
the presence of marked lymphoid sheath depletion, whereas
there was significant reduction in lymph node localization
(Woodruff & Woodruff 1972). The possibility arises that
the sites of net redistribution are the splenic red pulp
and the bone marrow which was not examined.
The distribution of newly formed B lymphocytes which are
known to migrate to secondary lymphoid organs by tracer
studies using marrow cells labelled locally with ^H-Tdr
(Brahim & Osmond 1976) may also involve migration to other
bone marrow sites. Occasional labelled cells were noted
in distant marrow sites in similar experiments (Brahim &
Osmond 1973) and the presence of cells in subcapsular
sinuses of lymph nodes and in efferent lymph sinuses
argues in favour of the migratory capacity of such cells.
Thus an explanation of the apparent random emigration of B
cells at different stages of maturation could be that cells
are released at similar stages of relative immaturity and
after more or less extramedullary maturation a proportion
of the cells could re-enter marrow at random sites. This
would give rise to a similar distribution pattern overall.
The apparent sparing of GVH reactivity of the bone marrow
in heavily irradiated rats which is unexpected in view of
the sensitivity of lymphocytes to irradiation may also be
explained by a redistribution of surviving cells from the
blood into the marrow. Evidence in favour of this
explanation is the increased early localization of ^*Cr-
labelled lymphocytes in bone marrow of irradiated
recipients as shown earlier and also by the similar increase
noted in irradiated marrow rather than control marrow in
cross-transfusion experiments in which H-cytidine
labelled peripheral blood cells were counted in tissue
autoradiography one hour after transfusion into rats (Bond
et al 1964).
The experiments involving the behaviour of parental strain
lymphocytes in hybrid recipients showed that lympho¬
cytes can recognize bone marrow tissue as foreign and
react by transformation and division in this site. Thus
a systemic graft versus host reaction includes the bone
marrow in its initial stages as well as the splenic white
pulp and lymph nodes (Gowans 1962, Ford, Simmonds & Atkins
1975). The reaction in the splenic white pulp is assoc¬
iated with destruction of this tissue (Gowans 1962) within
ten days of the injection of the parental strain lympho¬
cytes, and the splenomegaly that is noted during the first
week of the reaction is mainly a reflection of expansion
of the red pulp by proliferation of host haemopoietic
tissue. This would be expected if the normal haemopoi¬
etic organs were undergoing destruction as is highly
probable following retention and proliferation of donor
lymphocytes in the bone marrow. This could also provide
some explanation of the time course of fatal graft versus
host disease for it could be suggested that the animal
survives until the sites of extramedullary haemopoiesis
are also invaded and destroyed by cytotoxic effector
lymphocytes or their precursors which would follow only
after the splenic red pulp for example had enlarged to
such an extent that it supported a greater flux of lympho¬
cytes. This would include antigen reactive cells that
are eventually released into the recirculating lymphocyte
pool from the sites of primary proliferation (Sprent &
Miller 1973, Nieuwenhuis et al 1974).
The difficulties in demonstrating specific enrichment of
antigen reactive cells in the tissues of the F^ hybrids
within the first 24 hrs after initiation of a systemic GVH
reaction include the possible under-representation of such
cells in single cell suspensions, altered migration of
transforming cells, possible refractoriness of transform¬
ing cells to further antigenic stimulation, as well as the
effect of background reactions of the tissues in the assay
and the inability to quantitate the total numbers of donor
type cells in the cell suspensions assayed. Attempts to
clarify the situation particularly with regard to the
background activity by using splenectomized or irradiated
recipients as intermediates were unhelpful for the reasons
already discussed. Quantitation of donor cells using
^Cr labelled TDL as the initial parental population has
the inherent inaccuracy of labelling not just the antigen-
reactive cells and also reflects variation in the total
retention of labelled cells in lymphoid tissues of semi-
allogeneic recipients as described. This variability was
also noted by Heslop & Hardy ( 1971 ) in various allogeneic
and semi-allogeneic rat strain combinations.
A possible way of both quantitating donor type lymphocytes
and also abolishing the background activity of Fj bone
.marrow populations would be to treat the cell suspensions
in vitro with a powerful cytotoxic alloantiserum of
parental type directed against the alternative allele of
the particular hybrid.
In spite of these difficulties the results of both
functional and labelled cell studies suggest that there is
significant retention of parental lymphocytes in F^ hybrid
bone marrow but that this retention shows variable antigen
specificity. Depending upon the strain combination there
was retention of activity against one AgB antigen in Fj
hybrids of supposedly unrelated AgB type. Two explan¬
ations of this phenomenon can be considered. Firstly,
the reaction of transformation in antigen reactive cells
could release local mediators that cause retention of
third party lymphocytes that happen to be in the vicinity.
The variation between strain combinations must be explained
by variable liberation of such mediators. On the other
hand, if the retention of antigen reactive cells is not
associated with liberation of such factors it must be
suggested that there could be significant cross-reaction
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between cellular recognition of certain different AgB
antigen complexes. The lack of cross-reactivity between
such antigens as shown with serum antibodies or depletion
experiments using in vivo filters and examining thoracic
duct cells does not necessarily preclude such an explan¬
ation. If there was a range of avidities for each AgB
antigen it may follow that specific cells of all avidities
are retained in the tissues of an hybrid so that the
deficit in the recirculating pool is indeed complete. If
high avidity cells are disproportionately more powerful in
the local GVH assay and low avidity cells for third party
antigens were retained because of some cross reactivity,
then the real deficit of these latter cells from the
recirculating pool may not be measurable with this assay.
In the tissues, however, the presence of this type of cell
may be enough to show functional activity in the assay in
the absence of many high avidity 3rd party reactive cells,
although a few of the latter cell type would be expected
by random distribution.
Serum alloantibodies may not react to the same part of the
major histo-compatability complex as is important for
cellular recognition and therefore may not show the same
cross reactivity. The apparent non-cross reactivity of
selectively enriched populations parked in B rats follow¬
ing mixed lymphocyte cultures (Wilson et al 1976) or
fractionation using anti-idiotype antibody (Wigzell et al
1975) may be due to the selection of high avidity cells.
Recently significant cross reactions have been noted in
populations of rat lymphocytes reacting in sequential
mixed lymphocyte reactions after which enrichment for
reactivity against one AgB type is accompanied by variable
reactivity to other AgB antigens (Antzac D. pers.comm.).
One possible means of testing whether non-specific
retention of bystander cells occurs would be to examine
the retention of A strain parental cells specifically
tolerant of strain B antigen in the bone marrow of (A x B)
Fj hybrids undergoing a GVH reaction following the simult¬
aneous injection of normal A strain lymphocytes by assay
in A x C Fj hybrids. If non-specific retention occurred
then the reaction to the third party C antigen of bone
marrow cells would be expected to be as great with the
combination of normal and B tolerant lymphocytes as with
normal and normal lymphocytes whereas if the retention was
due to cross reactivity the B tolerant cells would not be
retained in the (A x B)F^ marrow and would not therefore
be available to react with the C antigen on adoptive
transfer, assuming that tolerance involves functional
inactivation of high + low avidity cells and that tolerant
B cells have normal GVH activity against C antigens. The
second assumption could be tested experimentally.
Similar difficulties arise in the interpretation of the
results of localization of HSA memory TDL in the bone
marrow of Fj hybrids. The trend towards retention or
even increase of memory activity at 12 hrs in Fj hybrids
as opposed to syngeneic parental controls can again be
explained in two ways: either by non-specific retention
of bystander cells in the Fj hybrid marrow at the site of
the GVH reaction, or by true cross-reactivity of a pro¬
portion of GVH reactive cells for the convential protein
antigen.
That specifically selected T cells for one AgB antigen
following mixed lymphocyte culture activation and 'parking'
in 'B' rats had normal reactivity against sheep erythro¬
cytes was reported by Herber-Katz & Wilson (1976) and it
is theoretically probable that GVH reactive cells must
carry specificity for at least one conventional antigen
complexes that exist within a species.
It is perhaps unfortunate that the particular strain avail¬
able for the HSA memory cell experiments was the same as
that which showed greatest apparent non-selective retention
of GVH reactivity (in hybrid recipients).
However, the bone marrow as a tissue that has a low back¬
ground of immuno-competent lymphocytes and supports a high
flux of such cells, could provide a useful tool for the
closer examination of problems of this type in various
strain combinations especially if allo-antiserum purific¬
ation of the retained cells proved effective.
Conclusions
The evidence argues strongly in favour of the bone marrow
being able to act as a secondary as well as a primary
lymphoid organ. This tissue supports a high lymphocyte
flux, has a rich and active macrophage compartment and is
able to support transformation and proliferation of
antigen-activated lymphocytes. Estimates of the likely
efficiency of this immune function in bone marrow in
comparison to the spleen with which it shows many similar¬
ities, suggest a figure of about 2-3% of total splenic
activity for intravenous antigens.
The bone marrow is also one of the sites of initial
reaction during a systemic graft-versus-host reaction.
CHAPTER SEVEN
General Discussion
Lymphocytes are vitally important for the maintenance of
homeostasis of complex animals with regard to the fate of
a wide range of substances most of which are large mole¬
cules. The ability of lymphocytes to recognise molecular
shapes by interaction with specific surface receptors and
to mediate immune reactions following such antigenic stim¬
ulation has allowed a great increase in the efficiency of
the inactivation or disposal of inappropriate molecules
and organisms by the general mechanisms of inflammation
together with phagocytosis and digestion. A major factor
that allows these functions to act economically is the
high mobility of individual lymphocytes, while the inter¬
action of lymphocytes with other cells - eg macrophages,
other lymphocytes and vascular endothelial cells - by
either direct contact or via humoral factors no doubt
increases both the efficiency and range of responses that
can be generated.
The phylogenetic development of antigen recognition, cell
mobility and vascular circulation systems are closely
linked. In invertebrates lacking blood systems wandering
protective cells - ameobocytes - are present. These
cells apparently originated as part of the feeding mechan¬
ism which retained protective function when the digestive
processes became fixed and external to the organism
(Barnes 1968). Also many invertebrates - eg the earth¬
worm, an annelid - have a coelom that performs some of the
functions of a fluid circulation and contains a system of
circulating cells and also performs some filtration
functions. These coelomocytes comprise a heterogeneous
mixture of cells that includes lymphocyte and phagocyte-
like morphologies and these cells have been shown to be
active in the rejection of allogeneic skin grafts (Cooper
1976). In early chordates - eg lamprey and amphioxus -
there is development of collections of immuno-competent
cells and haemopoietic tissue associated with the
supportive stromal tissue around the feeding tubes and the
intestine in the larvae (Young 1962); again a position
likely to be exposed to high concentrations of antigen.
These collections contain phagocytic and lymphocyte-like
cells and this tissue can be viewed as a forerunner of the
spleen which develops haemopoietic, lymphopoietic and
phagocytic filtration functions. In higher vertebrates
the first organized lymphoid tissue to appear in ontogeny
is the thymus which develops as an epithelial outpouching
of the pharynx - again part of the intestinal tract
(Rowlands 1976). This epithelial structure is soon
invaded by lymphocytes which presumably originate in
haemopoietic tissue in the yolk sac or foetal liver. As
the thymus develops reticular macrophages are also
included in the inductive stroma of the gland.
Thus protective lymphocytes and macrophages as mobile
intestitial cells antedate the organization of lymphoid
tissues or circulatory systems of either blood vessels or
lymph channels. However, the appearance of blood circul¬
ations in vertebrates is associated with the development
of mesodermal structures that produce circulating cells -
haemopoietic tissue which includes lymphopoiesis and this
type of tissue is closely associated with a stroma com¬
prising reticular macrophages, phagocytic macrophages and
endothelial cells. Thus haemopoietic tissue is usually
associated with a filtration function and production of
immuno-competent cells, and thus the immune, haemopoietic,
circulatory and reticulo-endothelial systems are intimately
interwoven.
As suggested in the introduction immune responses are the
result of interaction of antigen, macrophages and lympho-
cytes, all of which may be mobile and this mobility is
largely affected by the particular vascular arrangements
of a tissue and also by the type and state of the endo¬
thelium of such vessels. It might be expected from the
phylogenetic evidence that lymphocytes would be able to
migrate to most tissues and it is unlikely that this
function should be lost with the development of the very
high migratory flux through specialized secondary lymphoid
organs - the spleen - and in mammals the lymph nodes.
However, it was in these organs that this innate migratory
ability of lymphocytes was first recognized and therefore
it is not surprising that migration through other tissues
which occurs at much lower concentrations was considered
to be likely to be less important.
The experiments reported here were designed in the concept
ual framework of the recirculating lymphocyte pool as
described by Gowans and his colleagues, but the number of
potential compartments was extended to include all tissue
types. The results were consistent with the basic
assumptions involved in this model system but the experi¬
ments were not really designed to test these assumptions
in any new way.
Thus in the rat, thoracic duct lymphocytes which are
naturally destined for the central venous circulation, are
distributed to the tissues at random with the blood. The
rate of extravasation into each tissue can be experssed as
a clearance factor which can be defined as the proportion
of total lymphocytes presented to a unit weight of tissue
that is cleared from the blood on a single passage. Thus
total extravasation will depend upon: the blood concentra
tion, the blood flow, and the microvascular architecture,
as well as the nature of the vascular endothelium. The
total flux through a tissue will also depend upon the
interstitial route, distance and mode of exit traversed by
the lymphocytes as these factors will all influence the
transit time.
The evidence suggested that the flux of lymphocytes through
normal non-lymphoid tissues was significant and that though
the clearance rate was low the interstitial transit was
rapid. It was suggested that this transit time may be as
short as two or three hours which results in a much faster
flux than that through lymph nodes in which a modal transit
time for T lymphocytes of eighteen hours is well documented
(Ford & Simmonds 1972).
The vascular endothelium thus acts as a barrier through
which blood lymphocytes have to pass to enter any tissue.
Most lymphocyte emigration occurs in small post-capillary
venules. Evidence for this has come from (i) early
localization of radio-labelled cells by autoradiography
(Gowans & Knight 1964; Goldschneider & McGregor 1968) and
(ii) light and electron microscopy of inflammatory lesions
(Astrom et al 1968).
The- post-capillary venules in lymph nodes and Peyer's
Patches are morphologically specialised, and these part¬
icular vessels support a very high clearance rate and are
highly selective for lymphocytes. It has been estimated
that as many as 20% of blood lymphocytes entering a lymph
node in the blood emigrate to the efferent lymph (Hay &
Hobbs 1977) • This figure was derived from estimates of
blood flow by particle embolization, blood lymphocyte
concentration and efferent lymphatic lymphocyte content.
Similar values of blood flow to lymph nodes in the rabbit
have been reported (Herman et al 1976). The computation
did not take into account the possible contribution of the
afferent input to the sheep lymph node which might lower
the overall clearance factor but this factor would be
counteracted by the fact that the total blood flow would
overestimate the blood flow to the post-capillary venules
which are restricted to the paracortex.
Other vascular networks, which support such a high extra¬
vasation of lymphocytes, are post-capillary in position/but
are not morphologically specialized, are the marginal sinus
of the spleen (Gall 1950, Dubreuil et al 1975) and to a
slightly lesser extent the sinuses of the bone marrow and
possibly the liver. It is also significant to note that
the differential effect on the localization of trypsin-
treated lymphocytes follows the same pattern suggesting
that the morphological specialization that increases the
flux through lymph node blood vessels is intrinsically
different from the endothelial state of spleen sinuses. As
already argued, the similar trypsin sensitivity that was
seen in lymph nodes and cell-mediated immune inflammatory
lesions in which no morphological change was seen,
suggested that lymph nodes which are phylogenetically
very recent may have arisen as an adaptation that followed
the maintenance of a qualitative change in venular endo¬
thelium that occurred as a temporary change in inflamm¬
atory lesions. In other words the similarities observed
in structure and kinetics of lymphocyte migration through
chronic granulomata (Smith, Mcintosh & Morris 1970b) to
those through lymph nodes can be viewed as suggesting that
the lymph node acts as an analogue of the granulomatous
reaction rather than vice versa.
In consideration of the ability or efficiency of any
tissue to be able to support the generation of an immune
response itself the factors already mentioned must be taken
into account. Thus the lymphocyte flux dependent upon
the lymphocyte-endothelial interaction will control the
concentration of antigen reactive cells, while the con¬
centration of antigen and particularly that made more
immunogenic by processing, will depend upon the macrophage
content of the tissue.
In non-lymphoid tissues the antigen concentration may be
high but the likelihood of sensitization of the minority
of specifically reactive lymphocytes (contained in the 10^
- 105 cells that extravasate per gram each hour) being
important in the total response is low unless no antigen
reaches the draining lymph nodes in which relevant inter-
actions are many orders of magnitude more likely. However,
in the efferent arm of immune responses the peripheral
extravasation of specifically reactive cells must be of
importance in the triggering of inflammation.
The observations relating to lymphocyte flux through the
so called primary lymphoid organs suggested that partic¬
ularly in the bone marrow a substantial proportion of
blood lymphocytes entered the marrow parenchyma. This flux
could be explained in terms of the normal immune function
of lymphocytes rather than necessitating the suggestion of
some novel function of lymphocytes traversing an area of
rapid and extensive cellular proliferation. The evidence
of significant antigen concentration in bone marrow and
the ability of lymphocytes to undergo antigen stimulation,
blast transformation and mitotic division in this environ¬
ment in an antigenic Fj hybrid host suggested that the
bone marrow could act as a secondary lymphoid organ.
This similarity between type of lymphocyte flux and extent
of antigenic concentration in spleen and bone marrow can
be regarded as only part of a much more extensive similar¬
ity of structure and function of these two tissues. If the
microanatomy of the circulation to the two organs is con¬
sidered then both have similar arrangements in that the
major nutrient arteries branch acutely to give rise to
arterioles. In the bone marrow of mice the radial arter¬
ioles penetrate the bone and give rise to a capillary net¬
work. This network doubles back and drains into the
superficial venular sinuses of the marrow space which in
turn drain centrally to larger venous sinuses (de Bruyn
1970).
In the spleen the central arterioles of the white pulp
give rise to penicillar arterioles which supply capillaries
to the white pulp and then empty into the marginal sinus
and then the red pulp venous sinuses. In both tissues
there are some direct connections between arterioles and
the larger venous sinuses (Dubreuil et al 1975)-In addition
both tissues can support the full range of haemopoiesis
including non-antigen driven lymphopoiesis and it is
interesting to note that although the splenic lymphocytes
are clearly concentrated around the central arterioles in
the lymphoid sheath a similar anatomical localization of
lymphocytes around the distributive arterioles in the bone
marrow parenchyma has also been noted in the rat (Weiss
1976).
There is thus considerable overlap between the functions
of different organs. The bone marrow and spleen in adult
rodents can be viewed as two organs of haemopoiesis, blood
filtration and immune function that show different degrees
of efficiency for each aspect. Also it has been noted in
the embryo of the dog and marmosa (a marsupial) in the
mesenteric lymph node as it develops in the lymph spaces
around the mesenteric artery that some granulopoiesis
occurs before any concentration of lymphocytes and that
the arrival of large numbers of lymphocytes is correlated
with the development of 'specialized' post-capillary
venules (Bryant & Shifrine 1972, Bryant 1974)•
The other primary lymphoid organ is the thymus which has a
complex anatomy. The cortex which is a site of non-anti¬
gen driven lymphopoiesis is supplied by a capillary net¬
work arising from nutrient arterioles in the medulla,
here are very few post-capillary venules in the cortex as
the capillaries drain into subcapsular surface venules
(Blau 1977) • This may in part explain the very low
lymphocyte extravasation rate in the thymic cortex. The
vascular arrangement in the medulla has been less clearly
described but it is in this site that lymphocytes extra-
vasate, that macrophages that can localize antigen are
found, that germinal centre formation can occur, and also
that morphological specialization of venular endothelium
can be found under pathological conditions - eg myasthenia
gravis (Bradfield 1973)- Thus again at least the thymic
medulla has some secondary lymphoid function under some
circumstances and this idea is supported by the similarity
of lymphocyte migration kinetics in the thymus and lymph
nodes.
It is thus crucial in the interpretation of in vivo immuno
logical reactions and lymphocyte function to avoid the
notion that one particular organ has an exclusive function
within the system. The other important consideration to
remember is the mobility of lymphocytes such that the like
lihood of any lymphocyte found in a particular compartment
having been in that situation for longer than a few
minutes or hours is very low.
Most of the evidence suggests that lymphocytes are distri¬
buted with the blood mainly at random extravasating when
and where they have the chance. The segregation of sub-
populations either by type, antigen specificity, or tissue
of origin, appear to occur extravascularly. The latter
phenomenon is suggested by the different tissue distribut¬
ions of similarly treated populations of lymphocytes
collected from anatomically distinct efferent lymphatic
vessels - eg peripheral somatic lymph noces as opposed to
mesenteric lymph nodes. Changes have been noted with
^Cr labelled whole populations (Scollay et al 1976) and
small T lymphocytes (Cahill et al 1977) but are more
obvious in the lymphoblast populations labelled with
Udr (Hall et al 1977* Rose et al 1976). Although
differences are noted in the lymph node localizations it
is feasible that all of this difference can be accounted
for by differential extravasation at the peripheral tissue
level. This is perhaps a more likely site for critical
differentiation as the overall clearance rates are lower
than in the lymph nodes. However, rigorous testing of
any selection by any criterion occurring at the level of
the endothelium, either in lymph node or in peripheral
tissues, would require high cell specific activity
labelling and critical examination of tissue distributions
at very early time intervals, as the high flux rate and
low clearance factors in most tissues would make inter-
pretation of distribution data at later time intervals
very difficult.
The same random processes affecting lymphocyte distribution
are probably active in inflammatory lesions but the precise
site of interaction of antigen and lymphocyte that allows
the endothelial change which in turn allows a greater
clearance of blood lymphocytes, remains a mystery.
Presumably soluble factors released from lymphocytes may
be involved in influencing the vascular changes and it is
interesting to note that the increased blood flow, perme¬
ability and extravasation of blood leucocytes in short
term acute responses to such agents as carageenin injected
into rat footpads is abolished in leukopenic rats but the
response is largely restored by injecting washed lympho¬
cytes twenty minutes before the test injection (Bechara
et al 1976). This rapid response in normal rats is
unlikely to be mediated by a specific immune response and
suggests rather some non-specific effect on the normal
endothelium of varying concentrations of circulating
lymphocytes or their products in the blood. If this
effect is confirmed then it will be even more important to
investigate further the mechanism of the inter-relation¬
ship between endothelium and lymphocytes.
The important conclusions of the experiments reported in
this thesis include the confirmation of significant
migration of lymphocytes through all non-lymphoid tissues
which are therefore compartments in the recirculating
lymphocyte pool of rodents. This migratory flux is
enhanced by inflammation and at least in the case of cell
mediated immune responses this is the result of a qualitative
change in the lymphocyte-endothelial interaction as shown
by the effect of trypsin-treatment of injected lymphocytes.
The substantial migration of lymphocytes through the so-
called primary lymphoid organs indicates the immune
function of these organs is not solely the production and
maturation of precursor cells. This may explain many
observations relating to the development of immune
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Lymphocyte migration into cell-mediated
immune lesions is inhibited by trypsin
The lymph nodes and the white pulp of the spleen are
major sites into which lymphocytes migrate from the blood
and each organ is equally selective in that other blood cells
are efficiently excluded1,2. It might be expected that the
same mechanism for discriminating between lymphocytes
and other cells would have evolved in the spleen and
lymph nodes, but the entry of lymphocytes into each of
these organs can be distinguished in two ways. First, the
histological appearance of the vascular endothelium across
which lymphocytes migrate is dissimilar1,3 and second, the
capacity of lymphocytes to migrate from the blood into
lymph nodes is reduced by brief exposure in vitro to low
concentrations of trypsin, but migration of the same
population into the spleen is barely affected4. Lymphoctyes
are not irreversibly damaged by trypsin because they regain
their capacity both in vivo and in vitro5 to localise in lymph
nodes. The reduced numbers in lymph nodes is not a
consequence of increased localisation of trypsinised
lymphocytes elsewhere, as is testified by perfusing trypsin¬
ised lymphocytes through an isolated lymph node8 and also
by measuring the numbers of trypsinised lymphocytes in the
blood after intravenous injection8,7. For several hours the
concentration of treated cells in the blood was about 1.4
times that of control cells. This excess was attributed to the
failure of trypsinised cells to enter lymph nodes8. We have
extended these observations by comparing the capacity of
trypsinised and control lymphocytes to migrate from the
blood into several non-lymphoid tissues including sites of
inflammation. Exposure of lymphocytes to trypsin not only
exerts a differential effect on lymph node and spleen
localisation, it also differentiates the mechanism by which
lymphocytes migrate in small numbers into normal skin
and other non-lymphoid tissues (trypsin resistant) from that
responsible for the migration of increased numbers of
lymphocytes into cell-mediated immune (CM1) lesions in
the skin (trypsin sensitive).
To determine whether the differential effect of trypsin on
lymph-node and spleen localisation is merely a quantitative
effect, lymphocytes obtained by thoracic duct cannulation*
of AO rats were labelled in vitro with either 3H-uridine or
"C-uridine*. The :'H-labeIled lymphocytes were exposed
in vitro to graded doses of trypsin in phosphate-buffered
saline (PBS), washed, combined with the 14C-labeIled cells
as a reference population and injected into syngeneic
recipients. No reduction of spleen localisation was found
with a concentration of trypsin 125 times greater than that
needed to inhibit lymph-node localisation by 50% (Table 1).
The standard concentration of trypsin previously used
(0.02 mgrnf1) (refs 4 and 6) reduced lymph-node localis¬
ation to 10",, of untreated cells at 1 h after injection and
increasing the dose by 5- or 25-fold had little additional
effect on either the deficit in the lymph nodes or the excess
in the blood. The distribution of trypsinised cells at 24 h
resembled that of control cells and only at the highest
concentrations was there evidence of loss of a minority of
the cells. There thus seems to be a qualitative difference in
the trypsin sensitivity of lymphocyte migration into the
spleen and lymph nodes.
Lymphocytes also migrate from the blood into non-
lymphoid tissues such as skin, albeit in much smaller
numbers than into secondary lymphoid organs and the rate
of migration is increased into sites of CM! (refs 9-12).
Table 1 Effect of graded concentrations of trypsin on lymphocyte
localisation in organs of recipients*
Ratios of 3H (associated with trypsinised cells) to "C (control cells) !'
Time Concentration of trypsin (mg ml-1)
after Organ
injection 0.5 0.1 0.02 0.004
Lymph nodes 0.07 0.07 0.10 0.51
Spleen 0.99 0.96 1.02 1.02
Blood 1.47 1.46 1.32 1.17
1 h Lung 1.68 1.04 1.12 0.98
Liver 1.35 1.22 1.01 0.86
Gut 0.72 0.91 1.02 0.96
Bone marrow 0.78 0.97 1.07 0.98
Lymph nodes 0.72 0.76 0.89 0.89
Spleen 1.18 1.06 1.05 0.92
Blood 0.69 0.75 0.82 0.92
24 h Lung 0.82 0.88 0.88 0.95
Liver 1.15 0.91 1.07 1.04
Gut 0.86 0.78 1.01 0.94
Bone marrow 0.79 0.84 0.88 0.78
*Lymphocytes exposed to trypsin in vitro for 10 min.
+A11 ratios are standardised so that 3H/UC ratio in the injection
sample 1.00. A supplementary group of recipients received :,H-
labelled cells (untreated) and "C-labelled cells (untreated). As
expected the :,H/"C ratio generally fell in the range of 0.90-1.10
indicating an even distribution. In the Table, a ratio of less than
0.80 indicates a significant deficit of trypsinised cells and a ratio of
more than 1.20 a significant surplus.
We investigated whether migration into non-lymphoid
tissue resembled migration into lymph nodes in being
trypsin sensitive and whether trypsin treatment could
distinguish between migration into normal and inflamed
skin.
Lymphocytes were obtained by thoracic duct cannulation
of inbred AS or (PVG/cXDA)F, rats3. They were radio-
actively labelled in vitro by incubation with 5,Cr-sodium
chromate at 10/iCimL'. The cells were suspended in
medium RPM1 1640 with 10",, FCS at 37 C for 1 h. After
washing, half the suspension was treated with trypsin
(Boehringer) at 0.02 mg ml"1 for 10 min. After further
washing, trypsinised and control cells were injected
intravenously into separate syngeneic recipients, which were
killed at 0.5, 2 or 24 h after injection. A 2-ml sample of
blood was taken and the entire vasculature was perfused
through an aortic cannula with a large volume of PBS. The
use of 51Cr as a radioactive label for lymphocytes and the
perfusion procedure have been found to be the most
satisfactory method of measuring lymphocyte migration into
non-lymphoid tissues'3. The spleen and the six largest
superficial cervical lymph nodes were removed and also
samples taken of the tissues referred to in Table 2. The
specimens were weighed before radioassay in a LKB
7-counter.
Two series of experiments were performed involving
recipients with contact sensitivity lesions and adjuvant
granulomata. Contact sensitivity was induced by painting an
area of ventral abdominal skin with 0.1 ml of 5%, DNCB in
alcohol. Twelve days later a site on the back was painted
with a challenge dose of DNCB (0.1 ml of 0.5%,). As control
sites, primary application of two other contact sensitising
agents, TNCB (0.1ml of 1%,) and oxazolone (0.1ml of
0.5%), and croton oil (0.1ml of 10%) were applied
simultaneously to different areas of dorsal skin 24 h before
the injection of labelled lymphocytes. In other recipients
Table 2 Effect of trypsin on 51Cr-labelled lymphocyte localisation in contact sensitivity lesions
% injected activity per g tissue±s.e.
0.5 h
n = 7
2 h 24 h
Control Trypsin Control Trypsin Control Trypsin
Normal skin 0.029± 0.004* 0.032± 0.004| 0.013±0.003 0.013 ±0.002 0.014±0.001 0.011 ±0.001
DNCB' in = 16) 0.044 ±0.003? 0.034 — 0.002§ 0.032±0.0U 0.020 ±0.003 0.052±0.015 0.041^0.010
Croton oil 0.028 ±0.005 0.027 ±0.005 0.018 ±0.004 0.018 — 0.004 0.021 ±0.003 0.021^-0.004
TNCB 0.020 ±0.001 0.020 ±0.003 0.012±0.002 0.011 ±0.001 0.012± 0.002 0.012±0.002
Oxazolone 0.024 - 0.005 0.023 ±0.002 0.012±0.002 0.014±0.003 0.014±0.002 0.013 — 0.001
Blood leukocytes 0.41 ±0.09 0.51 ±0.08 0.07 ±0.007 0.15 ±0.03 0.14±0.01 0.14±0.01
Lymph nodes 11.3 ± 3.11 0.11 ±0.01 16.8±4.4 0.35±0.08 58.2±8.7 51.6 ±7.6
Spleen 82.1 ±5.6 104.7±7.9 94.6±7.9 139.6± 8.2 50.8±2.7 52.5 ±2.1
Liver 2.1 ±0.33 2.8 ±0.45 1.2 ±0.18 1.5 ±0.07 1.2±0.05 1.3 ±0.05
Muscle 0.013 ±0.002 0.019±0.002 0.006±0.001 0.008 ±0.002 0.006±0.001 0.004 - 0.001
Bone marrow 3.5±0.35 2.5±0.33 3.7±0.25 2.5±0.05 0.88 ±0.11 0.69 ±0.12
*Against t, P < 0.05; f against §, P < 0.02; J against §, not significant by the Mann-Whitney U test.
adjuvant granulomata had been produced by intradermal
injection 21 d previously of 0.1 ml of Freund's complete
adjuvant (Difco) emulsified with PBS.
The localisation of lymphocytes in normal skin was
clearly not impaired by trypsin; radioactivity associated with
trypsinised lymphocytes found in the skin soon after
injection was equal to or slightly greater than radioactivity
associated with untreated cells (Tables 2, 3) possibly reflect¬
ing the marginally higher numbers in the blood. It was
confirmed that the migration of lymphocytes into the spleen
and liver is unimpaired by trypsin treatment especially when
compared with the blood level. Similarly, migration into
muscle (Table 2), brain and ovary were almost equal for
trypsinised and control cells suggesting that migration of
lymphocytes into non-lymphoid tissues in general may be
trypsin resistant. By contrast, migration into lymph nodes
was reduced by trypsin to 1-2% of control values at 30 min
or 2 h after injection (Table 2).
The most striking result was that trypsin treatment
impaired the capacity of lymphocytes to migrate into sites
of CMI in the skin (Tables 2 and 3). In the case of the
DNCB lesion, the early localisation (0.5 h, 2 h) of untreated
lymphocytes was increased to 1.5-2.5 times that of nor¬
mal skin or sites painted with TNCB or oxazolone
(Table 2). Although small, this increase was significant and
occurred consistently in five other series of experiments on
the migration of lymphocytes into DNCB lesions. The
localisation of trypsinised cells was significantly less than
that of control cells in DNCB lesions and was nearly the
same as in normal skin. Thus, if it is acceptable to regard
the values for normal skin as a baseline, the data indicate
that very few if any trypsinised lymphocytes entered the
skin as a result of DCNB challenge. The results followed
the same pattern for the granuloma (Table 3) and were
more emphatic: 2-3 times as many untreated lymphocytes
were present in the lesions as were present in normal skin
at 30 min and 2 h but equal numbers of trypsinised
lymphocytes were present in the granuloma and in normal
skin at each of the early intervals.
We conclude that mechanisms of selective lymphocyte
migration can be placed into two categories. The first,
which is trypsin resistant, operates in the spleen and non-
lymphoid tissues and the second is trypsin sensitive and
operates in lymph nodes and sites of CMI. Non-immune
chronic inflammatory lesions have not been investigated.
It is possible that trypsin distinguishes two subsets of
thoracic duct lymphocytes rather than two mechanisms of
selective migration which are properties of different
endothelia. In particular, could the inhibitory effect of
trypsin on migration into sites of CMI be exerted solely
on large lymphocytes which are known to migrate especially
well into sites of inflammation10-12? The present results do
not completely exclude this but we feel it is likely that
trypsin does impair small lymphocyte migration into CMI
lesions for two reasons. First, small lymphocytes do migrate
into CMI lesions in increased numbers as has been
supported by cannulation of the lymphatic draining an
adjuvant granuloma in sheep9 and selectively labelling small
lymphocytes with 3H-thymidine in vivo and detecting an
increased localisation in DNCB lesions (G.FI.R., un¬
published). The effect of trypsin in preventing the increased
localisation in CMI lesions was complete within the limits of
detection (Tables 2, 3) and so the migration of both small
and large lymphocytes was probably impaired. Second,
large lymphocytes not only migrate preferentially into
inflamed tissues but seem to be superior in migrating into
non-lymphoid tissues in physiological conditions. This was
suggested by injecting alternately labelled large and small
lymphocytes and examining the cells migrating into normal
rat skin13 and non-inflamed peritoneal cavity (O. Braend-
strup and O. Werdelin, unpublished). In conclusion,
although it is possible that trypsin may affect lymphocyte
subsets differentially, it seems improbable that this factor
could wholly explain the present results; at least some
lymphocytes are capable of leaving the blood by either of
two mechanisms.
In an adjuvant granuloma in sheep, the increased flux of
lymphocytes was associated with a change in the appearance
Table 3 Effect of trypsin on 51Cr-labelled lymphocyte localisation in adjuvant granuloma

























Blood leukocytes 0.42±0.19 0.69 ±0.08 0.10±0.02 0.12±0.003 0.21 ±0.015 0.10±0.034
Other tissues similar to Table 2.
*Against t, P < 0.002; f against §, P < 0.002 by the Mann-Whitney U test.
of the endothelium of small venules, which came to
resemble the morphologically distinct high-walled endo¬
thelium in lymph nodes9. This is consistent with the notion
that a granuloma accepts an increased influx of lymphocytes
by the same mechanism as lymph nodes accept more
lymphocytes from the blood than do non-lymphoid tissues.
Of the two examples of a trypsin-sensitive mechanism of
selective lymphocyte migration, the endothelial change in
CMI may have appeared earlier in evolution since histo¬
logically well developed lymph nodes are confined to
mammals. Possibly lymph nodes developed when the
endothelium of small vessels in certain regions displayed
as a permanent feature an adaptation which was previously
unique to sites of chronic inflammation. Other features of
lymph node organisation may have ensued as a result of the
vascular change.
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ABSTRACT
The distribution of radioisotopes in tissues was measured following i.v. injection of
labelled thoracic duct lymphocytes into syngeneic rats. The rate of elution of an
isotope from the labelled cells and the subsequent fate of the eluted isotope were
shown to be the most important factors limiting the usefulness of such isotopes for
measuring cell localization particularly in non-lymphoid tissues. Comparison of
labelling procedures using [3H] and [14C]uridine, [3H] and [14C]leucine, [75Se]-l-
selenomethionine, [99mTc]sodium pertechnetate and [51Cr]sodium chromate in
vitro and [3H]thymidine in vivo showed that 5iCr had the fewest disadvantages in
the present context. Using 51Cr-labelled cells, the radioactivity was measured in a
wide range of non-lymphoid tissues, and estimates of cell traffic were obtained. In
skin, for example, the results indicate a cell flux in the range of 104—105
lymphocytes/gm/hr. Evidence is presented which suggests that the early
substantial localization of labelled cells in the lung is not an artefact due to
sequestration or embolization of traumatized cells but probably reflects a slow
intravascular transit time through this capillary bed. The primary lymphoid
organs, thymus and bone marrow were shown to include a subpopulation of
lymphocytes which belong to the recirculating pool. The thymus always contained
a greater concentration of radioactivity at 24 hr than all non-lymphoid tissues
except liver and kidney (approx. 0-1% of the recirculating lymphocyte pool) and
the bone marrow was capable of temporarily accepting a substantial proportion
(approx. 25%) of the injected cells.
The substantial recirculation of lymphocytes from blood into lymphoid tissue and back to
blood either via central lymph from lymph nodes or in the case of the spleen directly into the
* Present address; Department of Pathology, Medical School, University of Queensland, Australia.
Correspondence: Dr G. H. Rannie, Department of Pathology, Stopford Building, University of Manchester,
Oxford Road, Manchester M13 9PT.
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venous effluent is well documented (Gowans, 1959; Ford, 1969). Lymphocytes also pass
from the blood into the interstices of most, if not all, tissues from where they return to the
lymph nodes via afferent lymphatics and eventually to the blood in efferent lymph. Much less
information is available on the quantity of such cell traffic but the low cell numbers in hourly
collections of afferent lymph (Smith, Mcintosh & Morris, 1970a) suggest that it is of low
magnitude compared with the major recirculation pathways mentioned.
This paper presents estimates of such cell traffic to non-lymphoid tissues obtained by
measuring the tissue distribution of transfused thoracic duct lymphocytes (TDLs), labelled
with various radioisotopes, at several time intervals. To conclude that tissue radioactivity is
attributable to cells requires close attention to the behaviour of the isotope after cell labelling
and these considerations are particularly important in areas of expected low cell
concentration. The latter low cell concentration precludes quantitation by autoradiographic
histology which might be considered the ideal method as the presence of cells can be
confirmed positively.
MATERIALS AND METHODS
Animals. Male and female rats of several highly inbred strains and their Fj hybrid offspring
weighing between 100 g and 250 g were used as donors and recipients of lymphocytes. All cell
transfers were between syngeneic animals. The strains used were AO; PVG/c; DA; (PVG/c
x DA)F, and all were bred and maintained in this department.
Isotopes. All isotopes were obtained from The Radiochemical Centre, Amersham, England
except [75Se]-L-se!enomethionine which was supplied by C.I.S.* The preparations used are
shown in Table 1.
Operative procedures. Thoracic duct cannulation was performed under ether anaesthesia by
Gowans's modification of Bollman's method using polythene tubing (PP 50-Portex Plastics
Ltd.). The rats were maintained and lymphocytes were collected into ice-cold flasks as
described by Ford & Hunt, (in Handbook of Immunology, ed. by D. M. Weir, 1973).
Splenectomy was carried out via a left subcostal incision under ether anaesthesia either
Table 1. Isotopes used
Manufacturers Concentration used
Isotope Specific activity code no. Emission for labelling
l-|4,5-3H]leucine 55 Ci/mmol TRK 170 P 10 /tCi/ml
l-[U-uC]leucine 270 mCi/mmol CFB67 P 1 ,uCi/ml
15-3H luridine 25 Ci/mmol TRA 178 P 10 //Ci/ml
|2-14Cluridine 62 mCi/mmol CFA 315 P I ,uCi/ml
|6-3H]thymidine 5 Ci/mmol TRA 61 P 1 /rCi/g body wt/day
15-1125 |iodo-2-deoxyuridine 100 mCi/mg IM 352 y 0-5-1 //Ci/ml
Sodium! "Crlchromate 50-400 mCi/mg Cr CJS IP y 10 //Ci/ml
Sodium !"mTc)pertechnetate
from technetium-99m sterile
generator MCC 3 y up to 10 mCi/ml
175Sel-L-selenomethionine 70 mCi/mg SEMM-1 y 3.3 nC\/m\
* Via their British agent Eurotope Services Ltd, 104 East Barnet Road. New Barnet, Hertfordshire EN4 8RE.
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immediately or 10 days before cell transfer.
In vivo labelling. Radioactive label was confined to an age-cohort of relatively long-lived
small lymphocytes by administering [3H]thymidine at 1 //Ci/g body wt/day intraperitoneally
daily for three weeks and then allowing a lapse of three weeks after the last injection before
collecting TDLs.
Cell preparation. TDLs, collected for periods of up to 24 hr in duration, up to 72 hr after
cannulation, were centrifuged at 350 g for 10 min and resuspended in medium RPMI 1640
with L-glutamine and 10% Foetal Calf Serum (F.C.S.)-(GIBCO-BIOCULT, Glasgow,
Scotland) at 50-100 x 106 cells/ml for in vitro labelling.
Removal of contaminating red blood cells, even if the proportion was very low, was found
to be essential when using sodium [51Cr]chromate as this isotope labels all cell types. This was
most successfully achieved by layering TDLs (30 x 106/ml) in PBS* onto 5-0 ml of a mixture
of Ficoll and Hypaque (Ficoll-Pharmacia Fine Chemicals, Uppsala, Sweden. 50 ml of
14% plus 20 ml Hypaque-45% sodium diatrizoate, Winthrop Laboratories, Surbiton upon
Thames, Surrey), and centrifuging at 1200 g for 20 min at 15°C. The interface layer was
washed once in PBS by centrifuging for 10 min at 350 g and the resulting lymphocyte pellet
was resuspended in medium for labelling as before. The yield of lymphocytes after this
treatment was usually over 80% with no reduction in the high proportion of viable cells as
assessed by Trypan blue exclusion.
Cells were labelled with isotopes at the appropriate concentrations for 1 hr at 37°C in a
gently shaking waterbath, and washed three times in 50 ml volumes of PBS. The cells were
finally centrifuged through 5 ml of 50% FCS in PBS and resuspended in medium at concen¬
trations appropriate for injection. Cells which had been labelled by in vivo administration of
isotope were collected from the thoracic duct, washed once in PBS and resuspended for
injection.
A population of cells of accredited recirculating ability containing few labelled blast cells
was obtained by passaging labelled cells from blood to lymph in an intermediate syngeneic rat
with an indwelling thoracic duct cannula. Cells were collected between 6 and 24 hr after
intravenous (i.v.) injection (referred to as passaged TDL).
Cell doses ranging from 10 to 1000 x 106 lymphocytes per recipient did not alter the
proportional distribution of label. Most recipients received approximately 100 x 106 cells in a
volume of 2-0 ml via the lateral tail vein under light ether anaesthesia.
Processing of tissues. At timed intervals after injection of labelled cells, recipients were
killed and total body perfusion was performed. This procedure was designed to remove
intravascular cells and it also provided useful information about the leakage of isotope from
lymphocytes into extracellular fluid. Under deep ether anaesthesia and after a cardiac blood
sample had been obtained, the chest was opened and a polythene tube (PP 90, Portex Ltd.)
inserted through the apex of the left ventricle into the root of the aorta where it was sutured in
place. Approximately 250 ml of PBS with heparin (10 units/ml) to prevent clotting was then
infused either by gravity feed or by syringe. The inferior vena cava in the thorax, and the right
and left atria were transected to allow escape of the perfusate which was collected by suction
from the thoracic cavity. The pulmonary vasculature was also perfused via the right ventricle
and pulmonary artery. A similar procedure using 1-5% cacodylate buffered Glutaraldehyde
was used for tissue fixation in some experiments.
Tissues were then obtained by dissection, weighed and processed for estimation of total
radioactivity by liquid scintillation counting for /Lray emitters in a Beckman LS 250
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Spectrometer or by direct counting in a well type y-scintillation counter (L.K.B. Wallac
1280 Ultragamma) for y-ray emitters.
Heparinized blood samples were divided; 2-0 ml were diluted with 8-0 ml PBS and layered
on 3-0 ml of Ficoll (67 ml, 14%)/Hypaque (20 ml, 45%) mixture, centrifuged at 1200 g for 30
min at 15°C and the interface layer was collected for counting of blood white cell activity. A
further 2-0 ml was centrifuged at 1500 g for 10 min to obtain plasma.
Samples were processed for liquid scintillation counting by the method of Ford & Hunt
(1973) with one modification. The addition of hydrogen peroxide, necessary to bleach
pigment and therefore reduce colour quenching in many tissues, was found to cause spurious
counts in the low energy (3H) range when clear fluids, e.g. serum were examined, presumably
due to incomplete release of oxygen. This was most efficiently counteracted by the addition of
0-2% rat blood to the sodium hydroxide digestion mixture. The maximum weight of tissue
sample that can be emulsified in 15 ml of scintillation cocktail with this method is 50 mg and
this may prevent counting of tissues containing very few labelled cells. Much larger samples
(1 g, approximately) of such tissues can be counted directly in a gamma counter. /? and y
count rates of less than 2 SD's above mean background values were excluded and ft count
rates above background were converted to d.p.m.
Autoradiography was performed on routine histological sections using Ilford G5 dipping
emulsion.
RESULTS
Comparison of radioisotopic labels
The object of these experiments was to find the most suitable isotope for tracing
lymphocytes into non-lymphoid tissues allowing for the unsuitability of histological
autoradiography in this context. Examination of many sections of tissues of recipients of large
numbers (up to 2 x 109) of 3H or 14C labelled TDLs confirmed that labelled cells could be
found in the interstices of all tissues examined but at too low a frequency to allow any
meaningful attempt at quantitation. Table 2 shows the distribution of radioactivity 24 hr after
i.v. injection of syngeneic TDLs labelled with the radioisotopes which are commonly used for
this purpose. In each case tissues were sampled after whole body perfusion (see Methods).
The data were pooled from several experiments and expressed as the arithmetic mean
percentage injected activity per whole tissue. The total weight of each tissue was derived by
dissection of several animals and from these measured weights the approximate weight of
each tissue in a 'standard' 200 g rat was computed and is stated in Table 2.
Within an experiment using the same cell suspension, the standard deviation about the
mean of activities in quadruplicate recipients was between 10 and 30% of the mean.
However, when the results of several experiments were pooled the variation increased to give
a standard deviation of approximately 50% of the mean. The SD values have been excluded
from the tables for the sake of clarity. There were large differences in the measured activity in
each tissue when estimated with different labels and the important comparisons are
considered separately.
A. Tritium vs carbon 14. The pattern of distribution following injection of lymphocytes
incubated with the same molecule labelled with different radioactive atoms e.g. |3H] or [14C]
uridine or leucine was markedly different. 3H gave higher levels of activity in non-lymphoid
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Table 3. Ratio of percentage of injected 3H/injected l4C in tissues
24 hr after injection of thoracic duct lymphocytes double-labelled
with 3H and l4C uridine
Tissue Recip. A Recip. B
Injected cells 10 1-0
Spleen 0-82 0-80
Lymph node 0-93 0-88











Supernatant perfusate 18-6 19-3
tissues such as muscle when compared with 14C but the reverse was true in spleen and lymph
nodes, areas where many labelled lymphocytes might be expected. These observations were
confirmed in an experiment using double-labelled cells where the results were expressed as the
ratio of 3H/14C in each tissue (Table 3).
To test the possibility that the two isotopes were eluting from cells at different rates, double-
labelled cells were injected intravenously into a recipient with an indwelling thoracic duct
cannula. The radioactivity associated with the cells and the cell-free supernatant lymph in
successive 90 min collections of draining lymph was measured. Fig. la,b shows the results as










12 18 24 30 36 42 48
Time after injection (h)
Fig. 1. (a) Lymphocyte associated radioactivity (as per cent of injected activity) in sequential 90
min collections of lymph from a rat with a thoracic duct fistula which received at time zero a
'bolus' i.v. injection of syngeneic thoracic duct lymphocytes, double-labelled in vitro with 3H (O)
and 14C (A) uridine, (b) In the same experiment as (a) the supernatant cell free lymph radioactivity
was also measured in sequential 90 min collections and the results are expressed as per cent
injected activity for each isotope for each collection period. Bold line, 3H; dotted line, 14C.
- (b)
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The pattern of cell-associated activity was very similar for both isotopes but the absolute
quantity of 3H recovered over 48 hr was significantly less than 14C, in agreement with Ford &
Simmonds (1972). However, the cell-free supernatant lymph contained substantial quantities
of tritium very soon after injection and before any activity was associated with the cell pellet
and these levels showed a gradual decline with time. These observations of high levels in non-
lymphoid tissues, plasma and particularly the cell free supernatant of the perfusate suggested
widespread redistribution of eluted tritium. The total perfusate 3H activity was considerably
higher than the maximum estimates of total blood activity at 24 hr suggesting removal of
activity from the extravascular compartment. This was also shown by the significant
reduction in tissue activity by perfusion which was not seen with other labels, e.g. 51Cr.
B. [51Cr] sodium chromate. The radioactivity measured in lymph nodes due to 51Cr was as
high as with [3H]thymidine (in vivo) while the levels in all non-lymphoid tissues were
consistently the lowest of the isotopes used. Very little activity was measured in plasma or
cell-free perfusate suggesting that any eluted label is efficiently removed and probably not
reutilized. In support of this was the observation that when 5ICr-labelled cells were heat-killed
prior to i.v. injection, the majority of label was recovered in the liver and the proportion so
localized remained constant from 2-48 hr while the remaining activity was mainly in plasma
and this level fell steadily with time, this fall being associated with urinary excretion.
The considerable activity in liver after injection of viable cells also remained constant with
time and thus it is impossible to be sure how much of this activity was due to physiological
localization of normal cells and how much may be a reflection of a proportion of damaged
cells in the original population following labelling.
C. [niSe]-L-selenomethionine. This substituted amino acid is incorporated by lymphoid cells
without impairing their functional capacity (Bainbridge, 1976; Rose & Micklem, 1976).
However, as might be expected, the isotope eluted from cells and several findings indicate that
the label was reutilized. (i) High plasma activity which was found to be T.C.A. insoluble, (ii)
High non-lymphoid tissue concentrations particularly in the small intestine (cfd with 51Cr).
(iii) The redistributed label was not removed by perfusion, as the activity in the perfusate
could be accounted for by the blood alone.
D. [99m7c] sodium pertechnetate. Sodium pertechnetate as a lymphocyte label has been
reported to have similar characteristics to sodium chromate although such potentially toxic
compounds as stannous chloride were required in the in vitro incubation procedure to
maintain stability of labelling (Barth, Singla & Gillespie, 1974). In the present studies the
addition of stannous chloride or sodium chromate resulted in only a marginal increase in label
uptake. The behaviour of such labelled cells in vivo was inferior to those labelled with 99mTc
alone.
Tissue activity showed great variation between experiments. Low levels were noted in
lymph nodes and the ability of labelled cells to migrate from blood to thoracic duct lymph was
markedly impaired. High concentrations of label were found in liver and kidney. These results
all suggest a significant degree of cell damage and label elution which was also reflected by
massive urinary excretion.
E. [3//l thymidine. Labelled long-lived lymphocytes obtained by repeated administration of
[3H]thymidine to prospective TDL donors should have a stable DNA-associated label and the
trauma of in vitro manipulation for transfer experiments is minimized by such a labelling
procedure.
High concentrations were indeed measured in lymph nodes but elution problems similar to
those associated with [3H]uridine and [3H]leucine were encountered as shown by the
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following observations, (i) Levels in non-lymphoid tissue were about an order of magnitude
greater than those measured with 51Cr. (ii) Plasma and supernatant perfusate levels were high
with the latter being in excess of the total plasma activity.
F. [l25I]iododeoxyuridine. In vitro incubation with this analogue of thymidine was used to
label DNA-synthesizing lymphoblasts in normal thoracic duct lymph. Such cells comprise up
to 5% of the whole population and are generated for the most part in the area drained by the
thoracic duct, i.e. mainly mesenteric lymph node and gut associated lymphoid tissue.
Following i.v. injection of 125I-Udr labelled cells there was a steady decrease in total
recoverable label associated with urinary excretion. High plasma levels and slightly more label
in the cell free perfusate than in the total blood volume suggest that a proportion of the eluted
label is widely distributed. Absolute levels of 125I activity in non-lymphoid tissues may
therefore overestimate the cell content. However, after taking into account the effect of this
contamination, there still appeared to be a greater proportional distribution of lymphoblasts
compared to 51Cr-labelled whole TDLs in non-lymphoid sites.
The changes in tissue distribution of labelled cells with time
The migration of populations of lymphocytes was studied by sampling tissues at various
times after i.v. injection of a 'bolus' of labelled cells. Tissues removed at \ and 2 hr after
Table 4. Late time course of tissue radioactivity following i.v. injection of normal
51Cr TDL into syngeneic recipients (perfused)
Percentage of injected dose per gram of tissue
Tissue 24 hr 48 hr 72 hr
Spleen 42-5 26-5 28-9
Superficial lymph nodes 65-5 53-9 49-6
Mesenteric lymph node 52-9 55-3 41-9
Small intestine 0-65 0-70 0-51
Thymus 0-37 0-26 0-30
Bone (marrow) 0-78 0-53 0-49
Liver 1-4 1-2 1-4
Kidney 0-33 0-33 0-38
Muscle 0-004 0-006 0-007
Skin 0-011 0-010 0-010
Brain 0-003 0-0008 0-0004
White blood cells 0-153 0-070 0-086
Values are means of three recipients of the same cell suspension at each time point.
injection reflect the distribution associated with the initial emigration of cells from the blood
while 24 hr samples reflect the distribution at near-equilibration within the 'recirculating
lymphocyte pool', as suggested by the small fluctuation of any tissue concentrations noted
after this time (Table 4).
Three populations were studied using 51Cr and I25I as these isotopes were shown to have
fewer disadvantages for this type of study particularly in non-lymphoid sites: (1) whole
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TDLs-51Cr-labelled cells comprising lymphocytes of all types; (2) passaged TDLs-51Cr-
labelled cells depleted in labelled lymphoblasts (see Methods); (3) lymphoblasts-125I-Udr
labelled in vitro.
Table 5 shows the pooled results of several experiments using these three populations
expressed as the mean percentage injected dose per whole tissue after whole body perfusion.
(i) The spleen accounted for the majority of the injected label (less so for 125I) for the first 2
hr and the concentration then fell with equilibration by approximately 48 hr (Table 5).
(ii) The lymph nodes showed an early steep rise (approx. 8%/hr for the first half hour)
followed by a slower but progressive accumulation (average 1%/hr between two 24 hr) with
maximal levels at approximately 24 hr. The injection of 125I-labelled lymphoblasts was
followed by a three times greater concentration of label (per unit weight) in the mesenteric
lymph nodes compared with superficial lymph nodes (i.e. nodes draining sites other than the
intestine) at 2 hr but not later.
(iii) The bone marrow accounted for a considerable proportion of the injected label with
a temporal pattern similar to that in spleen.
(iv) The small intestine (excluding Peyer's Patches) accumulated a large proportion of 125I-
labelled lymphoblasts with a steady increase in concentration. Passaged 51Cr-labelled cells
also showed significant levels of activity in the small gut with slight accumulation by 24 hr.
(v) In the thymus radioactivity accumulated with a pattern similar to lymph nodes but at
much lower concentrations. These concentrations were significant and on a per gram basis
were higher than those of all non-lymphoid tissues except liver and kidney by 24 hr. The
presence of labelled cells was confirmed by autoradiography of 3H-labelled TDLs which
showed such cells located in the thymic medulla.
(vi) In blood the majority of the activity following injection of 51Cr-labelled whole TDLs
was associated with cells. The maximum level was soon after injection and this was followed
by a rapid fall in concentration with a minimum at 2—3 hr and a slight rise at 24 hr. However,
with 125I-labelled cells the label measured in blood was mainly in the plasma and the cell-
associated activity fell rapidly and progressively after injection.
(vii) Non-lymphoid tissues had low concentrations at all times with maximum activity soon
after cell injection and rapid equilibration in a similar manner to blood. Minimum
concentrations were sometimes measured in, e.g. skin and muscle at 2-3 hr, and this was
particularly noticeable within individual experiments using the same cell suspension. Central
nervous tissue consistently gave the lowest concentrations of activity, which might be
expected of a tissue lacking a lymphatic drainage.
In an attempt to accentuate these possible fluctuations in non-lymphoid tissue activity by
maintaining higher blood concentrations, experiments were performed using splenectomized
recipients; the rationale being that as approximately half the injected cells are at first removed
from the circulation by the spleen in the intact animal then removal of this 'sink' would allow
more cells a chance to migrate to other sites.
Table 6 shows the effect of splenectomy on the distribution with time of 51Cr label
associated with i.v. injected TDLs expressed as the percentage of injected activity per gram of
tissue. The rate of fall of blood leucocyte activity was decreased compared with that in intact
animals. Most tissues showed higher concentrations of label, particularly soon after injection,
but this effect was minimal in non-lymphoid tissues. The reduced rate of decline of the early
high levels in the lung was marked and the significance of this observation will be discussed.
These results also accentuated the capacity of the bone marrow to accept large numbers of
lymphocytes from the circulation.
534 G. H. Rannie and K. J. Donald
Table 6. Effect of splenectomy on recipients of 51Cr labelled syngeneic normal TDLs
Percentage of injected dose per gram of tissue
0-5 hr 2 hr 24 hr
Tissue Intact Splenect. Intact Splenect. Intact Splenect.
Lung 14-4 40-4 3-01 9-37 2-34 2-75
White blood cells* 0-217 0-854 0-047 0-145 0-125 0-115
Spleen 85-1 — 105-0 — 45-1 —
Superficial lymph nodes 8-13 33-5 9-45 30-1 61-4 80-0
Mesenteric lymph node 5-92 10-1 10-1 22-8 43-7 63-4
Bone (marrow) 2-50 4-78 2-57 7-09 0-52 1-47
Thymus 0-044 0-084 0-047 0-076 0-245 0-375
Small intestine 0-355 0-890 0-479 0-752 0-484 1-26
Liver 1-23 2-35 1-14 2-02 1-14 1-62
Kidney 0-323 1-33 0-297 0-402 0-388 0-425
Muscle 0-018 0-031 0-011 0-014 0-009 0-015
Brain 0-017 0-018 0-009 0-014 0-008 0-004
Skin 0-033 0-041 0-018 0-026 0-013 0-012
* Per ml of blood separated on Ficoll/Hypaque.
DISCUSSION
1. Lymphocyte markers
Any method of estimating lymphocyte migration in vivo requires lymphocytes to be
'marked' so that they may be recognized in other tissues. Such markers should be permanent,
non-injurious and have such activity that detection of small numbers is possible. No such
ideal label exists. Chromosome markers are permanent and non-toxic but have the great
disadvantage of being visible only in dividing cells and requiring laborious microscopic
scoring. Radioisotopes provide a convenient and objective measure of tissue radioactivity
after labelled cell injection but equation of such tissue activity with the presence of cells
requires that the isotope remains attached to the injected cells, and that these remain alive. In
practice this is never completely realized and therefore the usefulness of any isotope as a cell
marker is related directly to the degree of toxicity of the labelling method, the extent of label
elution from dead and living cells and the subsequent fate of such eluted label. These factors
are particularly important where the expected concentration of labelled cells is low, i.e. they
may limit the resolution of the system.
The data presented underline the limitations of several radioactive lymphocyte labels when
used to quantify in vivo migration.
(i) Tritiated compounds have the severe disadvantages of large scale elution and more
significantly of widespread redistribution and persistence in tissue of label which yield gross
overestimates of cell concentrations in non-lymphoid tissues, making such labels entirely
unsuitable for quantitative studies in such sites.
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The increased elution of tritium compared with 14carbon from lymphocytes double-labelled
with [3H] and [14C]uridine or leucine reflects the different metabolic fates of atoms within a
molecule. This can be explained by different pathways of catabolism with intracellular
conservation of 14carbon, or possibly by exchange of tritium for hydrogen at the surface of
the molecule.
The eluted tritium appears to move within the body water pool. In restrained rats receiving
a continuous intravenous infusion of normal saline approximately 30% (Fig. lb) to 50%
iGoldschneider & McGregor, 1968) of the injected activity was found in cell free lymph or
urine over 24-48 hr after [3H]uridine-labelled cell injection. However, in similarly restrained
rats with no infusion and therefore no excess water input we found only 3% of the injected
activity was recovered in urine over 24 hr after similar labelled cell injection.
This widespread redistribution of TCA-soluble tritiated material could provide an
alternative explanation of the fact that ratios of TCA-insoluble/TCA-soluble tritium increase
with time in lymphoid tissues but not elsewhere (Goldschneider & McGregor, 1968; Ellis &
de Sousa, 1974). Such results have been cited as evidence that lymphocytes continue to
synthesize radioactive RNA from TCA-soluble precursors after injection of in vitro labelled
cells only in lymphoid tissue. However, such alterations in this ratio would also arise if the
TCA-insoluble fraction increased due to accumulation of more labelled cells with time while
the TCA-soluble fraction decreased by elution and redistribution. Both these factors are in
fact operative.
The situation differs in non-lymphoid tissues because the influx of cell free TCA-soluble
tritium from net elution in lymphoid organs may more than balance the efflux of TCA-soluble
tritium from the few labelled cells in the tissue, resulting in no increase or even a decrease in
the TCA-insoluble/TCA-soluble ratio.
The autoradiographic evidence of an increase in TCA resistant grain count over TDLs
more than 27 hr after injection compared with the same population immediately after
labelling (Gowans & Knight, 1964) suggests that a continuation of labelled RNA synthesis
can occur but there is no convincing evidence of restriction of this ability to cells in lymphoid
tissue.
(ii) 14Carbon has advantages over tritium due to the lower contamination of tissues by
eluted label which may be due in part to excretion of catabolized label as 14C02.
(iii) [51Cr]sodium chromate. Of the markers investigated 51Cr has most advantages and
fewest disadvantages in the present context. The disadvantages are the following, (a) Toxicity.
The ability of 51Cr-labelled mouse lymphoid cells to survive and respond to mitogenic
stimulation in vitro after transfer to syngeneic recipients is reduced compared with similar
unlabelled cells as measured by chromosomal markers (Doenhoff & Davies, 1976). This
toxicity may explain in part the higher liver activity found with this label. Low labelling
concentrations must be used to minimize this effect, (b) Non-specific label uptake. This is only
a disadvantage if the starting population of cells is heterogeneous. Preliminary studies
provided evidence that up to 10% contamination with erythrocytes could be found in thoracic
duct lymph in the absence of obvious bleeding. Such contamination could be effectively
removed by centrifugation on a Ficoll/Hypaque gradient, with good recovery of lymphocytes
and no loss of viability. Ammonium chloride lysis proved a much less efficient method of
removing small numbers of erythrocytes, (c) Autoradiography. Good autoradiographs of
51Cr-labelled cells were obtained with cell smears but tissue sections gave much poorer results
with apparent loss of activity during processing. This limits studies of the precise anatomical
location of 51Cr-labelled cells, (d) Non-uniformity of label uptake. Large lymphocytes are
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labelled more heavily than small lymphocytes by approximately 2:1 (Eyre, Rosen & Perry,
1970). Thoracic duct lymph contains about 5% large lymphocytes and it is therefore
impossible to estimate accurately how much of a given tissue activity is due to this
sub-population of cells if they behave differently as the evidence suggests.
On the other hand the advantages of easy and efficient counting of the emitted y-rays and
good elution characteristics with low contamination of tissues by non-cell associated label
make this label very useful. 51Cr gives estimates of activity in non-lymphoid tissue that are
most likely to approximate to physiological levels. In fact the cell concentrations in tissues
may be underestimated with this label following net elution and excretion of free label but is
unlikely to be overestimated as is the case with the other labels studied.
(iv) The potential advantage of [75Se]-L-selenomethionine as an alternative y-emitting
isotope that has been shown not to impair lymphocyte function (Rose & Micklem, 1976) is
counteracted by the rapid and possibly uneven elution from different organs (Bainbridge,
1976) together with some degree of redistribution probably due mainly to reutilization. Thus
ratios between 51Cr and 75Se vary between lymphoid tissues with time unlike the ratio of
3H/14C in similar double-labelling studies.
(v) [3H]thymidine. Although thymidine is metabolically incorporated into DNA and
therefore should be stable throughout the life of the cell significant elution of tritium does
occur from transferred long-lived cells. This can be explained by the death of a small
proportion of the labelled cells, catabolism of a proportion of so called 'metabolic DNA'
(Harris, Pelc & Blackmore, 1973) or a more uniform elution of isotope by atomic exchange
as suggested for other tritiated compounds.
The expense in terms of isotope and time needed to label long-lived cells in vivo together
with the contaminatory elution of isotope in final recipients of labelled cells override the
potential advantage of transferring a less traumatized population, for quantitative studies in
non-lymphoid tissues.
(vi) [99mTc]sodium pertechnetate. With the in vitro labelling methods used (after Barth et
al., 1974) the potential advantages of the short half life (6 hr) and good imaging character¬
istics of the y-emission of 99mTc were nullified by the apparent toxicity as shown by poor cell
survival and function in vivo.
(viii) [125I]iodo-deoxyuridine. As a label for DNA synthesizing cells this analogue of
thymidine has the advantage over, e.g. [3H]thymidine of being a y-emitter. It also has slightly
better elution characteristics but there is a significant degree of tissue contamination and this
isotope is also inherently toxic to cells, as shown by the four to five times greater radiation
damage by 125I-Udr compared with 3H-Tdr (Hofer & Hughes, 1971) and also the changing
migration characteristics of murine 'activated T.TDL' labelled with increasing doses of
125I-Udr, with poorer splenic localization reflecting probable cell damage (Sprent, 1976). Thus
1 ^Ci/ml is the upper limit of an acceptable in vitro labelling dose.
2. Kinetic studies
The behaviour of inherently mobile cell populations is revealed by the changing patterns of
distribution of such cells with time after i.v. injection. After equilibrium has been achieved the
relative concentrations of activity in the tissues provide evidence of the proportional size of
the various compartments of the recirculating lymphocyte pool (RLP) if the following
assumptions are true, (a) The cells injected are part of and mix freely within the total pool in
vivo, (b) The cells behave in a uniform manner. This is not true for mixtures of large and small
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lymphocytes nor for mixtures of T and B lymphocytes (Nieuwenhuis & Ford, 1976; Freitas
& de Sousa, 1976). (c) Distortion due to loss of label and cell death are not too great.
The early changes in concentration of activity in tissues with time following a bolus
injection of marked cells yield clues about the proportional distribution of lymphocytes
entering the blood (e.g. from major lymphatic vessels), i.e. the likelihood of a given cell finding
itself able to extravasate at a given site. The latter is thus a function of blood concentration,
blood flow and a clearance factor which varies between tissues and may be a property of
venular endothelium.
The time taken to reach maximum levels of radioactivity always assuming this is cell
associated and the rate of decrease from this maximum must reflect the modal transit time of
lymphocytes through a tissue.
A. slO TDLs. The kinetic pattern of distribution of passaged 51Cr TDLs is generally
similar to that of 51Cr whole TDLs and these two populations will therefore be considered
together.
(1) Blood and lungs. The labelled cells are injected into the blood compartment and thus
maximal blood levels are achieved immediately. The rate of fall is rapid and a minimum is
attained at 2-3 hr with a rebound by 24 hr which is the same pattern as described by Bunting,
Kiely & Owen, 1963. This initial fall is associated with a high concentration in the lungs and
this has been explained by micro-embolization or retention of cells, traumatized by in vitro
manipulation, in the first capillary bed reached (Gowans & Knight, 1964; Hall, Scollay &
Smith, 1976).
However, such apparent hold-up in the lungs may reflect a physiological process rather
than an artefact. This is suggested by two observations. Intra-arterial injection of labelled
cells, which therefore must traverse a capillary bed before reaching the lungs, yields an early
distribution pattern including high lung levels essentially similar to that following i.v. injection
(Weisberger et al., 1951; Rannie, unpublished). Secondly the initial rapid fall in lung levels is
significantly slowed in splenectomized recipients whether the operation is performed
immediately or 10 days before labelled cell transfer. Splenectomy removes a tissue which
accepts large numbers of cells from the circulation and following removal of this 'sink' the
blood concentration remains higher for longer after i.v. injection of labelled cells. That the
lung levels are also maintained under such circumstances can only be explained if the cells in
the lung are part of the mobile circulatory pool and not temporarily sequestered. If lympho¬
cytes traverse the lung capillary bed slowly (i.e. measured in minutes rather than seconds) the
observed activity levels would be expected as many labelled cells would return to the lungs of
necessity having failed to extravasate elsewhere.
(2) Secondary lymphoid organs. The kinetics of migration in lymph nodes and spleen
confirm the observations of others in intact and splenectomized recipients (Gowans &
Knight, 1964; Goldschneider & McGregor, 1968; Ford, 1969; Bradfield & Born, 1973).
These tissues therefore acted as a positive control suggesting normal behaviour of the injected
cells.
(3) Primary lymphoid organs, (a) Thymus. Localization of significant quantities of radio¬
activity following injection of labelled large or small lymphocytes shows that the barrier to
recirculating cells in this tissue is not complete. On a per gram basis at equilibrium the thymus
shows concentrations intermediate between lymph nodes and most non-lymphoid tissues.
Autoradiographs using [3H]uridine-labelled cells showed these labelled cells to be mainly in
the thymic medulla and such cells were most easily visualized after large doses of labelled
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lymphocytes although the proportion of the injected dose remained constant. This may
explain the results of Gowans & Knight (1964) who found labelled small lymphocytes in the
thymuses of young rats but not of adults. Werdelin (1972) reported localization of newly
formed cells from antigen stimulated lymph nodes labelled in situ with [3H]thymidine in the
thymic medulla. The observation of accumulation of passaged 51Cr-labelled cells as well as
125Tlabelled blasts suggests that accredited recirculating cells also have this capability.
(b) Bone marrow. In the normal rat a small proportion of bone marrow cells share the
characteristics of recirculating small lymphocytes, such as graft versus host activity
of bone marrow (Yoshida & Osmond, 1971) which can be removed by prolonged thoracic
duct drainage (Howard & Scott, 1972). As early as 1951, Farr showed substantial
localization of fluorescent-labelled lymph node cells in rabbit bone marrow a few hours after
intravenous injection which was no longer apparent at 12 hr. This subsequent disappearance
was misinterpreted as being due to cell death or transformation as opposed to remigration.
Using 51Cr-labelled lymphocytes Shorter & Bollman (1960) give a maximum bone marrow
localization of 4% of injected dose but do not give the size of the sample. The present data
suggest that a major pathway of recirculating lymphocytes is through the bone marrow with a
transit time similar to that in spleen, i.e. 4-6 hr (Ford, 1969). The present estimates of 25% of
the injected cells in the bone marrow at 2 hr is computed assuming that 5% of body weight
comprises bones containing marrow to the same extent as the measured tibiae and femora.
That labelled cells enter and leave the marrow parenchyma in all sites was confirmed by auto¬
radiography of decalcified histological sections of perfused recipients at several times after
transfusion of 3H-labelled TDLs.
Recognition of this major recirculation pathway has been masked by the diffuse nature of
the tissue, and the large extent of lymphocyte production that occurs, rendering long-lived re¬
circulating cells a small minority in the equilibrium state. It remains to be shown that this
recirculation of lymphocytes between the blood and the bone-marrow has similar functional
significance to recirculation through the spleen and lymph nodes in the propagation of
immune responses (Gowans & McGregor, 1965, reviewed by Ford, 1975).
(4) Non-lymphoid tissues. In non-lymphoid tissues, the early low peak, the slight fall after a
few hours and rapid equilibration all follow the blood curve. This suggests a low clearance
factor and a rapid transit time of the cells that do extravasate. An alternative explanation of
the close association of blood and tissue concentrations could be that the latter is due to intra-
vascular-labelled cells incompletely removed by perfusion. If this is the case the tissue levels
measured would overestimate cell extravasation. Against this are the observations that: (i)
some vascular tissues, e.g. brain, can be perfused to give much lower levels than, e.g. skin,
even at early time intervals, when the blood concentration is high, (ii) At 2 hr although 51Cr
and 125I concentrations in most tissues are lower than at \ hr, this decrease is much less
dramatic than that measured in blood leucocytes over the same period.
The problem of transit time in peripheral tissues can only be approached directly by
collecting labelled cells as they leave such tissues via afferent lymphatic fistulae. In sheep it
has been shown that some labelled lymphocytes do emerge from afferent lymphatics soon
after i.v. injection (Hall et al., 1976). Presentation of the data as specific activity in afferent
and efferent lymph makes estimation of the true kinetics difficult without cell counts or
reference to a fixed standard such as the injected dose. However, such curves showed that the
afferent lymph curve anticipates that of efferent lymph by approximately 6 hr, and also that
significant activity was present in afferent lymph within the first 2 hr.
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Using the shape of the time course distribution curves to estimate transit time and
concentration at equilibrium to estimate the proportion of the RLP in a tissue an indirect
estimate of cell flux through that tissue may be made. For example, from the present data,
using passaged 51Cr-labelled cells as an accredited recirculating population, one gram of skin
in a 200 g rat contains approximately 0-006% of the RLP. Assuming the latter to be in the
region of 2-5 x 109 cells (defined from the total cells mobilizable into the thoracic duct over 4
days by which time the output curve has reached plateau levels (after Gowans & Knight,
1964)) then approximately 1-5 x 10s recirculating lymphocytes are present in 1 g of skin at
any given time. Depending on the mean transit time of this population, a proportion of the
cells will enter and leave the tissue each hour. If the transit time is, e.g. 3 hr, as suggested by
the rapid equilibration shown in this report, then one third of the population will enter each
hour or 5 x 104 cells/g/hr. Whereas if the transit time was 10 hr (Hall et al., 1976) then this
flux would be reduced to 1-5 x 104/g/hr.
This size of flux agrees reasonably closely with estimates computed from afferent
lymphatic cell output data in sheep (Smith, Pederson & Morris, 1970). Renal afferent lymph
contained approximately 2-0 x 106 lymphocytes/hr which, assuming the weight of the
kidney to be 100 g, would yield a figure of 2-0 x 104/g/hr. The testis had an output of 5-0 x
106/hr which, assuming a weight of approximately 250 g, gives a flux value of 2-0 x 104/g/hr.
The liver had a higher concentration of cells in afferent lymph with a total output of 75 x 106
lymphocytes/hr. If the total weight of tissue was approximately 1500 g the flux would be 5 x
104/g/hr. A reasonable estimate of tissue flux would therefore be 104— 10s lymphocytes/g/hr.
B. l25I-labelled lymphoblasts. The pattern of distribution of labelled lymphoblasts
corresponds closely with that reported by others (Hall, Parry & Smith, 1972; Gowans &
Knight, 1964) and suggests that large cells have a greater propensity for leaving the
circulation at all non-lymphoid sites. However, on a cell-for-cell basis, comparison of this
population with passaged 51Cr cells which contain few labelled lymphoblasts suggests that the
absolute numbers of large and small lymphocytes extravasating in non-lymphoid tissues
including gut are roughly equal.
The approximately three times higher concentration of 125I in the mesenteric nodes at 2 hr
as opposed to, e.g. cervical lymph nodes (see Table 4) is similar to that described by others
(Griscelli, Vassalli & McCluskey, 1969). The majority of large lymphocytes recirculate
poorly from blood to lymph and therefore those in thoracic duct lymph are mainly recently
formed in the drainage area, i.e. mesenteric nodes and gut associated lymphoid tissues. One
suggestion is that lymphocytes, particularly lymphoblasts, show some degree of recognition
for and thus preferred migration to their tissue of origin (Rose, Parrott & Bruce, 1976).
Another possible explanation is that this early high concentration in the mesenteric node is
due to substantial localization of cells in the lymph node following extravasation in the gut
and transport up the afferent lymphatics—such a large afferent supply would not be available
to lymph nodes in other sites.
It would appear that there is a significant recirculation of lymphocytes through non-
lymphoid tissues which although of low volume may be rapid. The functional significance of
this migration requires elucidation but it is presumed to be of importance in, for example, the
effector limb of the delayed type hypersensitivity response.
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SUMMARY
The suitability of two radionuclides (99mTc,111 In) for labelling lymphocytes have been evaluated
in rats by comparison with a standard method using 51Cr. For the study of lymphocyte migration
in patients labelling with nlIn-IabeIled oxine is clearly the most promising because both in vivo
and in vitro it remains associated with lymphocytes and the labelled cells migrate normally into
lymphoid tissues. The physical characteristics of111 In are also favourable. Not only does "mTc
rapidly dissociate from lymphocytes but also it compromises their ability to recirculate from blood
to lymph.
INTRODUCTION
?he radioactive labelling of cells has been chiefly responsible for elucidating the migration pathways of
^mphocytes in experimental animals. By this and other methods the unique recirculation of lymphocytes
as been shown to be central to the unfolding of cellular events in immune responses (Gowans &
dcGregor, 1965; Ford, 1975). In man the direct study of this function has been very limited because of
he lack of a suitable radioisotopic label. Of the many isotopes used in animals, [51Cr]sodium chromate
as been the most popular as a lymphocyte label and enough is known of its properties to regard it as a
tandard against which other radioactive labels can be compared for specific applications. At least two
roups have used 51Cr to study lymphocyte migration in patients (Hersey, 1971; Scott et al., 1972).
fhey labelled peripheral blood lymphocytes in vitro, re-injected them i.v. and followed their accumula-
ion in certain lymphoid tissues by surface-detection devices. These studies, as well as complementary
vidence obtained by injecting 3H-labelled lymphocytes into patients with thoracic-duct fistulae
Revillard et al., 1968), have suggested that the model of the recirculating lymphocyte pool built up from
nimal experiments is broadly applicable to man. However, more extensive evidence as well as insight
ito abnormalities of lymphocyte recirculation in disease would be obtained if invasive procedures
icluding thoracic-duct cannulation could be avoided.
Labelling with MCr has several serious disadvantages for clinical studies: (a) the low gamma-photon
mission cannot usefully be detected by the gamma camera; (b) the half-life of 28 days is unnecessarily
tng; (c) the uptake of label in vitro is low and compensating for this by increasing the concentration of
>otope produces cell damage (Doenhoff & Davies, 1976), therefore about 500 ml of blood is necessary to
'rovide enough lymphocytes for surface detection; (d) significant dissociation of label from lymphocytes
,ithin 24 hr is apparent.
In the hope that they might be more suitable in the context of lymphocyte studies in patients we have
ivestigated two isotopes (Indium-Ill and Technetium-99m), which have already been widely used in
* Present address: M.L. Thakur, Yale University School of Medicine, Department of Diagnostic Radiology, Cedar Street,
lew Haven, Connecticut 06510.
Correspondence: Dr W.L. Ford, Department of Pathology, Manchester University Medical School, Oxford Road,
lanchester M13 9PT.
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nuclear medicine because of their desirable physical characteristics. "mTc has been reported to be a
suitable isotope for following lymphocyte migration in mice (Barth, Singla & Gillespie, 1974), and '"In-
labelled oxine has been successfully applied to both experimental and clinical studies of the distribution
of polymorphs (Thakur et al., 1976a) and platelets (Thakur et al1976b). Therefore these two isotopes
were used to label rat lymphocytes and their behaviour on re-injection was assessed.
MATERIALS AND METHODS
Animals. Rats of either sex belonging to the highly inbred AO strain were used.
Cell preparation. Thoracic-duct lymphocytes were collected by the method of Gowans as described by Ford & Hunt
(1973). They were resuspended in PBS at a concentration of 3 x 107/ml and layered over 3 ml of Ficoll-Hypaque (5 vol. 14° ;
Ficoll and 2 vol. 45% Hypaque). After centrifugation (1200 g, 20 min, 20°C) the interface layer was collected, washed ir
PBS and resuspended for labelling with 51Cr, 99mTc or 11 'In. The Ficoll-Hypaque centrifugation step completely removec
contaminating erythrocytes which would otherwise have been labelled with each of the three isotopes. This would hav<
distorted the estimates of lymphocyte localization in the recipients, especially in the blood compartment.
Radioactive labelling of cells. Chromium-Si. Lymphocytes were incubated at 108/ml in medium RPMI 1640+10% foeta
calf serum (FCS) with 10 /tCi/ml Na25 'CrOi (CJS1P, Radiochemicals, Amersham) for 1 hr at 37°C. Before injection the cell
were washed three times and centrifuged through a layer of 50% FCS-PBS.
Technetium-99m. A similar procedure was followed for labelling with Na299mTc04 which had been eluted with NaC
from a sterile generator (MCC.3, Radiochemical, Amersham). The concentration of isotope was up to 3 mCi/ml. The usi
of SnCl2 and/or Na2Cr()4 to increase label uptake as suggested by Barth et al. (1974) was avoided because they were fount
to be excessively toxic to the cells.
Indium-111. '"In (INS.l, Radiochemicals, Amersham) was chelated with oxine as previously described by Thakur
Coleman & Welch (1977). Lymphocytes were incubated with 0-1 to 0-5 /(Ci/ml in normal saline at 108/ml at room tempera
ture for 10 min. A higher dose as specified later was used for external detection studies. They were then washed as afte
51Cr labelling.
For comparison labelled cells were heat-killed by incubation in PBS at 108/ml for 30 min at 56°C. After each labellini
procedure cell viability was assessed conventionally by trypan-blue exclusion which was also applied to check the effectivenes
of heat-killing.
Sample preparation and assay of radioactivity. At 2 or 24 hr after the i.v. injection of labelled cells the recipients wer
killed and large volumes ofPBS were perfused through their entire vasculature to remove intravascular label (Rannie & Donald
1977). Tissues were then removed, weighed and counted in a dual channel (LKB Wallac) gamma-scintillation counter
Leucocyte samples obtained from cardiac blood were also counted. The counts in the tissues were always compared to th
radioactivity measured in an aliquot of the injected cells. In other experiments cells were injected i.v. into recipients witl
thoracic duct fistulae and the draining lymph was subsequently examined for radioactivity associated with cells and super
natant lymph. Recipients were examined at different times with a gamma camera (N.D. Selektronic A/S). Dissociation o
isotope from cells in vitro was measured by counting cells and supernatants from cultures maintained in RPMI+10% FCS a
a concentration of 5x 106/ml at 37°C.
RESULTS
Approximately 2% of the 99mTc or the 5'Cr which was added to the incubation mixture was incorporate!
into the cells after 1 hr at 37°C, whereas more than 85% of 111 In-labelled oxine was incorporated afte
10 min and this occurred equally as well at 37°C or room temperature, although the uptake was slower a
4°C. Labelling with lnIn did occur in RPMI+10% FCS but was significantly reduced compared t
normal saline. With each method thorough washing was found to be essential to remove unbound label
The distribution of labelled lymphocytes after i.v. injection into syngeneic recipients is summarize!
in Table 1. In general, 11'In-labelled viable cells behaved similarly to 5'C.r-labelled viable cells. O
particular significance were the observations that about 10 times as much "'In was found in lympl
nodes at 24 hr as at 2 hr after injection, while the lymph-node activity following the injection ofdead cell
was negligible at both time intervals. The splenic localization following injection of" 'In-labelled cell
accounted for more than 50% of the injected radioactivity at 2 hr and fell to about half this value at 24 hr
which can be confidently attributed to physiological redistribution (Ford, 1975). The radioactivity ii
non-lymphoid tissues using '"In was low as expected; in particular the hepatic localization at arouni
10% was much less than when labelled dead cells were injected.
The radioactivity in the plasma and in the urine gives some insight into the fate of each isotope after i
has been released from living or dead cells. Of the little "'In which was released only a small amoun
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Table 1. Mean per cent injected dose per whole organ in syngeneic recipients
after i.v. injection of labelled lymphocytes
2 hr 24 hr
vi gaua
51Cr "'In 51Cr '"In 99m'j,£
Lymph nodes 341 2-39 26-5 30-8 3-9
0-06 042 041 0-26
Spleen 47-7 56-2 22-0 31-5 84
1-7 2-6 2-6 5-2
Liver 11-3 10-8 9-0 9-6 18-9
37-1 39-9 384 53-5
Kidney 0-28 0-39 0-29 0-30 6-7
4-8 2-0 5-6 1-8
Gut 4-5 1-9 2-9 3-6 —
0-52 0-68 0-27 0-75
Lung 4-5 4-3 1-8 1-6 0-34
22-7 234 1-5 2-2
Bone (marrow) 14-7 184 2-3 21 —
3-9 3-2 7-2 104
Blood (w.b.c.) 1-3 1-6 1-3 2-3 —
04 11 0-23 14
Plasma 0-27 044 048 0-34 0-76
4-9 5-7 11 1-3
Total recovery
(viable cells
injected) 88-0 964 66-3 824 38-7
Urine — — >10 >0-6 >25
Values for heat-killed cells appear under those for viable cells for each tissue.
The standard errors about the means (of the order of 10%) have been excluded
for clarity. Times are hours after i.v..injection.
Table 2. Comparison of isotopes
Physical Suitability Uptake by Labelling Elution in Injected activity recovered
Isotope half-life for lymphocytes time in culture in recirculating
(days) external imaging (°/„) (after 3 hr) thoracic-duct cells 0-42 hr
(°/o) afterwards (°/)
'"In-labelled oxine 2-8 Good 85 10 min 5 45
"Cr 28 Poor 2 1 hr 30 22
'9mTc 0-25 Good 2 1 hr 30 0-6
ippeared in the urine; some was present in plasma, and was probably due to avid binding to transferrin
'Thakur et al., 1977). By contrast, the released 5ICr was largely excreted in the urine and relatively less
ivas bound to plasma protein. After injection of cells labelled with "mTc, the levels of radioactivity in the
spleen and lymph nodes were much lower than with 51Cr or lnIn, and high levels were found in the
iver, kidney and urine suggesting that the cells had been damaged and had rapidly lost their isotope. The
dmost complete failure of "mTc-labelled cells to recirculate from blood to lymph (Table 2) was the
nost damning testimony to the inadequacy of this tracer. By contrast, both 51 Cr- and 111 In-labelled cells
•ecirculated well from blood to lymph, each with a peak recovery typically at 18 hr after injection (Ford
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Fig. 1. Recirculation from blood to thoracic-duct lymph of lymphocytes labelled with '"In or 51Cr. Radio¬
activity was measured in 45 min sequential collections of lymphocytes. With 99mTc-labeIled cells the total
recovery in 45 hr was was 0-6% of the injected activity and was too low to plot. The total recovery in 45 hr was
36-04% for 11'In, and 21-60% for MCr.
& Simmonds, 1972) (Fig. 1). There was a progressive divergence between the recoveries of 5lCr- and
111In-label!ed cells in favour ofxllIn which we attribute to the greater rate of dissociation of 51Cr from
cells in vivo. The very low rate of elution of U1ln, from lymphocytes was supported by the recovery ol
36-44% of the radioactivity from thoracic-duct lymphocytes within 45 hr of injection, and was further
confirmed in vitro, since the loss of isotope from lymphocytes over a 3 hr period in culture was only 5%
compared to the spontaneous release of about 30% 51Cr or 99mTc under the same conditions.
Gamma-camera images were obtained from rats which had received 300 /(Ci of111 In associated with
between 5 x 106 and 5 x 108 cells. At 24 hr after i.v., injection groups of lymph nodes weighing approxi¬
mately 100 mg could be discerned (Fig. 2 and 3). The images produced by the spleen and the liver were
contiguous, but especially at a few hours after injection, when the splenic localization was maxima,
(Table 1) and the spleen image was more intense.
It would be of great interest to study lymphocyte localization in those patients in whom altered migration
is probably significant. This includes most chronic inflammatory diseases and neoplastic diseases,
especially the lymphomas and leukaemias. For clinical application the ideal characteristics of a radio¬
active tracer for lymphocytes are lack of toxicity, suitability for external detection and a half-life lone
enough for studies to be made over 1-2 days and short enough to minimize the body burden of radiation.
Above all, the radioactivity should not be lost from the cells in such a way as to give a misleading im¬
pression of cellular localization. The present results suggest that nlIn-labelled oxine is the most
promising agent for the study of lymphocyte recirculation in man and confirms its advantages which have
been underlined by previous work (Thakur et al., 1976a,b, 1977) on the evaluation and clinical applica¬
tion of labelling other cell types. The close agreement between the localization of111 In- and51 Cr-labelled
lymphocytes indicates that U1ln is suitable for migration studies and this, taken together with the
high specific activity obtainable, the efficient detection characteristics and the near ideal (2-8 days) half-
life of this isotope, suggests that detailed kinetic studies in patients will be possible following reinjection ol
labelled lymphocytes separated from about 50 ml of blood.
Two notes of caution should be sounded. Firstly, a vital factor in obtaining favourable results is the
DISCUSSION
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Fig. 2. Fig. 3.
Fig. 2. Gamma-camera image of a rat which had received lymphocytes labelled with 300 /tCi of 1' 'In 24 hr
previously. The large group of cervical lymph nodes (arrowed) as well as other groups of lymph nodes in the
thorax and abdomen are visible. The major concentration of radioactivity is present in the liver and spleen. The
latter is responsible for the small area of intense activity indicated by the triangle.
Fig. 3. Gamma-camera image (using a pin-hole collimator) of the neck region of a rat which had received
lymphocytes labelled with 300 //Ci of 1" In 24 hr previously. The major concentration of radioactivity is over
the superficial cervical lymph nodes. The group of nodes on each side weighs about 100 mg. (Magnification
x 3.)
urity of the labelling material. Preliminary trials with U1ln produced by a-particle bombardment of a
Iver target (in contrast to a cadmium target used by the Radiochemical Centre) suggests that certain
npurities not only reduce the efficiency of labelling but also impair the migratory function of labelled
mphocytes. Chemical instability or impurity of the oxine are other uncertain factors.
The second point concerns the possibility of long-term radiation hazards to patients. Radioactive
belling of lymphocytes above a certain intensity will inevitably give rise to radiation damage of these
sceptionally radiosensitive cells. Rannie (unpublished) found that labelling thoracic-duct lymphocytes
ith A11In at 200 ^tCi/ml almost completely abolished their capacity to mount a graft-xts-host (GVH)
taction as assessed by the sensitive popliteal lymph-node assay (Ford, Burr & Simonsen, 1970). This
•as hardly surprising since labelling lymphocytes with 51 Cr at 100 /(Ci/ml (producing only about 1%
f the radioactivity in the cells compared with the above situation) markedly impaired GVH activity by
re same test (Rolstad, personal communication). The clinical relevance of radiation damage to a small
indom sample of the whole-body lymphocyte population lies not in the probable death of these cells but
t the possibility of inducing neoplastic transformation. However, we are unaware of any evidence that
eripheral lymphocytes as obtained by blood sampling are exceptionally liable to radiation-induced
talignant change. The most pertinent information is derived from studies of patients who have been
"eated by intra-synovial injections of 90Y or 198Au for rheumatoid arthritis of the knee joint which leads
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to an accumulation of the isotope in the draining lymph nodes (Stevenson et al., 1973). These nodes (ant
therefore recirculating lymphocytes) were subjected to intense local irradiation, as witnessed by the higl
proportion of chromosome aberrations found in the blood lymphocyte population. So far, this pro¬
cedure has not been associated with any serious consequences (Dolphin, 1973). It should be noted thai
the size of the labelled sample that is proposed (50-100 x 106 lymphocytes) is only about 0-1% of th(
recirculating lymphocyte pool.
In experimental animals, labelling lymphocytes with ulIn has, at present, the practical disadvantage;
of a short half-life, necessitating weekly or fortnightly orders of 111 In, and the lack of a source o
ready-made nlIn-labelled oxine complex. However, 111 In labelling, being potentially more sensitivi
than 51Cr labelling, might be indispensable for the study of a subset of lymphocytes when only a smal
number of cells are available for labelling, and then only a minority localize in the compartment of inter¬
est, such as a skin lesion. As with 5ICr, autoradiography of 111In-labelled cells is feasible by exploiting
the low-energy emission attributed to internal conversion. Such autoradiographs of TDL have suggestet
that all cells are labelled with 111 In with no more heterogeneity of labelling intensity than is found witl
51Cr labelling. For labelling target cells in cytotoxicity assays the slow spontaneous release of 11'In it
vitro would be a great advantage. Unless unforeseen difficulties arise 111 In labelling would appear to havi
widespread experimental as well as clinical application.
We thank Ms T. Asian for technical assistance, Dr D.D. Vonberg and Dr D.J. Silvester for their interest and Professor B.R
Pullan for Technetium-99m and gamma-camera facilities. The work was largely supported by MRC programme grant No
G972/455B.
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PHYSIOLOGY OF LYMPHOCYTE RECIRCULATION IN ANIMAL MODELS
G.H. Rannie and W.L. Ford
Department of Pathology, University of Manchester Medical School,
Manchester, U.K.
Several lines of evidence presented at a symposium in Paris in 1968 (1) supported
the idea that the dynamics of lymphocyte migration in man was similar in broad
principle to the situation which had been established in several other mammalian
species in particular the sheep, the calf and the rat. This notion remains valid
although a good deal of new information on lymphocyte migration has been forth¬
coming in the intervening years. The extension of knowledge in this field has
mainly been attributable to animal experiments because there has been a lack of
technical advances in methods of studying lymphocyte migration in patients. The
purpose of this communication is to review briefly some recent advances in lymph¬
ocyte recirculation kinetics in the context of possible application to studies in
patients. Clinical information of this kind may help to elucidate the cellular
events in transplantation and other immune reactions. The functional significance
of lymphocyte recirculation has been reviewed previously (2).
A simple description of the concept of lymphocyte recirculation is given in
Figure 1. This serves to make a number of basic points as follows. Firstly
lymphocytes are unique cells in that they leave the blood to enter tissues and
subsequently return to the blood; what is more they follow this circuit many times.
Other leucocytes of course enter tissues but they do not return to the blood regul¬
arly and in large numbers. Secondly each organ or tissue is an individual case with
respect to its capacity to support the migration of lymphocytes and the routes of
entry and return may be structurally different in different organs. Thirdly while
B and T lymphocytes leave the blood by crossing the same vascular endothelium they
later segregate and take divergent routes before returning to the blood. A relat¬
ed question concerns the capacity of subpopulations of B and T lymphocytes to
recirculate. In the case of the subpopulations which carry immunological memory
the evidence is clear that both B and T memory cells are present in the recircul¬
ating pool as are virgin T cells. The evidence as to whether other subpopulations,
such as virgin B cells and suppressor cells, recirculate is not yet adequate to
give a definite answer (2).
A fuller description of lymphocyte migration kinetics is provided in Figure 2 and
Table 1. The Figure is a simplified "wiring diagram" in which the blood compart¬
ment is intentionally given a central position. Table 1 gives estimates of a) the
flux of small lymphocytes exchanging between the blood and a number of tissues in
terms of cells per gm per hour. b) the modal transit time of T lymphocytes migra¬
ting through the tissue and c) the content of recirculating small lymphocytes
which is of course partly dependent on parameters a) and b). Some of these estim¬
ates can be stated with confidence e.g. the modal transit time through skin (blood->
-^skin —^ peripheral lymphatic) of 1-3 hours. The model presented in Figure 2
and Table 1 is eclectic, that is it is based on data drawn from several sources.
Most of the recent data is from a series of experiments in which thoracic duct
lymphocytes were labelled in vitro with ^''Cr and injected i.v. into syngeneic reci¬
pients. The number of cells in many different tissues at a range of time intervals
after injection were estimated by organ counting and checked by autoradiography.
The recipients were killed and their vasculature was perfused with 300ml. of hepar-
inized PBS before samples of the tissues were removed. This removed intravascular


























Spleen 210 4-5 1200 Ca.0.4
Lymph-nodes 75 15-18 1300 Ca0.75
'Bone (marrow) 2 3-4 6 10
Blood 12 0.4 5 15
>
'Lung ? ? (mins) 45 1 .2
Liver ? ? 23 10
Thymus 0.12 Ca. 1 8 2 0.3
ma11-intestine 0.6 ? 8 5
Skin 0.05 Ca.1-3 0.15 30
Muscle 0.03 » 0.09 100
Ovary 0.25 » 0.75 0.10
Uterus 0.08 « 0.25 0.4
B rain 0.01 " 0.03 1 .5
The data refer to whole bone. The great majority of lymphocytes recirculate
within the marrow.
2 Since the lymphocytes in lung may not be extravascular the concepts of flux
and transit times may be rather meaningless.
3 Data refer to the migration of small lymphocytes into the small intestine less
Peyer's patches.
A Approximate weight of tissue in a 200 g female rat. A major source of uncert¬
ainty is the great variability in the spleen and lymph-node weights. A very
approximate estimate of the flux and content per whole organ can of course be
obtained by multiplication.
MA30R SITES OF LYMPHOCYTE RECIRCULATION
a) The spleen
The spleen maintains a greater flux of lymphocytes (per gram) than any other organ.
In the rat somewhat more than half of the lymphocytes leaving the blood enter the
spleen and of these the great majority enter the white pulp. The transit time of
T lymphocytes from blood to spleen to blood is rather short with a mode of 4-5
hours and therefore the splenic content of recirculating lymphocytes accounts for
only about 20% of the whole recirculating pool (3, 4, 5). Both B and T cells enter
via the marginal zone but the former take a more circuitous route including the
lymphocyte corona around germinal centres (6). The average transit time of B
lymphocytes is several times longer than that of T lymphocytes and in consequence
the B lymphocyte content of the spleen is greater than that of T lymphocytes.
Neither cell returns to the blood by long lymphatic channels since the isolated
spleen releases large numbers of cells into the venous effluent (4). The marginal
zone bridging channels (7) carry at least some lymphocytes back into the venous
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sinuses of the red pulp. At present no may is known of modifying lymphocytes so
as to abolish their capacity to migrate into the spleen; although dextran sulphate
administered i.v. reduces the number of lymphocytes entering the spleen compared
to the blood level the inhibitory effect on lymph-node localization is much greater
(8).
b) The lymph-nodes
The flux of lymphocytes through lymph-nodes is less than half that through the
spleen but the transit time of T cells is 3-4 times longer so that content of
recirculating lymphocytes is greater (both comparisons per gm. of tissue) (9).
There is a good deal of evidence for the longer transit through lymph-nodes but
perhaps the simplest is obtained by counting the two organs at 2 hours and 24
hours after injecting radiolabelled lymphocytes. Whereas the splenic activity
regularly falls by a factor of between 2 and 4 the lymph-node activity rises by a
factor of between 3-8. This divergent trend has been noted after applying several
different labels (10, 11, 12). Both B and T lymphocytes enter lymph-nodes by
traversing the specialized vascular endothelium in post-capillary venules within
the deep zone of the cortex. They subsequently segregate into characteristic
areas and eventually return to the blood (6). In the rat at least,there is strong
evidence that lymphocytes return exclusively via efferent lymphatic channels; the
direct entry of lymphocytes into blood vessels within lymph-nodes does not occur
at least within the rat mesenteric lymph-node (13). Several means are available
for reversibly inhibiting the entry of lymphocytes into lymph-nodes including
treatment of the cells with trypsin (14), papain or sodium azide (13) and treat¬
ment of the recipients with dextran sulphate (8, 16).
c) The bone-marrow
It has been realized for some time that the bone-marrow has a small content of re¬
circulating lymphocytes. Recent kinetic studies of transfused, 51gr labelled lymp¬
hocytes has revealed that the flux of recirculating lymphocytes through bone-marrow
is substantial and the transit time at 3-4 hours is even shorter than that of the
spleen (3, 17). The weight of marrow tissue is several times that of the spleen
or of the combined lymph-node mass. Thus the flux per gm is much less than that
through the spleen but the flux through the whole marrow is not a great deal less.
The functional significance of lymphocyte recirculation within the bone-marrow is
probably the same as in other tissues, that is it extends the pool from which anti¬
gen-reactive cells can be recruited by antigen. This has been supported by a rec¬
ent study of a systemic graft-versus-host reaction initiated by the i.v. injection
of parental strain lymphocytes into F^ hybrid recipients. Antigen-reactive parent¬
al strain cells were sequestrated in bone-marrow and by 24 hours had transformed to
blast cells (17). It seems likely^although it has not been proved, that an immune
response can proceed from alpha to omega entirely in the marrow. The anatomical
route followed by lymphocytes within the marrow is unclear but it seems likely
that they cross a sinusoidal vascular endothelium (18) and later re-enter the blood
directly since no lymphatics have been described in bone marrow. The release of
recirculating lymphocytes from .bone-marrow may be especially susceptible to inhib¬
ition by corticosteroids (19).
ORGANS WHICH ARE SPECIAL CASES
a) The lung
The high proportion of lymphocytes which are found in the lungs for the first 30-
60 min after i.v. injection has been regarded as a reflection of cell damage and
thus essentially artefactual. Several recent observations have suggested that on
the contrary this early localization of lymphocytes may be a consequence of a phy¬
siological property of the pulmonary vascular bed. These include the following -
1) Early pulmonary localization is equally as pronounced if the lymphocytes are
injected into the aorta so that they initially pass through another capillary bed
(20, 3).
2) Removing the major site into which lymphocytes migrate from the blood by splen¬
ectomy substantially increases the numbers localizing in other sites including the
lungs (3).
3) Exposure of lymphocytes to concanavalin A in vitro delays their passage through
the spleen and lymph-nodes and also prolongs their retention in the lungs (3).
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5traightforoiard autoradiography of paraffin sections is inedequate to pinpoint
the location of lymphocytes in the lung; whether or not they remain intravascular
is uncertain.
b) The liver
Another prominent site of lymphocyte localization early after i.v. injection is
the liver but in this case the radioactivity in the whole organ falls slightly to
reach a plateau by two hours and remains at about 6-10% of the injected dose up to
24 hours after injection (3, 11). There is no doubt that dead lymphocytes or lym¬
phocytes damaged by a long list of chemical and physical agents (including labell¬
ing with excessive radioactivity) are mainly removed by the liver (reviewed in 2).
Nevertheless it seems that the liver is a site of normal lymphocyte traffic which
is intermediate in scale between the major sites of lymphocyte recirculation and
non-lymphoid tissues. This is supported by the observation that hepatic lymph in
the sheep conveys a greater flux of cells to the draining node than does other per¬
ipheral lymph (22) and that the localization of antibody coated cells in the liver
can be reduced by carbon blockade of the recipients but untreated lymphocytes are
barely affected by such a manoeuvre (23).
c) The thymus
The thymus is one lymphoid organ which is not a major site of lymphocyte recircul¬
ation (24). Most of the lymphocytes in the thymus are produced by local cell-
division of precursors originally from the bone marrow. However after injecting
recipients with radioactively labelled lymphocytes the migration of cells from
the blood can be measured by scintillation counting and detected by autoradio¬
graphy (3). The flux is less than that into the spleen by a factor of about 500
but is 10 times more than the average flux into a non-lymphoid tissue such as skin
(comparisons on a per gm basis). The transit time may be of the same order as
that through lymph-nodes because the temporal accumulation of radioactivity resem¬
bles that in lymph-nodes. The immigrant cells are not uniformly dispersed but
are almost all in the medulla. The content of recirculating lymphocytes in the
medulla could account for at least some of the mature B and T cells that are pres¬
ent in the cortisone resistant population. The endothelium of post-capillary
venules in normal thymus is not high walled although this may alter in disease (25).
It is uncertain by which route recirculating lymphocytes return from the thymus to
the blood although a lymphatic route would seem more likely. The route may not
necessarily be the same as that taken by virgin T cells leaving the organ.
RECIRCULATION IN NON-LYMPHOID TISSUES
a) Under physiological conditions
The observation that peripheral lymph derived from a number of non-lymphoid tissues
such as skin, muscle and bone contains a much lower number of lymphocytes than does
efferent lymph from a lymph-node established that lymphocyte recirculation through
these tissues is on a much smaller scale than through most lymphoid tissues (22).
The flux of lymphocytes into a node via afferent lymph is only approximately 5—10%
of the flux of cells from the node in efferent lymph although the weight of non-
lymphoid tissue in the catchment area of the node is generally many times greater
than the weight of the node itself. Nevertheless at least 10 times as many of
those cells bound eventually for efferent lymph leave the blood in the node as
leave it in the non-lymphoid tissue. By measuring the localization of i.v. inject-
ted Cr-labelled lymphocytes in a number of non-lymphoid tissues in the rat the
flux of lymphocytes was estimated to be less than the flux into spleen or lymph-
nodes by a factor of the order of 10^-104 per gm of tissue (3). This is of the
same magnitude as can be estimated from the sheep data (22). In that species it
was found that the transit time of lymphocytes migrating from blood to tissue to
afferent lymph was substantially shorter than the time for cells to traverse the
major route from blood to lymph-node to efferent lymph (26). Of course efferent
lymph returns cells directly to the blood (unless a chain of nodes is involved)
whereas cells ariving at the node in afferent lymph firstly enter the subcapsular
sinus and then traverse the node before emerging in efferent lymph. Another study
on the sheep from a different group (27) showed that the transit time through the
lymph-node of cells injected proximally into the afferent lymphatic was shorter
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than that of cells injected i.v. and therefore arriving via the post-capillary
venules. This is presumably because the cells arriving via the afferent lymphatic
take a faster route (it may be entirely intralymphatic) although they may have
further to travel to the efferent lymphatic as the crow flies.
Because lymphocytes spend only a few hours in non-lymphoid tissues before return¬
ing via a peripheral lymphatic and becajse the flux is so low the content of re¬
circulating lymphocytes per gm of tissue is very low indeed which is obvious from
inspection of a histological section of many normal tissues in which lymphocytes
are present but are few and far between. It is presumed that lymphocytes enter
non-lymphoid tissues by crossing the endothelium of small venules but this has not
been defined by autoradiography because of the paucity of labelled cells in these
tissues. It is also uncertain whether the lymphocytes which enter non-lymphoid
tissue are a random sample of the recirculating pool. In the sheep most of the
lymphocytes in afferent lymph are immunoglobulin negative suggesting they are T
cells. However they display less activity against alloantigens in an intradermal
transfer test than do the T lymphocytes in efferent lymph (28). This raises the
possibility that different subsets recirculate a) via post-capillary venules in
lymph-nodes and b) via non-lymphoid tissues and afferent lymphatics (29), but
this proposition needs much additional support before it is accepted.
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The kinetic distribution of Cr-labelled lymphocytes was studied in the following
non-lymphoid tissues of the rat - skin, muscle, ovary, uterus and brain. There
are only minor differences between these tissues in the temporal pattern and flux
(per gm) of lymphocyte migration. The brain has the lowest flux but even in this
case a very occasional labelled lymphocyte can be found in autoradiography after
transfusion of large numbers of tritium labelled lymphocytes (3). Recently the
idea that immune responses can be effective against allogeneic cells which are
present in what has been regarded as an immunologically privileged site has been
neatly supported by an experiment in which allogeneic lymphoma cells were inoculat¬
ed into the brains of either untreated recipient rats or recipients which had been
rendered tolerant to the alloantigens of the donor strain (30). Only the former
survived presumably by rejecting the lymphoma in the intracerebral site. This
suggests that even the very low grade traffic of lymphocytes into the brain can be
effective in eliminating antigenic cells.
b) Sites of inflammation
Large and small lymphocytes are present in cell-mediated immune (CMI) lesions.
Sometimes they are the predominant cell type in the cellular infiltrate but in the
particular case of allografts undergoing rejection they are usually a substantial
minority. The concentration of* recirculating lymphocytes in a tissue could increa¬
se because of an increased influx from the blood or because of prolonged or indefi¬
nite retention within the lesion. There is no doubt that lymphocytes enter CMI
lesions at an increased rate as has been shown by an increased localization of lab¬
elled cells injected i.v. (31) and an increased traffic of cells in the peripheral
lymphatic draining the lesion (32). The recirculating cells are probably retained
for a longer time and the subset of antigen specific cells are probably immobilized
indefinitely as shown most clearly using grafts of a sponge matrix impregnated
with allogeneic fibroblasts (33) .
Two observations suggest that lymphocytes may enter CMI lesions by the same mechan¬
ism as they selectively enter lymph-nodes 1) Endothelial cells in the small ven¬
ules within an adjuvant granuloma (32) or in peroxidase arthritis (34) are plump
with large nuclei resembling the high endothelium in the lymph-node paracortex 2)
Trypsin treatment of lymphocytes inhibits their migration into lymph-nodes and in-
flammed skin although entry into other sites including normal skin is unaffected
(31). The key to the increased rate of migration is thus an acquired change in the
functional properties of vascular endothelium but the stimulus to this change and
specifically whether a lymphokine is involved is completely unknown. Between 24
hours and 48 hours after grafting there is a spectacular increase in lymphocyte
traffic through an allografted sheep kidney greatly exceeding that through a syn¬
geneic graft (35) suggesting that "recognition factors" liberated following the
encounter between virgin lymphocytes and alloantigen may be able to influence vasc¬
ular endothelium. A lymphokine is by strict definition a product of a sensitized
T lymphocyte and is therefore an unlikely candidate in this situation.
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CONCLUSION
Although the kinetics of lymphocyte recirculation through different compartments
can now be described in some detail little is known of the factors which control
the process and may be responsible for alterations in disease. A deeper understa¬
nding of the controlling factors and development of the agents which affect the
distribution of lymphocytes may afford the possibility of manipulating immune res¬
ponses. The recent introduction of radiolabelling cells with ^^Indium-oxine (36,
37) may possibly be modified in order to follow the distribution of lymphocytes
in patients (12). Such a diagnostic tool would be an almost essential step in ach¬
ieving some practical means of influencing the fate of lymphocytes in patients.
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